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ABSTRACT 
Introduction: Great progress has been made to understand how cancer survivors transition 
from treatment to survivorship. However, few studies include the experiences ofunder-
served populations who often face significant disparities in cancer, primarily low-income 
Black and Hispanic survivors who encounter sub-optimal treatment and inadequate follow-
up care. This dissertation sought to address this gap by: 1) Exploring the transition 
experiences oflow-income Black and Hispanic cancer survivors, 2) Using the data to adapt 
a care coordination tool, called a survivorship care plan (SCP), and 3) Evaluating the 
usability of the SCP among colorectal cancer (CRC) survivors and healthcare providers. 
Methods: A qualitative interview study was conducted with 26 low-income Black and 
Hispanic cancer survivors recruited from Boston Medical Center and Boston Public 
Housing Developments. Interview topics discussed included perceptions of life after 
cancer treatment, difficulties and challenges, coping mechanisms, post-treatment resources 
and information, and communication with healthcare providers. Interviews were 
audiotaped, transcribed verbatim and analyzed using framework analysis. 
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Findings: Survivors reported several challenges to a successful transition, including poor 
relationships with primary care physicians, family obligations, cost of prescription 
medications and healthy foods, burden of follow-up appointments, and unaddressed mental 
health needs. Engagement in spiritual activities and social support were viewed as critical 
in transitioning to survivorship. Survivors reported wanting survivorship programs that 
reinforced the importance of follow-up visits, addressed their mental health, were delivered 
in their native language, and involved the family. 
Intervention: These findings were used to adapt an SCP for low-income CRC survivors. 
Eight CRC survivors, five primary care physicians, and 13 oncology providers participated 
in a Quality Improvement project. All thought the adapted SCP had the potential to be a 
valuable tool but expressed that the care plan needed improvements by providing concise 
clinical information, including more patient friendly medical terms, and focusing more on 
mental health. A final SCP was developed to reflect these changes. 
Conclusion: These fmdings illustrate that low-income Black and Hispanic cancer 
survivors have various unmet needs. The adapted SCP template for low-income colorectal 
cancer survivors attempted to address these needs by incorporating cultural and social 
factors important to this group. 
Vl 
TABLE OF CONTENTS 
ACKN"OWLEDGMENTS ............................................ ................................................ ... iv 
ABSTRACT ........................................................................................................................ v 
TABLE OF CONTENTS ............................................................................................... vii 
LIST OF TABLES .................................................................. ........................................... x 
LIST OF FIGURES .................................................................... ..................................... xi 
LIST OF APPENDICES .............................................................................................. .. xii 
LIST OF ABBREVIATIONS ....................................................................................... xiii 
INTRODUCTION .............................................................................................................. 1 
CHAPTER 1: BACKGROUND ON CANCER SURVIVORSHIP .............................. 8 
1. Defining Cancer Survivorship ....................................................................................... 9 
2. Burden of Cancer Survivorship .................................................................................... 9 
3. Survivorship Care Plans: How can they help cancer survivors? ................................ 15 
4. Issues in Survivorship Care ................................................................................... ...... 20 
5. Survivorship Care Plans: Challenges to Implementation ........................................... 23 
6. Survivorship Care Plans and Minorities ..................................................................... .27 
7. Journey Forward Survivorship Care Plan .................................................................... 29 
8. Gaps in the Research .................................................................................................... 30 
9. Theoretical Frameworks .............................................................................................. 31 
CHAPTER 2: QUALITATIVE STUDY ON SURVIVORSHIP EXPERIENCE. ..... 36 
1. Introduction to the Chapter .......................................................................................... 37 
2. Methods ........................................................................................................................ 38 
Vll 
A. Research Design ................................................................................................ 38 
B. Rationale for a Qualitative Approach ................................................................ 39 
C. Participant Selection .......................................................................................... 39 
D. Sample Size ....................................................................................................... 41 
E. Setting ................................................................................................................ 42 
F. Participant Recruitment Process ....................................................................... .43 
G. Data Collection Instruments .............................................................................. 45 
H. Interview Process .............................................................................................. 4 7 
I. Data Analysis ..................................................................................................... 48 
H. Ethical Considerations ...................................................................................... 52 
I. Credibility, Transferability, and Dependability ................................................. 53 
2. Results ......................................................................... .-................................................ 54 
A. Participant Characteristics ................................................................................. 54 
B. Themes and Concepts ........................................................................................ 57 
3. Summary ...................................................................................................................... 84 
CHAPTER 3: CREATING THE SURVIVORSillP CARE PLAN ............................ 91 
1. Introduction to the Chapter .................................................... ...................................... 92 
2. Methods ........................................................................................................................ 94 
A. Research Design ................................................................................................ 94 
B. Description ofPDSA Cycle at BMC ................................................................. 96 
C. Translating and Adapting the SCP for Hispanic Survivors ............................... 98 
D. Participant Selection ......................... ..... ........................................................... 99 
V111 
E. Sample Size ..................................................................................................... 1 01 
F. Participant Recruitment .. ................................................................................. 1 0 1 
G. Data Collection Instruments ............................................................................ I 02 
H. Interview Process ......................... ..... .. ..... ...................................................... . 1 04 
I. Data Analysis .................................................................................................... 1 06 
J. Ethical Considerations ...................................................................................... ! 07 
2. Results ........................................................................................................................ l07 
A. Participant Demographic Characteristics ...................................................... .. 1 07 
B. Findings from Quality Improvement Project .................................................. 113 
3. Summary .................................................................................................................... 133 
CHAPTER 4: IMPLEMENTING THE SURVIVORSHIP CARE PLAN AT 
BOSTON MEDICAL CENTER ................................................................................... l40 
1. Introduction .............. .......... ... ............................. .. ....................... .... ........ ................... l41 
2. Overview ofToolkit ..................................... .............................................................. l43 
3. Resources and Materials for Implementation ............................................... ............. 1 71 
CHAPTER 5: DISCUSSION & CONCLUSION ....................... ... .. ............................ l91 
APPENDICES ............ .................................................................................................... 204 
BillLIOGRAPHY ............................. ............................................ ................................. 274 
CURRICULUM VITAE ................................................................................................ 289 
lX 
LIST OF TABLES 
Table No. Title Page No. 
1 Demographic characteristics of cancer survivors who 56 
participated in interviews 
2 Findings from Interviews with Black and Hispanic 58 
Cancer Survivors 
3 PDSA Cycle for Survivorship Care Plan Project at 98 
Boston Medical Center 
4 Overview of Quality Improvement Project Data 103 
Collection Instruments 
5 Demographic characteristics of colon cancer survivors 109 
who participated in the Survivorship Care Plan Quality 
Improvement Project at Boston Medical Center 
6 Demographic characteristics of medical providers who 110 
participated in the Survivorship Care Plan Quality 
Improvement Project at Boston Medical Center 
7 Findings from QI Interviews with Survivors and 112 
Medical Providers 
8 Suggested Revisions to the Journey Forward 134 
Survivorship Care Plan Template for Colon Cancer 
9 Revisions to the Survivorship Care Plan Summary Page 137 
10 Elements of a Survivorship Care Plan Recommended 151 
by the Institute of Medicine 
11 Survivorship Care Plan Summary Page for Colorectal 157 
Cancer 
12 Adapted Journey Forward Survivorship Care Plan for 159 
Colorectal Cancer 
X 
LIST OF FIGURES 
Figure No. Title 
1 Ecosqcial Theory: Levels, Pathways, and Power 
2 Model for Improvement 
Xl 
Page No. 
32 
94 
LIST OF APPENDICES 
Appendix Title Page No. 
A Overview of Existing Survivorship Care Plans 205 
B Study Recruitment Flyer: English 206 
c Study Recruitment Flyer: Spanish 207 
D Screening Eligibility Form 208 
E Demographic form: English 210 
F Demographic form: Spanish 212 
G Interview Guide: English 214 
H Interview Guide: Spanish 219 
I Consent Form: English 225 
J Consent Form: Spanish 229 
K Survivorship Care Plan Summary Page: English 232 
L Survivorship Care Plan Summary Page: Spanish 234 
M Final Adapted Version of Journey Forward 236 
Survivorship Care Plan 
N Survivor Survey: English 241 
0 Survivor Survey: Spanish 242 
p Quality Improvement Interview Guide-Survivors 244 
(English) 
Q Quality Improvement Interview Guide-Survivors 249 
(Spanish) 
R Quality Improvement Interview Guide-Providers 254 
s Training Slides 259 
Xll 
ACOS 
ASCO 
BMC 
BUMC-IRB 
CSP 
CRC 
coc 
EMR 
10M 
NCCN 
QI 
PHH-PRC 
PCMH 
PRC 
PCP 
PDSA 
NCI 
RHA 
SCP 
SES 
LIST OF ABBREVIATIONS 
American College of Surgeons 
American Society of Clinical Oncology 
Boston Medical Center 
Boston University Medical Center Institutional Review Board 
Cancer Specialist Physicians 
Colorectal Cancer 
Commission on Cancer 
Electronic Medical Records 
Institute of Medicine 
National Comprehensive Cancer Network 
Quality Improvement 
Partners in Health and Housing Prevention Research Center 
Patient Centered Medical Homes 
Prevention Research Center 
Primary Care Provider 
Plan Do Study Act 
National Cancer Institute 
Resident Health Advocates 
Survivorship Care Plan 
Socioeconomic Status 
xm 
INTRODUCTION 
Statement of the Problem 
An estimated 1.6 million people are diagnosed with cancer each year in the United 
States. 1'2 A cancer diagnosis is often accompanied by intense cancer treatment and a host 
of medical, emotional, and practical consequences for the patient and family.3A The day 
cancer treatment ends, cancer patients face a new set of challenges as they transition from 
being a patient to being a survivor.5 These challenges include difficulties adjusting to life 
after cancer (e.g., reestablishing family roles), new health problems, secondary cancers, 
recurrence of disease, and psychological distress usually in the form of anxiety and 
depression. 5,6 Many of the consequences that cancer survivors experience after completing 
treatment can be prevented and managed with appropriate follow-up care.7 Unfortunately, 
survivors and their primary care providers rarely receive a clear plan from the oncology 
team about what to do post-treatment.5'8 Survivors are often left wondering: What' s going 
to happen next? Who will monitor their care after treatment? What support services are 
available to help address their survivorship needs75 Poor communication and coordination 
of survivorship care contributes to the physical, psychological, and social consequences 
that cancer survivor's experience after treatment. 
A report released by the Institute of Medicine (IOM) was the first to outline many 
of the issues that cancer survivor face. This report, From Cancer Patient to Cancer 
Survivor: Lost in Transition , found that there is no systematic process for moving cancer 
patients from treatment to survivorship care. 5 As a result, cancer survivors are said to be 
"lost in transition"5 as they lack awareness of their changed healthcare needs9, often feel 
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abandoned by their health care team5,10, and are unclear which medical provider (oncologist 
or primary care) is responsible for their follow-up care.U-13 This period of transition is 
also difficult for primary care providers (PCPs) caring for survivors. PCPs lack familiarity 
with survivorship care guidelines and thus feel unprepared to address the concerns of 
survivors. 14,15 Helping cancer survivors transition is also challenging due to the absence 
of evidence-based guidelines for follow-up, 16,17 limited physician training and education 
on survivorship issues, 18,19 and barriers to patient and provider communication.20,21 These 
findings have prompted the IOM and the President's Cancer Panel to recommend the use 
of Survivorship Care Plans (SCPs) to improve a cancer patient's transition to survivorship 
care and help avert some of the physical, psychological, and social consequences that 
persist or develop after treatment. 5 
A survivorship care plan is a hard copy or electronic document that contains 
information about a cancer survivor's treatment history and instructions for follow-up care, 
such as recommended cancer screening and surveillance tests.22,23 SCPs have been 
identified as a promising public health strategy to 1) optimize communication among the 
patient, primary care provider, oncologist, and other specialists about follow-up care,22,23 
2) improve patient knowledge of their long-term survivor needs,5,24 and 3) facilitate better 
coordination of care. 22 While there remains a lack of consensus on what information 
should be included in SCPs and how they should be delivered, 8,25 large scale 
implementation of SCPs is underway. In August of 2011, the American College of 
Surgeons (ACOS) issued new cancer accreditation standards requiring that all cancer 
survivors receive a survivorship care plan upon completion oftreatment.26 With these new 
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guidelines in place, all 1,500 ACOS accredited hospitals in the U.S.27 will be charged with 
developing and implementing a survivorship care plan by the year 2015.26 Despite this 
new recommendation, several barriers exist to the implementation ofSCPs including a lack 
of physician training on survivorship care planning, 19,28 lack of a standard template,28 time 
needed for preparation and delivery,29 and lack of reimbursement.29 Successful 
implementation of SCPs will require addressing these barriers as well as producing a plan 
that meets the needs of the diverse cancer survivor population. 
It has been well documented in the literature that survival is particularly difficult 
for minority cancer survivors.30,31 Low-income Black and Hispanic cancer survivors 
experience significant disparities in cancer care such as suboptimal treatment, 32 later stage 
cancer diagnosis,33- 36 and poorer cancer survival for many cancer sites compared to non-
Hispanic, Whites. 32 After completing cancer treatment, they also experience greater 
physical and psychosocial issues due to factors such as poor access to quality care, ability 
to pay, and cultural beliefs.32,37,38 Today, little is known about the use and acceptability of 
SCPs in this population.37,39 Studies that explore the use of SCPs have very little 
representation from low-income groups, racial and ethnic populations, and non-English 
speakers. 39,40 In the literature there are no reports of survivorship care plans that take into 
account factors that are important in minority populations such as personal beliefs and 
traditions, spirituality, and level of trust with medical providers. Survivorship care plans 
that incorporate the survivorship experience of Black and Hispanic cancer survivors can 
potentially reduce barriers in communication and improve coordination of care. 40 
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Understanding how minority cancer survivors' transition from treatment to 
survivorship is also an understudied area for research and intervention. There are countless 
questions that arise due to the lack of research. For example, how do low-income Black 
and Hispanic cancer survivors adjust to life after cancer treatment? How do they 
communicate with their health care team about their long-term health? What programs and 
information would facilitate their transition to survivorship? Studying the transition 
experiences oflow-income Black and Hispanic cancer survivors is important because these 
populations often face significant disparities and challenges in survivorship care that 
directly impact their long-term health and quality of life. The transition experiences of 
these diverse populations can help guide the development of interventions, which could 
ultimately reduce survivorship disparities, improve post-treatment survivorship care, and 
improve the quality of life for diverse cancer survivors. 
This dissertation aimed to respond to these 2 gaps in the literature. First, this 
dissertation explored the experiences of low-income Black and Hispanic cancer survivors 
as they transition from treatment to survivorship. An in-depth analysis of these transition 
experiences helped shape the adaptation of an SCP. Secondly, a Quality Improvement 
approach was used to evaluate the usability of an already existing SCP, called Journey 
Forward, among low-income colorectal cancer survivors at Boston Medical Center. 
Public Health Relevance of Dissertation Topic 
With recent mandates from the American College of Surgeons, most cancer 
treatment facilities in Massachusetts will be charged with providing survivorship care plans 
to their cancer patients.26 It is of utmost importance that the needs ofunderserved minority 
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populations be addressed and incorporated into these plans. This is of public health 
significance because survivorship disparities continue to exist among racial/ethnic 
populations and we continue to lag behind in our understanding of how Black and Hispanic 
cancer survivors perceive their transition experience to survivorship care. Such 
information is important for designing, implementing, and evaluating interventions and 
tools, such as survivorship care plans, that will address the cancer survivor's varying needs 
and reduce disparities in cancer care. 
Survivorship care plans will also assist with the coordination of care in Patient 
Centered Medical Homes (PCMH). A PCMH is a model of care designed to improve 
patient health outcomes and patient-physician communication.41 In a PCMH, every person 
has a primary care physician, care is coordinated, and providers work together to meet the 
needs of the patient.42,43 Such coordination is particularly critical for cancer survivors who 
are dealing with the complexities of a cancer diagnosis and are transitioning between 
different care settings such as oncology, primary care, and specialty care (e.g. , cardiology, 
physical therapy). A survivorship care plan can help coordinate care at the medical home 
by increasing communication among the entire team, engaging patients and family in their 
care, providing a set of standards for survivorship care, and enhancing the management of 
post-treatment needs among providers. This comes at a critical time as the Massachusetts 
Executive Office of Health and Human Services expects all primary care practices to 
become PCMH by the year 2015.44 
Purpose of the Study 
The purpose of the study was three-fold: 1) to explore the experiences of low-
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income Black and Hispanic cancer survivors as they transition from cancer treatment to 
survivorship care, 2) to use these data to adapt an existing survivorship care plan for low-
income survivors of colorectal cancer, and 3) to evaluate the usability of the adapted 
survivorship care plan among low-income colorectal cancer survivors, primary care 
physicians, and oncology health care providers at Boston Medical Center. 
The overarching public health question guiding this dissertation was: How can 
cancer-serving organizations create and use a survivorship care plan to best meet the 
survivorship needs oflow-income cancer survivors as they transition from active treatment 
to post-treatment survivorship care? 
The specific aims included: 
Specific Aim 1: To describe the experiences of low-income Black and Hispanic cancer 
survivors as they transition from active cancer treatment to post-treatment survivorship 
care. Specific questions that pertain to this aim include: 
• How do low-income Black and Hispanic cancer survivors perceive their life after 
cancer treatment? 
• What are the difficulties and challenges associated with the transition from active 
cancer treatment to survivorship? 
• What helps low-income Black and Hispanic cancer survivors cope with the 
transition from active cancer treatment to survivorship? 
• What do low-income Black and Hispanic cancer survivors describe as services, 
resources, and information that would facilitate their transition to survivorship? 
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• How do low-income Black and Hispanic cancer survivors perceive the role of the 
oncologist and primary care physician after they complete cancer treatment? 
Specific Aim 2: To adapt an existing survivorship care plan for low-income survivors of 
colorectal cancer. Specific questions that pertain to this aim include: 
• What topics/elements should be included in the survivorship care plan? 
• What should the content and format of the survivorship care plan look like? 
Specific Aim 3: To evaluate the usability ofthe adapted survivorship care plan for low-
income colorectal cancer survivors using a Quality Improvement Approach. Questions 
that pertain to this aim include: 
• How do survivors perceive the usefulness of the survivorship care plans m 
transitioning patients from treatment to survivorship care? 
• How do primary care providers and the oncology team perceive the usefulness of 
the survivorship care plans in transitioning patients from treatment to survivorship 
care? 
This dissertation addresses the above aims in five chapters. Chapter 1 serves as a literature 
review on cancer survivorship and presents the conceptual frameworks guiding this work. 
Chapter 2 presents the fmdings from the qualitative study among low-income Black and 
Hispanic cancer survivors. Chapter 3 focuses on the process of adapting the Journey 
Forward Survivorship Care Plan using a Quality Improvement approach. Chapter 4 
presents an implementation toolkit for the survivorship care plan at Boston Medical Center. 
Chapter 5 provides steps for future research and public health practice. 
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CHAPTER I: 
BACKGROUND ON CANCER SURVIVORSHIP 
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1. Defining Cancer Survivorship 
The definition of a cancer survivor varies, but most often a survivor is defmed as 
any person who has received a diagnosis of cancer.45 The number of cancer survivors has 
increased throughout the years due to improvements in the early detection and treatment 
of cancer.46 Today, an estimated 68% of adults in the U.S. are expected to live five years 
after diagnosis1 and the survivor population has now grown to an estimated 13.7 rnillion.47 
Of the 13.7 million cancer survivors, 64% were diagnosed five or more years ago_47 In 
Massachusetts (MA), there are an estimated 344,440 cancer survivors.47 Among the 
survivor population in MA, greater percentages are women (59%) than men (41 %). 48 Non-
Hispanic Whites account for 94% of the survivor population while African Americans and 
Hispanics account for 2.7% and 3.4%, respectively.48 More than half of cancer survivors 
are over the age 55 (72%) and have had breast, prostate, or colorectal cancer. 48 
While the term cancer survivor can be used to describe anyone who has been 
diagnosed with cancer, the National Cancer Institute (NCI) Office of Cancer Survivorship 
recommends that cancer survivorship be viewed as "a distinct phase in the cancer care 
trajectory between primary treatment and cancer recurrence or end oflife."5 Therefore, the 
remainder of this dissertation focuses on the phase of cancer care that occurs after treatment 
ends. 
2. Burden of Cancer Survivorship 
Cancer survivorship encompasses the physical, psychological, social, and financial 
aspects of the cancer experience. 5 It is only recently that cancer survivorship has made its 
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way to the public health agenda. In the past, the focus was mostly on the prevention, early 
detection, and control of cancer. As the focus shifts to include survivorship care, we have 
come to recognize that cancer survivors face a range of problems that persist well after 
treatment is complete and will need to be addressed during follow-up care. 
After completing treatment, approximately 80% of cancer survivors return to 
normal functioning within two years.49,50 However, a segment of the survivor population 
suffers from a range of long-term and late effects. 5° Long-term effects of cancer begin 
during treatment and continue after treatment ends while late effects develop years later. 51 
The extent to which these health effects are experienced by cancer survivors depends on a 
number of factors including cancer type, stage of the disease, treatment received, genetic 
predisposition, comorbidities, lifestyle behaviors, age, gender, and race/ethnicity. 5 The 
most common late and long-term effects of cancer can be categorized as physical, 
psychological, and social. Lifestyle behaviors and nonmedical needs, such as education 
about survivorship and employment discrimination, are also important to consider. 
Physical problems are often a result of the toxicity of cancer treatments. Common 
long-term physical effects among cancer survivors include chronic pain, fatigue, infertility, 
and sexual issues. 5° A study conducted by the University of Michigan found that 20% of 
cancer survivors experience chronic pain at least two years after being diagnosed with 
cancer. 52 It has also been reported that over 20% of cancer survivors experience chronic 
fatigue. 53 Fatigue has been shown to effect quality oflife, mood, and work productivity. 54 
Cancer survivors are also more likely to report physical limitations and being in fair or 
poor health compared to the general population. 55 
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Extensive literature also exists on the effects of treatment on infertility and sexual 
function. Infertility affects mostly young cancers survivors who are of reproductive age. 
There are an estimated one million cancer survivors in this age group and only about 50% 
have ever recalled receiving information about the risk of infertility. 56 Sexual problems are 
also persistent among women and men. Over 50% of women who are survivors of breast, 
colorectal, or gynecologic cancers experience post-treatment sexual problems such as loss 
of desire, vaginal dryness, and pain during intercourse. 57 Among men who are survivors 
of testicular and prostate cancer about 25% and 75% suffer from sexual dysfunction, 
respectively.57 
Compared to persons without a cancer diagnosis, cancer survivors are at greater 
risk for recurrence of disease, secondary cancers, and co morbid conditions. 58 In fact, 
approximately 16% of new cancers occur among individuals who have had a prior cancer 
history. 59 Cardiovascular disease, obesity, diabetes, musculoskeletal problems, 
lymphedema, and osteoporosis are also common and are a result of the cancer treatment 
received and survivors getting older.58,60 Weight gain and obesity are of particular concern 
as they increase the risk of secondary cancers and other chronic conditions like 
diabetes. 60,61 
While the negative effects of treatment are well documented, survivorship has also 
been known to lead to positive health effects. 62 Many cancer survivors report a healthier 
lifestyle after completing treatment. 60 This is often referred to as a "teachable moment" as 
survivors are more willing to adopt healthier behaviors in order to reduce their risk of a 
cancer recurrence. 6° Currently, 30%-60% of survivors report consuming a healthier diet63,64 
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while 27% report engaging in more physical activity after cancer.63,65 Although many 
cancer survivors engage in positive health behaviors, over time many stop being physically 
active and live sedentary lifestyles.66,67 This is partly attributed to barriers associated with 
a healthy lifestyle (e.g., availability and cost of healthy foods), confusion about the benefits 
of physical activity and nutrition, and lack of recommendations from physicians.66 Cancer 
survivors who are male, undereducated, and older are less likely to exercise and eat 
healthy.67 
Psychological issues associated with cancer survivorship include distress, anxiety, 
depression, fear of recurrence, and body image. 68 In the U.S., the prevalence of depression 
varies by cancer type from 33%-50% for pancreatic cancer survivors, 1.5%-46% for breast 
cancer survivors, and 11%-44% for lung cancer survivors.69 Factors that contribute to 
depression and poor psychological functioning among survivors include a history of 
depression, comorbid conditions, lack of social support, low socioeconomic status, and 
intensity of cancer treatment.67,70 Additionally, fear ofrecurrence71 '72 and body image is a 
major concern among survivors, especially in women.72,73 However, not all cancer 
survivors experience negative psychological effects, many experience positive 
psychological well-being including an improved view of the self/4 greater appreciation of 
life,75 increased self-confidence,75 stronger interpersonal relationships,75 and strengthened 
spirituality and relationship to God.67,76 
Social and practical issues such as changes in interpersonal relationships, 
employment discrimination, and information needs are common challenges reported by 
cancer survivors.68,77 Interpersonal relationships have been known to change as cancer 
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survivors feel disconnected from their partners, families, and friends. 77 In regards to 
employment, most cancer survivors return to work after treatment. However, an estimated 
16.8% of working-age survivors do not return because of physical, mental or emotional 
complications.55•78 Loss of employment and reduced hours at work are also important 
f h . ul . 79 issues among a subset o t e cancer survivor pop anon. 
There are also data to suggest that the survivorship experience is different for 
minority populations. Although the data is limited, the 2002 Institute of Medicine report, 
Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care found that 
racial and ethnic minorities receive poorer quality of care than non-Hispanic, Whites. 
Quality of care is lower even when insurance status, income level, age, and severity of 
disease are similar to other groups. 80-82 This report also found that racial and ethnic 
minorities have poorer cancer related health outcomes compared to Whites. 80-82 
Disparities exist in cancer outcomes along the entire cancer care continuum including 
prevention, screening, treatment, and survival. Specifically, African Americans have the 
highest cancer death rate of all racial and ethnic groups.83 Cancer deaths are 32% higher 
for Black men and 16% higher for Black women compared to Whites. 84 Differences in 
treatment are also well documented. For example, Blacks are 34% less likely to receive 
timely cancer treatment for stage III non-small cell lung cancer than Whites. 85•86 Black 
women are less likely to receive radiation therapy for breast cancer. 87 After completing 
treatment, African American survivors also report lower physical functioning and general 
health and greater role limitations than White survivors. 88 Because African Americans are 
often diagnosed at later stages of the disease and receive more aggressive treatment, studies 
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report that they may be at any increased risk for late and long term effects. 89 Surveillance 
for certain cancers, such as breast, have also been found to be lower among African 
American women. 90 
Hispanics are the fastest growing minority group in the U.S. representing 16.7% of 
the total population.91 For most cancers they have lower incidence and lower mortality 
rates than non-Hispanic, Whites.92 However, they are more likely to be diagnosed at later 
stages.93 Low screening participation for certain cancers, like colorectal cancer, is a 
contributing factor to advanced disease.94 Hispanics also experience disparities in 
treatment with women being less likely to receive radiation therapy for breast cancer. 88 
Hispanic survivors also less likely to receive pain medication for cancer treatment95 and to 
have lower health related quality of life.38•96 In one survey of colorectal cancer survivors, 
African Americans, Asians, Hispanics and non-English speaking survivors reported more 
problems with coordination of care.97•98 These groups were also more likely to report 
difficulties with knowledge of their cancer and treatment compared to White survivors. 
Data from the National Health Interview Survey (NHIS) has also found that African 
American and Hispanic survivors are at an increased risk of going without prescription 
medications due to cost. 99 
Socioeconomic status (SES) is clearly an important determinant of cancer 
disparities among these populations. Cancer patients with low levels of education and 
lower SES are less likely to have adequate access to care and to survive five years after 
diagnosis.89•100 They also experience later stage diagnosis, suboptimal treatment, and 
inadequate follow-up care.80•89•100 Blacks and Hispanics comprise the largest raciaVethnic 
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populations living in poverty. 101 Compared to 11% of Whites, 30% ofBlacks and 38% of 
Hispanics are living below the federal poverty line in MA. 102 Low socioeconomic status 
has been known to increase cancer risk factors such as obesity and tobacco use. 100 In fact, 
rates of obesity are higher among Black and Hispanic cancer survivors which may 
contribute to further complications and increase their risk of recurrent and secondary 
cancers.to3,l04 
Cancer disparities among Black and Hispanics are attributed to a number of factors 
including SES, racism, cultural beliefs and tradition, living near environmental hazards, 
lack of access to care, difficulties navigating the health care system, patient-provider 
communication, and mistrust of the health care system. 32 These are all important barriers 
to consider in transitioning low-income Black and Hispanic cancer patients to survivorship 
care. 
Because of the challenges associated with cancer survival and the disparities that 
exist among raciaVethnic populations, it is important to provide survivors with a tool they 
can use to make sense of their survivorship experience and help streamline their follow-up 
care. Survivorship care plans (SCPs) have been recommended as a possible strategy to 
guide follow-up care and improve the patient and primary care provider's knowledge of 
the disease and its consequences. 
3. Survivorship Care Plans: How Can They Help Cancer Survivors? 
A Survivorship Care Plan (SCP) is a written, personalized document that 
summarizes a survivor's cancer history and presents recommendations for follow-up 
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care.22•105 Recommendations for follow-up care may include the type and frequency of 
surveillance tests, lifestyle changes that reduce the risk of cancer, and education about 
follow-up tests and late and long-term effects oftreatment.5•106 The target audience for the 
SCP is both the patient and the primary care provider, as the PCP is typically responsible 
for monitoring the patient's late effects, providing psychosocial support, and managing 
their overall health. 5 
The public health and medical community has a vested interest in SCPs because 
cancer survivors are not getting the care they need after they complete treatment. This 
includes surveillance for recurrence, screening for late and long-term effects of treatment, 
management of cancer related symptoms, and psychosocial support.24 This is a result of a 
fragmented cancer care system, lack of evidence based guidelines for follow-up care, and 
poor communication between care providers. 5 However, if survivors and their primary 
care providers were given a blueprint of what needed to occur post-treatment and who was 
responsible for this care, there would be better coordination of care and many of the 
physical, psychological, and social consequences of cancer could be prevented or managed 
effectively.? The following are a few ways that SCPs can help facilitate care and improve 
survivor outcomes. 
First, the SCP may help address a cancer survivor' s psychosocial needs such as 
distress and worry about the cancer returning. 5•24 The end of treatment is a time for 
celebration. However, studies have found that cancer survivors experience distress over 
the cancer coming back, returning to work, and reestablishing their roles within the 
family.68 The SCP can help reduce feelings of distress by reassuring patients that these are 
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common concerns and issues among cancer survivors. The SCP can be used to provide 
survivors with educational information, outline coping strategies, and recommend 
interventions and programs, such as support groups. 
The SCP may also reduce a cancer survivor's perceived sense of abandonment from 
their cancer care team. While in treatment, cancer survivors establish a strong relationship 
with their care team. Once treatment is over, survivors see their oncology care team 
infrequently; this leads to a perceived sense of loss of support. Family support also 
diminishes as survivors are expected to return to their everyday lives. 5 The SCP can reduce 
these worries and concerns by clearly outlining a plan of care. The cancer care team will 
still be actively involved in the patient's care and will be monitoring their cancer closely 
for the next five to ten years. Additionally, the SCP can serve as a tool to educate family 
members and caregivers about the needs of survivors post-treatment and what they can do 
to assist them during this transition process. 24 
Secondly, the SCP may increase a survivor' s knowledge of their cancer and follow-
up needs so they can be better informed and empowered to take a greater role in their care. 
For example, even when patients receive verbal instructions about post-treatment care, they 
do not recall much of the information.24 At this point, survivors are overwhelmed and still 
trying to make sense of their cancer experience. They also lack awareness of their cancer 
treatment and their heightened risk for complications. 89 An SCP may educate survivors on 
possible symptoms related to their treatment and late and long term effects to watch out 
for. If survivors are aware of these symptoms and effects, they can report them to their 
providers in a timely manner, potentially leading to better management and earlier 
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detection of post-treatment complications. Additionally, some of the symptoms that 
patients experience after cancer are common and not a reason for alarm. By understanding 
which symptoms are important to report, anxiety and worry can be reduced. 
The SCP may also encourage survivors to take an active role in their care. After 
treatment, survivors often wonder what they can do to prevent their cancer from returning. 
An SCP may be a prime opportunity to promote positive behavioral and lifestyle changes 
(e.g., maintain a healthy weight) that can reduce a survivors risk of recurrence and 
secondary cancers. 66 The SCP can also promote adherence to follow-up test and routine 
surveillance by improving a patient's understanding of required tests, their purpose, and 
which provider is responsible for administering the tests. Cancer surveillance is important 
for detecting recurrence of disease and secondary cancers early. Compared to the general 
population, cancer survivors are more likely to receive cancer screening exams. 107 
However, adherence to surveillance varies with some survivors not getting recommended 
exams. 108,109 For some cancers, like colorectal, African Americans and populations with 
low socioeconomic status are also less likely to undergo surveillance tests such as 
colonoscopies. 109 Thus, communicating a schedule of follow-up tests to the patients that 
are based on the NCCN and ASCO guidelines could help ensure that survivors do not fall 
through the cracks. 
Thirdly, the SCP can help promote continuity of care and communication with the 
PCP.5,24 While undergoing cancer treatment, cancer patients rarely see their primary care 
physician. The oncology team takes care of the patient's cancer needs and all other medical 
conditions, including comorbid conditions. After cancer, patients are expected to transition 
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back to their PCP for their everyday health needs. At this point PCPs have not seen their 
patients for months and may not be familiar with the details of their treatment and what 
their role is in caring for survivors. In fact, PCPs lack confidence in their ability to provide 
survivorship care. In one study only 50-55% of primary care providers reported feeling 
comfortable providing follow-up care.U0 Primary care providers report that they are not 
familiar with cancer survivorship guidelines and recommendations for surveillance and 
lack information about the late effects oftreatment.22 Cancer survivors have also reported 
a lack of confidence in their PCP to address their survivorship needs including identifying 
late effects of treatment and symptom management. 111 
Limited communication between the oncology team and the PCP is also a 
contributing factor to poor coordination of care.13 Oncologists may periodically 
communicate via letters or electronic medical records, but a follow-up plan is rarely 
communicated. Studies have reported that poor communication between oncology 
specialists and PCPs can lead to over or underutilization of services. 103 For example, 
oncologist may perform one test and PCPs, not being aware that the test was performed, 
may replicate the test. As a result, some survivors are aggressively followed while other 
survivors are lost to follow-up. An SCP can help address this gap. Specifically, an SCP 
can facilitate care by assisting PCPs with the following: 
• Clearly listing the late and long-term effects of each treatment and providing 
screening and intervention/treatment recommendations. For example, breast 
radiation to the chest wall can increase a woman's risk of cardiac dysfunction. 
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If PCPs are told by oncologists that this is a possible late effect, they can be 
aware of signs and symptoms and screen for cardiac dysfunction.24 
• Increasing PCP awareness of the follow-up tests that survivors need and when 
they are scheduled. This way PCP can remind their patients to adhere to follow-
up tests.24 
• Increase PCP awareness of the signs and symptoms of possible recurrence so 
they monitor for these symptoms. 24 
• Clearly outline what needs to be done (e.g., surveillance, screening for other 
cancer types, lifestyle changes, psychosocial assessment) and who is 
responsible for that aspect of care. This could reduce duplication of services 
and ensure that survivors are not lost to follow-up. 24 
It is important to note that these are all possible benefits of SCPs. The impact of SCPs has 
yet to be tested. However, SCPs hold promise in improving survivor outcomes and 
improving how care is delivered to survivors. 
4. Issues in Survivorship Care 
How survivorship care is structured and delivered to cancer patients is important 
for transitioning them to long-term survivorship. As a result, it is important to examine the 
essential components of survivorship care and the challenges that occur in delivering this 
care to the growing population of survivors. The IOM has identified four essential 
components of survivorship care: "1) Prevention and surveillance of new or recurrent 
cancers, 2) Surveillance of the medical and psychosocial effects of cancer treatment, 3) 
Interventions to prevent or reduce the effects of cancer and its treatment, and 4) 
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Coordination of care among specialists and primary care providers."5 Survivorship care 
also includes health promotion strategies such as diet, exercise, and smoking cessation. 5 
The IOM recommends that all individuals who have completed treatment receive 
survivorship care. This care should be individualized and will vary for each survivor based 
on cancer type, stage of diagnosis, treatment received, comorbidities, and other factors. 
Survivorship care should be coordinated and delivered by cancer specialists, primary care 
providers, or both. 
Despite the importance of survivorship care, there is little guidance on how to help 
cancer patients transition to this phase of care. Transition is most commonly referred to as 
"a set of interactions necessary to go from one type of care to another." 112 The transition 
period from active treatment to survivorship care can be defmed as the period immediately 
following completion of treatment up to the first two to five years off treatment. 113 During 
this transition period, survivors not only experience the late and long term effects of 
treatment, but often experience significant issues in obtaining survivorship care. These 
issues include: 
• A .fragmented delivery system characterized by a lack of evidence-based follow-up 
guidelines, poor coordination of care between the primary care physician and 
cancer specialists, and lack of clarity on who is responsible for care. 5 
• Lack of Survivor Awareness of the Late Effects of Cancer and its Treatment: Upon 
completing treatment, cancer survivors should be aware of their risk for late effects 
of treatment and how to reduce those risks. Unfortunately, cancer survivors do not 
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routinely receive information about their treatment and what to expect after 
cancer.5•114 
• Barriers to Patient-Provider Communication: During the post-treatment period, 
the oncology provider focuses primarily on recurrence of disease and secondary 
cancers. However, less time is allotted to educating the patient on their long-term 
needs and addressing psychosocial issues. 114 More communication between the 
provider and patient on instructions for follow-up care is needed. 115 
• Lack of Provider Education and Training: Currently, medical providers do not 
receive formal training and education on how to care for cancer survivors. 5 As a 
result, these providers report feeling unprepared to address the concerns of 
survivors. 116 
• Lack of Survivorship Standards of Care: Evidence-based clinical guidelines are 
essential for follow-up care. However, evidence-based guidelines are only 
available for breast and colorectal cancers. 117 For many other types of cancers, 
consensus based guidelines are available through the National Comprehensive 
Cancer Network (NCCN). 117 The lack of evidence-based guidelines has led to 
survivors being followed differently. 103•117 Some guidelines are also available for 
the management of late effects of treatment (e.g., lymphedema, depression, and 
osteoporosis)118 and for health promotion (e.g., exercise and healthy diet).66 
However, these guidelines are not widely distributed to primary care providers who 
are often the ones responsible for preventive care and screening of the late and long 
term effects of treatment 5 
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• Physician to Physician Communication: During and after treatment, cancer 
patients see both the primary care physician and multiple cancer specialists (e.g., 
oncologist, surgeon, radiation oncologist). Assuring communication among these 
providers about a patient's cancer history and post-treatment needs is difficult and 
rarely occurs. 13 In fact, in one study only 28% of survivors reported that 
communication occurred frequently between their providers. 111 
No single solution will solve all the problems in the cancer care system. However, 
survivorship care plans have been presented as a possible strategy to facilitate a smooth 
and coordinated transition from cancer treatment to survivorship. 5 A survivorship care 
plan would address three of the barriers to a successful transition 1) patient knowledge of 
what to expect after treatment, 2) patient and provider communication, and 3) 
communication and coordination of care between oncology team and primary care 
physicians. 
5. Survivorship Care Plans: Challenges to Implementation 
The goal of an SCP is to improve continuity of care for survivors as they leave 
oncology care and are followed by primary care physicians. 119 Such a plan informs patients 
about what to expect in the future and facilitates referrals for resources and support 
services. 5 The need for an SCP has emerged from research indicating that patients receive 
little information about their post-treatment needs and a follow-up plan is rarely 
communicated to the patient and primary care provider. Therefore, after completing cancer 
treatment, the primary care physician and the patient should receive an SCP. 5 The IOM 
recommends the following core elements be included in the content of the SCP5: 
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Treatment Summary5 
• Specific tissue diagnosis and stage 
• Initial treatment plan and dates of treatment 
• Toxicities during treatment 
• Supplemental therapy (e.g., adjuvant therapy) 
Follow-Up Care5 
• Expected short and long-term effects of therapy 
• Late toxicity monitoring needed 
• Description of recommended cancer screening and other period testing and 
examinations 
• Who will take responsibility for survivorship care 
• Contact information of treating institutions and key individual providers 
• Psychosocial and vocational needs 
• Recommended preventive behaviors/interventions 
Despite the potential of SCPs to improve survivorship care, these plans have not been 
widely adopted in Massachusetts. In 2009, a study was conducted by the Massachusetts 
Comprehensive Cancer Control Coalition to assess the use of treatment summaries and 
survivorship care plans among cancer specialist physicians (CSPs) and primary care 
physicians (PCPs).28 A survey was mailed to 3,568 CSPs and PCPs of which 490 
responded. Among the CSPs who responded, 56% reported ( 42% of oncologist compared 
to 85% of radiation oncologist) that treatment summaries were developed while 14% 
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reported they prepared care plans. Only 54% of PCPs ever recalled receiving a treatment 
summary for a survivor. While this study did not assess the use of survivorship care plans 
among cancer survivors, data from the 2010 Behavioral Risk Factor Surveillance Survey 
(BRFSS) found that only 30% of cancer survivors received a written summary and 75% 
received verbal or written follow-up instructions.48 
There are significant issues to the implementation of SCPs in MA. The top three 
issues include lack of training, no standard template, and lack of reimbursement for the 
time it takes to complete each plan.28 Other obstacles include the time needed to complete 
the SCP and determining who is responsible for creating the plan. The absence of 
survivorship standards of care and evaluation data about their usefulness are also 
significant problems.29 Specifically, there is little evidence on the efficacy of survivorship 
care plans and how best to implement them. 22 
To date, only one study has measured the effect of SCPs on health outcomes. 
Grunfield et al. conducted a randomized trial among 408 patients with early stage breast 
cancer. 121 Two hundred eight patients were randomized to the usual care group while 200 
patients received an SCP along with brochures, supportive care resources, and follow-up 
guidelines. The study found that there were no differences on self-reported health 
outcomes, such as distress, patient satisfaction, and general health, between the group of 
breast cancer survivors randomized to receive an SCP and the usual care group. This study 
does not support the IOMs recommendation and premise that SCPs can improve patient 
outcomes. However, it is important to note that there were several limitations to this study. 
For example, the study was only conducted on women with early stage breast cancer. 
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Survivors of other cancer types were not included. 122•123 Additionally, this study was 
conducted in Canada where all cancer patients receive a discharge planning visit while 
primary care providers receive a discharge letter. 122•123 Therefore, the setting and practices 
may not be comparable to those in the U.S. 
Other studies have evaluated survivor and physician preferences regarding the 
content and delivery of SCPs. A study by Mayer et al. explored the use of five survivorship 
care plan templates among survivors and primary care providers.25 Of the five templates, 
survivors preferred the Journey Forward Survivorship Care Plan because it was well 
organized and the sections were clearly labeled. Survivors also reported wanting additional 
information on which provider to call for specific symptoms that develop post-treatment, 
local resources, and health promoting behaviors. The PCPs also preferred the Journey 
Forward Survivorship Care Plan but did not want health promotion or support resources 
included. Several other studies have also reported that primary care providers and 
oncologists support the use of a survivorship care plan. Primary care physicians want to 
know how to care for their patients post-treatment, including how to detect and manage the 
late effects oftreatment.22 Oncology providers also see the value in SCPs but are concerned 
about the challenges in developing and implementing them including the time, staff 
resources, and lack of compensation. 22 
It is evident that further research is needed to understand the delivery and impact 
of survivorship care plans, particularly among populations at risk for disparities. To date, 
much of the research is limited to non-Hispanic, Whites and breast cancer survivors.37 The 
few studies that have examined the use of SCPs among minority populations have found 
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they are too technical, contain too much medical jargon, and do not provide enough 
information on treatment side effects and self-care.20,39.4° Despite evidence that 
raciaVethnic disparities exist in screening rates, stage of diagnosis, treatment, and 
survival, 80 few studies have examined the transition to survivorship and how survivorship 
care plans can improve this phase of care. 
6. Survivorship Care Plans and Minorities 
Given the disparities in treatment and cancer outcomes for low-income Black and 
Hispanic cancer survivors, SCPs may be an important tool for addressing their specific 
needs and transitioning them to follow-up care. Unfortunately, few studies have explored 
the use and acceptability ofSCPs among diverse cancer survivors.39.4°,124 In one qualitative 
study conducted among minority breast cancer survivors, the women reviewed the 
American Society of Clinical Oncology (ASCO) SCP and thought it was too technical and 
did not contain enough resources and information on wellness. 40 In the same study, women 
also reported that they did not receive enough information on late effects of treatment, did 
not feel prepared for long-term survivorship, and wanted more information on psychosocial 
needs. Among Latino cancer survivors, one qualitative study explored the transition from 
pediatric to adult survivorship care among adolescents and young adults. This study found 
that family support is integral in obtaining and overcoming barriers to survivorship care. 125 
No other studies were found that looked at the content and delivery of SCPs for Latino 
cancer survivors and non-English speaking groups. 
Interestingly, Black and Hispanic cancer survivors are more likely to report 
receiving a treatment summary and follow-up care instructions than non-Hispanic, Whites. 
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Sabatino and colleagues used the 2010 National Health Interview Survey (NHIS) data to 
determine which characteristics were associated with the receipt of these plans. 126 Among 
a sample of 1,345 survivors who participated in the 2010 NHIS, 22% reported receiving 
both a treatment summary and follow-up care instructions. Survivors who were Black or 
Hispanic, between the ages of 50-64 years, had prostate or colorectal cancer, were 
diagnosed with the past five years, and had fair/poor health status were more likely to report 
getting a summary of their treatment and written instructions. Those who were of low 
socioeconomic status, age 80 and over, non-Hispanic White, and had low levels of 
education were less likely to receive an SCP. Jabson and Bowen reported similar 
findings. 127 After analyzing data from the BRFSS 2010 cancer survivorship module, it was 
found the Hispanic cancer survivors were more likely to report receiving a treatment 
summary. There were no differences for Black cancer survivors compared to Whites. 
Older cancer survivors, those who reported an annual income of less than $50,000, and 
those with less than a college education were also less likely to receive a treatment 
summary and written follow-up care instructions. 
It is not clear why Black and Hispanic cancer survivors are more likely to report 
receiving a written summary of their treatment and follow-up care instructions. One 
possible explanation is that these groups may have misinterpreted or did not fully 
understand the questions that were asked in the survey. It is also possible that Hispanic 
survivors were more likely to receive written instructions because their medical providers 
were concerned about language barriers and low levels of health literacy. A written 
summary may help clarify and reinforce verbal instructions provided by the care team. 
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Despite Blacks and Hispanics reporting higher receipt of care plans, more work needs to 
be done. Survivorship care plans need to be investigated among these populations because 
they may have the potential to reduce barriers in communication with medical providers, 
improve coordination of care, and increase adherence to follow-up. 
7. The Journey Forward Survivorship Care Plan 
The Journey Forward Survivorship Care Plan is one of four existing survivorship 
care plans available to cancer centers for use with patients completing active cancer 
treatment (Appendix A). The Journey Forward Survivorship Care Plan was developed by 
the UCLA Comprehensive Cancer Center, the National Coalition for Cancer Survivorship, 
WellPoint, and Genentech.9 It is available through a free downloadable software program 
that is installed on computers and can be used to personalize the care plan for each patient. 
Journey Forward is modeled after the American Society of Clinical Oncology SCP 
templates and is available for each major cancer site including colorectal, breast, prostate 
and lung. A toolkit for oncologists and patients is also available. The oncologist toolkit 
serves as an implementation guide and provides an overview of how to create SCPs for 
patients. The patient toolkit covers the benefits of SCPs and tips on talking with your 
doctors. Compared to the other three existing SCPs (Livestrong, Prescription for Living, 
and American Society for Clinical Oncology), the Journey Forward Survivorship Care Plan 
has been preferred by both patients and primary care providers due its simplicity, format, 
and content.25 As a result, the Journey Forward Survivorship Care Plan was chosen for 
adaptation in this dissertation project. 
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8. Gaps in the Research 
Survivorship research has grown in the past couple of decades but several gaps still 
remain. First, limited research exists on the experiences of low-income Blacks and 
Hispanics as they transition from the end of treatment to survivorship. 37 Very little is 
known about how they cope after completing cancer treatment; what are the challenges and 
concerns they face; how they communicate with their medical providers about follow-up 
care; and what services and programs would be helpful in their transition to survivorship. 
Much of the research has been conducted among breast cancer survivors, non-Hispanic 
Whites, English speakers, and survivors who tend to be middle class. More knowledge and 
research is needed to better understand how low-income Black and Hispanic survivors 
perceive their transition to survivorship in order to reduce disparities and facilitate a 
smoother transition. This is critical because minority cancer survivors face additional 
barriers to care and may need greater assistance with follow-up.32,80 
Secondly, survivorship care plans have not been adapted, tested, or studied among 
this growing population. Further research is needed to determine whether the content, 
format, and delivery of these plans are acceptable and meet the needs of this population. 39 
As previously mentioned, minority cancer survivors have found existing templates to 
contain too much medical jargon and not enough information on support services and 
psychosocial needs.40 Additionally, there is a dearth of information on how these plans 
should be delivered to survivors whose primary language is not English. This dissertation 
lays the foundation for addressing some of these research gaps by adapting the Journey 
Forward Survivorship Care for low-income colorectal cancer survivors at Boston Medical 
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Center and evaluating it' s usability through a Quality Improvement approach. An 
implementation toolkit, which includes strategies to deliver the plan to non-English 
speaking survivors, was also developed. 
9. Theoretical Frameworks 
Transitions Theory 
There are two theories guiding the work of this dissertation: the Transitions Theory 
and the Ecosocial Theory. The challenges that arise as a result of transitioning from cancer 
treatment to survivorship can be conceptualized through the Transitions Theory. The 
Transitions Theory, developed in 1991 by William Bridges, is a framework for navigating 
major life changes. 128 Transitioning from cancer treatment to survivorship is considered a 
major life change replete with challenges. 129 For example, many cancer survivors leave 
the comfort of their cancer care team only to experience confusion and a void as they 
transition back to mainstream life. The Transitions Theory provides a useful framework 
for understanding this transition through three stages: endings, the neutral zone, and 
beginnings. 128 
The ending stage implies that people need to let go of the past before they can 
embrace the transition to the new. 128,129 The ending stage is characterized by leaving what 
is most familiar to the person and this often results in a sense of loss, identity, and grief. 129 
For cancer survivors, the ending stage may signify a time for letting go of old relationships 
with the oncology team and shedding their old role as a cancer patient. 
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The second stage of the transition, the neutral zone, is a time of chaos and confusion 
where neither the new or old ways are working. 128,129 During this period, there is often 
times a lack of structure in survivorship care and many survivors feel lost and unaware of 
their needs. Cancer survivors enter the neutral zone when they begin to question their 
values, priorities, and who they are. They express that while they are no longer a cancer 
patient they have also not returned to a life of normalcy. 
In the beginning stage the survivor accepts the new situation and a new identity 
begins to emerge. 128,129 At this stage, life seems back in order and there is a new sense of 
purpose. The survivor, having gone through the first two stages, has now developed the 
skills, confidence, and a plan for moving forward. 
Ecosocial Theory 
The Transitions Theory provides a framework for understanding how survivors go 
through multiple stages in transitioning from active treatment to survivorship. However, it 
is important to recognize that this transition is subject to influences from multiple levels 
and that social inequalities can facilitate or hinder the transition. The Ecosocial Theory 
serves as a guide for understanding how racial/ethnic inequalities in survivorship arise from 
unfair or unjust conditions in the world we live. 130 Developed by Nancy Krieger, the 
Ecosocial Theory is concerned with the link between biology and society and how this 
interaction manifests in patterns of disease and social inequalities in health. 131 As 
illustrated in Figure 1, the Ecosocial theory has four core constructs. 
Figure 1: Ecosocial Theory: Levels, Pathways & Power 
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-Embodiment 
-Pathways of embodiment 
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& agency 
Source: Krieger, N. Proximal, distal, and the politics of causation: what' s level got to do with it? 
Am. J. Public Health 98, 221-230 (2008) 
(1) Embodiment refers to how we biologically integrate the physical and social world, 
throughout the course of our life. 132 For example, from an ecosocial perspective 
perceived racism among low-income Black and Hispanic cancer survivors could be 
embodied as stress, which could in turn lead to poorer health behaviors (e.g. , poor 
diet) and lower quality of life. 
(2) Pathways of embodiment refers to how there are multiple pathways to a given 
outcome via exposure to the physical, social, and biological world. 133 For example, 
greater economic deprivation among low-income Black and Hispanic cancer 
survivors is a pathway that can result in inadequate access to survivorship care, 
such as access to follow-up screening tests. 
(3) Cumulative interplay between exposure, susceptibility, and resistance refers to the 
interplay, at multiple levels and multiple domains, of these three factors. 134 For 
example, cancer survivors account for 16% of new cancer cases. 59 The risk of a 
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recurrence or secondary cancers among low-income Black and Hispanic cancer 
survivors is dependent upon their exposure, susceptibility and resistance along with 
societal influences at all levels (e.g. , individual, interpersonal, organizational). 
(4) Accountability and agency: refers to who and what is accountable for the 
inequalities that exist in health. 130 Among low-income Black and Hispanic cancer 
survivors, health disparities in survivorship are a result of multiple factors at all 
levels including cultural beliefs, socioeconomic status, and inadequate access to 
care. 
Both the Ecosocial and Transition Theories were used to formulate specific questions in 
the interview guide and to inform the analysis process in order to gain a better 
understanding of the transition experiences of low-income Black and Hispanic cancer 
survivors. 
10. Conclusion 
Low-income Black and Hispanic cancer survivors experience disparities in 
survivorship such as lower quality of life, lack of knowledge of cancer treatment received, 
and problems with coordination of care post-treatment. Disparities are attributed to a 
number of factors including languages barriers, cultural traditions and beliefs, limited 
access to care, lack of health insurance, and the burden of co-morbid conditions. These 
disparities may place low-income Black and Hispanic cancer survivors at greater risk for 
mortality and late and long-term effects of treatment. Survivorship care plans are now 
mandated by the Commission on Cancer to improve a patient's transition from treatment 
to survivorship and ultimately improve survivor outcomes. However, the acceptability and 
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usability of SCPs among low-income Black and Hispanic cancer survivors as well their 
transition experiences remains understudied. Furthermore, more research is needed to 
understand how best to meet the needs of this growing population through the 
implementation of SCPs and an exploration of their survivorship experience. 
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CHAPTER2: 
QUALITATIVE STUDY ON SURVIVORSHIP EXPERIENCE 
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1. Introduction to the Chapter 
The transition from active treatment to post-treatment survivorship care is a critical 
period in the life of cancer survivors. After completing primary cancer treatment, like 
chemotherapy, radiation, and surgery, most cancer survivors must transition from the 
oncology care setting and return their everyday lives and care of their primary care 
physician. During this transition period, survivors deal with many issues such as physical 
and psychosocial long-term effects and challenges to obtaining coordinated follow-up care. 
Great progress has been made to understand how survivors experience the transition 
from treatment to survivorship and to develop interventions and tools, such as survivorship 
care plans, to address their post-treatment needs. However, few studies take into account 
the experiences of diverse populations, such as survivors who are low-income, non-English 
speakers, and member of racial/ethnic populations. Low-income Black and Hispanic 
cancer survivors are one of these understudied populations. Studying the transition 
experiences oflow-income Black and Hispanic cancer survivors is important because these 
populations often face disparities and challenges to survivorship care. For example, 
compared to non-Hispanic Whites, low-income Black and Hispanic survivors often 
experience later stage cancer, differences in cancer treatment, poorer cancer related 
survival, and greater physical and psychosocial issues after treatment. Understanding how 
low-income Black and Hispanic survivors perceive and experience their transition from 
treatment to survivorship may provide valuable insight on survivorship care planning. 
This study aims to address this knowledge gap by gaining an in-depth 
understanding of the experiences of low-income Black and Hispanic cancer survivors 
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during the transition from treatment to survivorship. Specifically, how do they perceive 
their life after treatment? What are some of the ways they cope during this transition 
period? How do they communicate with their medical providers about their post-treatment 
needs? The data gathered from this qualitative study will be used to generate ideas about 
the survivorship issues that need to be addressed in the adapted Journey Forward 
Survivorship Care Plan. 
This chapter provides a detailed description of the methods and results of the 
qualitative study. First, a description of the research design, setting, participants, 
instrumentation, and methods for data analysis are included. Then the demographic 
characteristics of the participants and the themes and concepts generated from the in-depth 
interviews are presented. Lastly, the limitations of the study and implications for the 
adaptation and implementation of the Journey Forward Survivorship Care Plan are 
discussed. 
2. Methods 
Research Design 
This study was a cross-sectional, semi-structured, qualitative interview study with 
26 low-income Black and Hispanic cancer survivors recruited from the Boston Medical 
Center Cancer Care Center (BMC Cancer Care Center) and Boston Public Housing 
Developments. Study participants were asked to complete a demographic survey and 
participate in one-on-interviews to elicit data on the following topics: perceptions of life 
after cancer treatment, difficulties and challenges, coping mechanisms, post-treatment 
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resources and information, and communication barriers with cancer care providers and 
primary care physicians. 
Rationale for a Qualitative Approach 
Qualitative research is a method of inquiry that seeks to gam an m depth 
understanding of human behavior. 135 It is naturalistic, which means research occurs in the 
real world setting where participants experience the problem being studied. 135 Qualitative 
research methods were appropriate to use for this dissertation because feelings, thoughts, 
and intentions cannot be observed. Therefore, questions must be asked that will allow us 
to understand the beliefs, attitudes, emotions, and opinions from the point of view of the 
participants. 135 Additionally, the transition period from active treatment to survivorship 
care is a relatively new topic that has not been studied among low-income Black and 
Hispanic cancer survivors. As such, qualitative research is the best method for addressing 
unexplored areas ofinquiry. 135 
Participant Selection 
Because of the qualitative nature of this study, participants were selected through 
purposeful sampling. In purposeful sampling, information rich cases are selected in order 
to obtain in-depth information about an issue or problem there is little knowledge of. 135 
Purposeful sampling is not aimed at empirical generalizations. 135 Instead participants are 
selected because they provide useful information about the phenomena of interest. 135 There 
are various purposeful sampling techniques. The method used for this study was criterion 
sampling. Criterion sampling entails selecting participants that meet some predetermined 
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criteria for participation in the study. 135 Participants were eligible to participate in this study 
if they met the following inclusion criteria: 
1. Self-identified as Black or Hispanic 
2. Completed active cancer treatment (e.g., surgery, chemotherapy, and radiation) a 
minimum of 6 months prior to the interview 
3. Cancer was in remission (i.e., absence of disease) 
4. Diagnosed with cancer less than 5 years ago 
5. Spoke English or Spanish 
6. Were 18 years of age or older 
7. Self-identified as low-income 
Participants were excluded if: 
1. They failed or were unable to give informed consent. 
2. Completed treatment less than 6 months ago. These individuals recently 
completed treatment and may still be processing their cancer experience. 
3. Completed treatment more than 5 years ago. These individuals are entering long-
term survivorship and may not be able to recall their experiences, especially the 
period immediately following completion of active cancer treatment. 
These inclusion and exclusion criteria are consistent with the literature and studies 
examining the transition from cancer treatment to cancer survivorship. 
An effort was also made to recruit and interview at least 5 low-income Black and 
Hispanic colorectal cancer (CRC) survivors. The rationale for recruiting a greater number 
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of CRC survivors was that the Journey Forward Survivorship Care Plan adapted in Study 
2 was specifically for survivors of colorectal cancer. Therefore, it was important to capture 
the experiences of CRC survivors in the study. Cancer survivors were also selected to 
ensure diversity in terms of age, sex, stage of diagnosis, cancer type, and length of 
treatment. Although diversity was achieved for many of these areas, fewer males than 
females were interviewed. Only 3 males participated in the study. 
Sample Size 
In qualitative research, there is no exact rule for determining sample size. 135,136 
According to Patton, sample size is dependent on a number of factors including the purpose 
of the study, population being investigated, research inquiries posed, time and resources, 
and what is needed to ensure credibility. 135 Unlike quantitative methods, where statistical 
power and numerical data is important, qualitative inquiry is less concerned with numbers 
and a large sample size. 135 The goal of a qualitative study is not to generalize but to 
generate meaning and understanding of the participants' experiences. 135 Therefore, as a 
guiding principle for determining sample size, Lincoln and Guba' s recommendation for 
sampling until a point of saturation was reached was used. 137 Saturation occurs when "no 
new information or themes are observed across the data."138 One-on-one interviews were 
conducted until no new themes emerged. To ensure that no new themes were emerging, 
data collection and analysis occurred simultaneously. Data saturation for this study was 
reached at 26 interviews. 
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Setting 
Participants were recruited from two sites: 1) Boston Medical Center Cancer Care 
Center (BMC Cancer Care Center) and 2) Boston Public Housing Developments. Boston 
Medical Center (BMC) is the largest safety net hospital in New England treating over 2,400 
cancer patients each year. BMC serves as a tertiary care center for Boston HealthNet, an 
affiliate of 15 community health centers, serving mostly urban and multiethnic populations. 
BMC was purposefully selected as a study site because it serves a large minority, 
predominantly low income population. According to the BMC Cancer Registry, BMC 
treated 1,3 78 newly diagnosed patients between May of20 11-May 2012. Of these, patients 
who self-identified as Black represented 30% of newly diagnosed cancer patients while 
Hispanics comprised 12%. Additionally, over 70% of the patient population at BMC were 
underserved and working class. The demographics of the patient population at BMC made 
it an ideal site to recruit and study minority cancer survivors. The strong partnership 
between the Cancer Center at BMC and the Boston University School of Public Health 
also facilitated easy access to the cancer survivor population. 
Survivors were also recruited from Boston Public Housing Developments. Boston 
Public Housing Developments presented a unique opportunity to explore the needs of 
cancer survivors for the following reasons: 1) they house approximately 10% of the city's 
residents, 3) they represent a large number of racially and ethnically diverse populations 
(80% of residents are Black or Hispanic), 3) residents are oflow socioeconomic status and 
it is within this population where we may see the highest concentration of disparities and 
the need for survivorship care plans, and 4) they provide a feasible location for recruiting 
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survivors due to the presence and strong relationship of the Partners in Health and Housing 
Prevention Research Center (PHH-PRC) with the housing residents. The PRC is a four-
way partnership between the BU School of Public Health, the Community Committee for 
Health Promotion, Boston Housing Authority, and Boston Public Health Commission. 
Participant Recruitment Process 
Recruitment of participants at Boston Medical Center occurred through the 
survivorship staff at BMC. The survivorship staff approached cancer survivors at several 
different venues, including post-treatment visits, follow-up visits, and other clinical contact 
visits. They also used the electronic medical records to generate a list of cancer patients 
who met the eligibility criteria. Staff called patients to determine if they were interested in 
participating in the study. In particular, the Cancer Survivorship Program Coordinator was 
instrumental in recruiting survivors at support groups and other survivor events. The 
principal investigator also attended several support group meetings and survivorship 
programs to share information about the study and recruit participants. 
All potential participants were told about the study and provided with a recruitment 
flyer that contained the principal investigator's contact information (Appendix B and C). If 
the survivor was interested in participating, they could call the principal investigator or the 
staff at BMC asked permission to pass along their name and contact information. The 
survivors were then contacted and asked to complete a screening form via the telephone to 
determine eligibility (Appendix D). The eligibility screening form included 5 questions 
related to age, race/ethnicity, year of cancer diagnosis, type of cancer, and whether 
treatment was completed with the past 5 years. If eligible, an interview was scheduled. 
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Interviews took place at the patient's home or in private offices at the Boston University 
School of Public Health. 
Participants at the Boston Public Housing Developments were recruited by 
Resident Health Advocates (RHAs). RHAs are employees of the Boston University School 
of Public Health who promote health and well-being among housing residents and are 
themselves residents of the public housing developments. The RHAs placed recruitment 
flyers in mailboxes, hallways, and other public areas. They also approached residents at 
PHH-PRC health and dental screening events. If survivors were interested in participating 
in the study, there contact information was written down and shared with the principal 
investigator. Additionally, residents who previously completed a health assessment survey 
through the PHH-PRC "Project Heart" study and indicated they had cancer and would like 
to participate in future studies, were also contacted by telephone. 
Residents interested in participating also had the option of calling the principal 
investigator directly to schedule an interview. All participants were told about the purpose 
of the study and were screened for eligibility. If participants were eligible, an interview 
was scheduled. Because transportation barriers are common among housing residents, the 
interviews were conducted at the individual's home in the public housing development. 
All participants in the study received a $25 gift card for participating in the 
interview. Participants who traveled to BMC for the interview were offered reimbursement 
for bus fare or parking. 
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Data Collection Instruments 
There were two data collection instruments used in this study: 1) a short 
demographic form and 2) a semi-structured, open ended interview guide. To develop the 
demographic form, the literature was reviewed to determine what demographic 
characteristics were important to collect among cancer survivors. The fmal demographic 
form elicited information on race/ethnicity, gender, age, education level, marital status, 
employment status, type of cancer, number of times diagnosed with cancer, date of 
diagnosis, type of treatment received, and year treatment was completed (Appendix E). 
These demographic characteristics were commonly reported in survivor studies and were 
deemed important to include. 139 
A semi-structured, open-ended interview guide was also used to obtain information 
on the participant's experience transitioning to survivorship care. Compared to a structured 
interview guide where the interviewer cannot deviate from a set of questions, a semi-
structured interview guide provides flexibility so that other areas or issues that emerge 
during the interview can be explored. 135 The interview guide was developed in a series of 
steps. First, the literature on cancer survivorship was reviewed to determine what topic 
areas may be important to include in the interview guide. Specifically, articles were 
reviewed that focused on the transition from treatment to survivorship, disparities in the 
survivorship experience, barriers in the delivery of survivorship care, and survivorship 
programs and interventions. From the literature review, the following topic areas were 
considered to be important and were included in the interview guide: 
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• Experiences with the oncologist during the last visit 
• Provider and patient communication 
• Family support during the transition process 
• Barriers to obtaining follow-up care such as transportation, financial 
difficulties, and health insurance 
• Program and information needs during the survivorship phase of care 
After incorporating these topic areas in the interview guide, the second step taken was to 
create topic areas based on the Transitions Theory and Ecosocial Theory. These theories 
help us understand how survivors go through multiple stages in transitioning to 
survivorship and how social inequalities can facilitate or hinder this transition. Based on 
these theories the following topic domains were incorporated in the interview guide: 
inadequate health care, economic deprivation, social deprivation, toxic substance and 
hazardous conditions, targeted marketing of commodities, socially inflected trauma, and 
resistance to racial oppression. The interview guide also included topic domains, lead off 
questions, and probes. 
In the third step, interview and focus group guides were reviewed from studies that 
explored the transition from treatment to survivorship. These interview guides were used 
to generate ideas about possible topic areas and phrasing of questions. Specifically, topic 
areas and questions were adapted from 3 studies: Allen et al. 140, Kantsiper et al.,2° and 
Ashing-Giwa et al. 141 In the fourth step, the demographic form and interview guide were 
translated to Spanish and then back translated. The documents were than compared to the 
original to ensure validity of the translation. 142 Then in the final step, the English and 
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Spanish interview guides were reviewed with 4 low-income, Black and Hispanic cancer 
survivors (2 English speakers and 2 Spanish speakers) to obtain feedback on the 
appropriateness of the questions (e.g., wording) and overall interview process. Two of the 
survivors interviewed were Black and two Hispanic. One of the survivors was male. 
During the interview, the principal investigator elicited feedback on the wording of the 
questions and length of the interview. The principal investigator also wrote down notes 
on questions that survivors did not seem to understand and needed further clarity on. 
Based on the interviews with survivors, several changes were made to the interview 
guide. First, during the interviews the survivors kept referring back to their experiences 
during treatment versus the period immediately following treatment. As a result, the 
following verbiage was added to all the interview questions "think back to when you 
finished your cancer treatment." Secondly, additional probes were added to all the 
questions to elicit more data. Lastly, the following question was re-worded in the Spanish 
interview guide because both of the Hispanic cancer survivors interviewed expressed 
confusion about the wording: How do you think physical activity affects cancer for cancer 
survivors? Overall, however, the survivors reported that the interview questions were 
appropriate and clear. The survivors were pleased with the length of the interviews, which 
lasted less than 1 hour. The changes mentioned previously were incorporated in the 
interview guide and a final English and Spanish interview guide were produced (Appendix 
GandH). 
Interview Process 
At the time of the scheduled interview, participants read and signed an IRB 
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approved consent form. The consent form was available in English and Spanish (Appendix 
I and J). All participants received a signed copy of the consent form for their personal 
records and were reminded of their right to withdraw from the study at any time during the 
interview. Participants were also informed that the interview would be tape recorded but 
they would not be identified by name on the tape. All participants agreed to the interview 
being recorded. Participant questions regarding the study were answered prior to beginning 
the interview and a demographic form was also completed. 
Data Analysis 
The frrst step in analyzing the qualitative data was transcribing the interviews. 
Transcribing is the process of writing down, word for word, the contents of an interview 
that have been recorded. 143 All audio-recorded tapes were transcribed verbatim by a 
transcription company, a research assistant, and the principal investigator. Interviews in 
Spanish were also transcribed verbatim and translated to English. Once transcribed, all 
transcripts were uploaded to Nvivo; a qualitative research software program used for 
organizing, managing, and coding data. 
In the second step, analysis of the transcripts was carried out using Framework 
Analysis. Framework Analysis is an approach that was first developed for analyzing 
qualitative data in the area of applied policy research. In recent years, it has gained 
popularity in health related research and many other disciplines. 144 Framework Analysis 
was selected for this study because it provides a systematic way of analyzing the data by 
clearly outlining a series of stages used to make sense of the data and identify emerging 
themes and concepts. 145 The 5 stages in Framework Analysis are: 
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• Familiarization 
• Identification of a thematic framework 
• Indexing 
• Charting 
• Mapping and interpretation 
In the familiarization stage, the researcher becomes familiar with the data collected. 
The principal investigator in this study first became familiar with the data by conducting 
all ofthe interviews with the cancer survivors. By conducting the interviews, the principal 
investigator gained firsthand knowledge of the survivors' experiences. Secondly, the 
principal investigator transcribed 13 of the 26 interviews. Through this process, the 
principal investigator was able to become immersed in the data enabling her to identify 
emerging themes. For the remainder of the interviews transcribed by the transcription 
company and the research assistant, the principal investigator listened to the audiotapes 
while reading the transcripts. The principal investigator also read all the transcripts and 
summary notes at least 2 times in their entirety. While familiarizing herself with the data, 
the principal investigator kept a record of recurring issues and themes. 
In the second stage, a thematic framework for the data was developed. A thematic 
framework is a coding scheme developed from a priori issues identified in the 
familiarization stage and emerging issues identified in the raw data. 146 To develop the 
coding scheme, 4 transcripts were selected; 2 in English and 2 in Spanish. The transcripts 
were read multiple times by the principal investigator and important segments such as 
words, phrases, and ideas were underlined. A summary of these important segments was 
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written on the right hand margin of the text. The principal investigator then combined 
repeated ideas and larger themes to develop the code names. A code name is a word or 
short phrase that represents a theme found in the data. 147 These codes formed the basis of 
a code book. The code book consisted of the code name, full definition of the code, and 
examples. These 3 components are commonly included in codebooks developed for 
qualitative research. 147 
After completing the code book, a research assistant was trained to use the code book 
to code the interviews. Training included a discussion on qualitative research, the purpose 
ofthe study, and a review of the code names, definitions, examples, and non-examples. To 
ensure consistency in the coding and improve inter-rater reliability, the research assistant 
and principal investigator coded the same interview independently. Miles and Huberman's 
approach to calculate inter-rater reliability was used. Specifically, reliability was 
calculated as "the number of agreements divided by the total number of agreements + 
disagreement."147 Agreement was reached on 82 of the coded text and disagreement on 23; 
leading to a reliability of 78%. The principal investigator and research assistant compared 
their work and discussed the discrepancies in the coding. Once it was clear that both 
understood the coding scheme, a second interview was coded independently and a 91% 
inter-rater reliability was reached. A reliability of 90% or higher is considered important 
for ensuring maximum consistency in coding. 147 The interviews were then coded in the 
next stage: indexing. 
Indexing means going through the data and identifying sections of the text that 
correspond to that code. Nvivo Qualitative Software was used for indexing the data. While 
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indexing the data, if new codes emerged, they were added to the coding scheme, and the 
transcripts were reread and recoded. In the fourth stage, charting, the sections of the 
transcripts that were coded were lifted from the text and organized into charts ofthemes. 148 
Arranging the data by themes facilitated the interpretation of the data, which is the final 
stage in Framework Analysis. In the mapping and interpretation stage the principal 
investigator analyzed the data in the charts by looking for larger trends, concepts, and 
patterns. 
Data Analysis of Spanish Transcripts 
Thirteen of the 26 interviews were conducted in Spanish with Hispanic cancer 
survivors. Studies have shown that direct translation is not enough and several steps need 
to be taken to ensure that the meaning, context, and nuances of the participant interviews 
are captured. 150 This is particularly critical in qualitative data analysis because how a word 
or phrase is translated could to lead to significant problems when interpreting the data and 
reporting the results. 149•151 For example, the researcher can assign a different meaning to a 
survivor's experience based on an inadequate translation. As a result, the following steps 
were taken to analyze the Spanish interviews: 
1. Interviews conducted in Spanish were transcribed verbatim by a bilingual 
transcriber. 
2. Interviews were translated from Spanish to English by a bilingual transcriber. 
To ensure that all issues related to linguistic and cultural nuances were 
identified and addressed, the principal investigator reviewed all the 
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transcriptions. The principal investigator is native Spanish speaker and has 
taken several translation courses. 
3. Revisions were made to the transcripts to address any discrepancies that 
occurred in the English to Spanish translation. 
4. As described in the previous section, the transcripts were analyzed in English 
using Framework Analysis. The decision to analyze the transcripts in English 
comes from evidence indicating that if translated appropriately, no significant 
differences should be observed between the themes and concepts of interviews 
analyzed in the participant' s native language versus the researcher's primary 
language. 149 
Ethical Considerations 
Approval for this study was obtained from the Boston University Medical Center 
Institutional Review Board (BUMC IRB). After obtaining IRB approval, several steps 
were taken to ensure confidentiality and privacy of study participants. First, all the data 
was maintained in a secure building in a password-protected computer and in a locked file 
cabinet. This data included the consent forms, demographic surveys, field notes, audio 
recordings, and transcriptions. Only study personnel had access to this information. 
Secondly, no identifiers were recorded during the eligibility telephone screening or during 
the one-time interviews. There were also no identifying information included in interview 
materials including field notes, interview transcripts, demographic survey questions, or 
audio recordings. Thirdly, there was a possibility that participants would feel 
uncomfortable discussing certain questions or topics during the interview. To minimize 
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this distress, participants were informed that they could skip any questions they did not feel 
comfortable answering. Every caution was taken to ensure that participants felt 
comfortable during the interview, that the ethical guidelines outlined in the BUMC IRB 
were followed, and that the data were managed appropriately. 
Credibility, Transferability, and Dependability Measures 
Several strategies were used to enhance the credibility (internal validity), 
transferability (external validity), and dependability (reliability) of this study. First, 
credibility is the process by which the researcher seeks to establish that the results of the 
study are in fact credible or true. 135 To enhance credibility, the principal investigator 
engaged in reflexivity and triangulation with multiple analysts. 
Reflexivity is the process of engaging in self-awareness. 135 Reflexivity allows the 
researcher to explore the implications of their subjectivity and bias in the research 
process. 135 To accomplish this, after each interview, the principal investigator wrote a 
series of notes on what she was thinking, what she perceived, and what her biases were. 
The principal investigator attached these notes to all transcripts to increase her awareness 
of these biases. Additionally, she made sure to ask questions and use probes in the interview 
guide that were neutral. The principal investigator did not want to bias the questions by 
leading survivors towards negative answers. The principal investigator also used a strategy 
called triangulation with multiple analysts. During this process different investigators were 
involved in the analysis. 152 The principal investigator's adviser, who has extensive 
experience in qualitative research, was involved in the analysis of the data. Both analyzed 
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the data independently for themes and concepts and arrived at similar conclusions. This 
enhanced the credibility of the findings. 
Transferability refers to the extent to which the fmdings can be generalized or 
transferred to other populations or settings. 153 While we cannot generalize the findings to 
other populations and settings, we can enhance transferability by doing a thorough job of 
describing the research methods, settings, and biases inherent in the study. 135 Thus, the 
principal investigator addressed issues of transferability by providing a detailed description 
of the setting and population and engaging in reflexivity. 
Dependability is when the researcher accounts for changes that have occurred 
during the research process in order to ensure some reproducibility ofthe study. 135 In order 
to enhance dependability, the principal investigator kept an accurate record of the methods 
used in the study and any deviations that occurred. By providing a detailed description of 
the methods (e.g., setting, recruitment process) it enables future researchers to repeat the 
work and arrive at similar fmdings. 
3. Results 
In the next section, the demographic characteristics of the survivors and findings 
from the interviewers are presented. Examples of quotes from interviewees that exemplify 
each theme are also provided. 
Participant Characteristics 
A total of 26 survivors were interviewed for this study. The interviews were 
conducted in the language preferred by the participant; English or Spanish. Nine of the 26 
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interviews occurred at private offices at the BUSPH while 17 of the interviews took place 
at the participant's home. Interviews ranged from 31 minutes to 1 hour and 33 minutes in 
length. Nineteen of the survivors were recruited from Boston Medical Center and 7 were 
recruited at the Boston Public Housing Developments. Of these, 3 survivors were male and 
23 were females. Several attempts were made to recruit more males at Boston Medical 
Center. For example, the study was introduced to men at the prostate cancer support group. 
Additionally, the Cancer Survivorship Program Coordinator approached men at various 
survivor events and informed them of the study. Unfortunately, some men did not meet 
the eligibility criteria, others did not want to speak about their cancer experience, and others 
were simply not interested in participating. 
Thirteen of the survivors self-identified as Black/ African American while 13 self-
identified as Hispanic/Latina. The age of the participants ranged from 33 to 78 years old. 
All survivors self-identified as low-income with 23% reporting never having completed 
high school and 69% reporting being unemployed. The majority of participants were 
survivors ofbreast cancer (58%) followed by colorectal (19%), cervical (8%), lung (8%), 
and uterine cancer (8%). Seventy seven percent of survivors had been diagnosed with 
cancer once while 19% had been diagnosed twice and 4% diagnosed 3 times. Five 
survivors received only surgery, 1 survivor only chemotherapy, and 20 survivors received 
a combination of surgery, chemotherapy, and radiation. The demographic characteristics 
of the cancer survivors are presented in more detail in Table 1. 
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Table 1: Demographic Characteristics of Cancer Survivors who Participated in 
Interviews 
Characteristics Variables 
Gender Male 
Female 
Race/Ethnicity Black/ African American 
Hispanic/Latina 
Age <40 
40-49 
50-59 
60-69 
>70 
Type of Cancer* Breast 
Cervical 
Colorectal 
Lung 
Non-Hodgkins Lymphoma 
Ovarian 
Pancreatic 
Prostate 
Skin 
Throat 
Uterine 
# of Times diagnosed with cancer 1 
2 
3 
Date ofDiagnosis < 1 yr 
2 yrs ago 
3 yrs ago 
4 yrs ago 
5 yrs ago 
Treatment Received Surgery Only 
Chemotherapy Only 
Radiation Only 
Combination of Surgery, 
Chemotherapy and/or 
Radiation 
Recruitment Site Boston Public Housing 
Boston Medical Center 
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n (%) 
3 (12) 
23 (88) 
13 (50) 
13 (50) 
2 (8) 
6 (23) 
9 (34) 
7 (27) 
2 (8) 
15 (58) 
2 (8) 
5 (19) 
2 (8) 
1 (4) 
1 (4) 
1 (4) 
1 (4) 
1 (4) 
1 (4) 
2 (8) 
20 (77) 
5 (19) 
1 (4) 
1 (4) 
5 (19) 
10 (38) 
4 (16) 
6 (23) 
5 (19) 
1 (4) 
0 (0) 
20 (77) 
7 (27) 
19 (73) 
Marital Status 
Education 
Married/Domestic Partners 
Never Married 
Divorced 
Widow 
Less than high school 
High school or GED 
1-4 years at university/college 
Bachelor's degree 
Master' s degree 
6 (23) 
7 (27) 
10 (38) 
3 (12) 
6 (23) 
7 (27) 
9 (34) 
4 (16) 
0 
Employment Status Full Time 2 (8) 
Part Time 6 (23) 
Unemployed 18 (69) 
*Numbers do not add up to 100% because some patients were diagnosed with cancer multiple times. 
Findings from Interviews 
From the data, 5 themes emerged that together portray the experiences of low-
income Black and Hispanic cancer survivors. These themes are: 1) Processing the cancer 
experience, 2) Ideas about providers, 3) Issues with follow-up post-treatment, 4) Family 
interactions, and 5) Unmet needs during the process. The themes generated by the 
interviews were diverse and centered on interactions with the family, medical providers, 
and the health care system. These themes are listed in Table 2 and are described below. 
Theme 1: Processing the Cancer Experience 
Disbelief 
Many survivors described an initial period of disbelief after completing treatment. 
Survivors reported not believing their diagnosis; and finding it real. They often described 
the period immediately following treatment as a state of "limbo." It was after treatment 
that survivors began to process what they had been through and tried to accept the fact they 
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had cancer. For example, one survivor said, "In the first months [after treatment] .. .! had 
this disbelief still inside of me . . .I realized I had cancer. I needed to accept that I had it." 
Table 2. Findings from Interviews with Black and Hispanic Cancer Survivors 
Themes and Subthemes 
Processing the Cancer Experience 
• Initially, disbelief 
• Denial, doubt, and avoidance common 
• Strength comes eventually 
• Personal relationship with God 
Ideas about Providers 
• Oncology providers continue to be source of encouragement and counseling 
• Disconnected from primary care doctors 
• Language cited as a communication issue 
Issues with Follow-up Post Treatment 
• Confusion between primary care provider and oncologist roles is common 
• Follow-up visits are burdensome 
• Reducing risk is important but confusing 
• Coming to follow-up visits important but surveillance is "scary" 
• Fear of recurrence is common and important 
• Support groups helpful for some, not others 
• Becoming one's own advocate 
Family Interactions 
• Family critical for some 
• Others found family a burden 
• Others did not tell family 
Unmet Needs during the Process 
• Medical & Psychological 
• Legal 
• Financial 
• Knowledge 
• Hispanic specific information/resources 
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Survivors reported having a difficult time talking about their cancer experience 
post-treatment, even years later. They were relieved to have completed treatment, but 
emotionally, were still struggling to cope with the idea of cancer. 
I felt relief. I felt like oh my God. I am a very positive person, and I'm 
always thinking positively, so I felt like I was delivered. I was set free from 
this cancer. But I have a problem. Every time I talk about it . . . I have to cry. 
I don't know. It just. It stayed with me. So, I know God set me free, but 
still I can't. 
Survivors also commonly expressed feelings ofhappiness and joy. However, these 
feelings were coupled with feelings of shock, loneliness, and depression. 
I was happy [after treatment] . I was happy but I was also depressed because 
of what I went through. I know that the chemicals were still in my body ... it 
was six months that you had to go through that. .. so I was sort of like 
depressed. You know what I'm saying. 
Denial, Doubts, and A voidance Common 
Some survivors expressed doubts about being cancer free. One survivor stated, "I 
wonder if I'm really sick and they hiding this from me?" Even though the oncologist had 
assured them the cancer was gone, they were still concerned the cancer was present or had 
spread. This led survivors to question whether they would undergo cancer treatment again 
if diagnosed with a recurrence. 
My worry ... after I finished [treatment], I have always and I don't know 
when it' s going to go away, think that the cancer hasn' t been cured. And it 
worries me to think about the treatment that awaits me again or if I'm even 
going to take the treatment . . . That' s my biggest worry. 
Fear of the unknown, the burden of daily treatments, and the side effects experienced 
during radiation and chemotherapy were cited as major barriers to undergoing treatment a 
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second time. One survivor stated, "I didn't want to go for treatment because I was tired of 
going every day. I just didn't want to go. And I said, well I'm not going anywhere." 
Survivors described their cancer experience as a constant battle that led to skipping 
treatments and avoidance of going to the cancer center for medical appointments. 
I was happy [after treatment] .. . but it' s one of those things that you, 
especially when you already have your breast burnt, that you knew [going 
to radiation] was going to cause you more damage but at the same time you 
had to go to save your life. So, it was all mental. Real confusing. You get 
confused a lot. You feel bad that you have to go [to treatment], but don' t 
want to go. It' s like a battle. It is a battle, you have to convince yourself. 
Relationship with God 
Cancer was also viewed as a test from God. Survivors often cited several examples 
from the Bible such as the story of Job; a man whose character and faith in God was tested 
by Satan. 
There were a lot of things that happened at the same time .. . a lot of emotions 
together, but then I read .. . the story of Job. I said Lord, but if Job went 
through more than me, I am not going through anything, and if it is for me 
to forget You, forget it, I'm not going to leave You. I'll always be withY ou. 
That lifted me up. That gave me encouragement. And all the things that I 
went through, I went to them with the love of God. 
Survivors felt that God would give them the strength to overcome this test. God was seen 
as a source of support, not only during treatment, but also after treatment. They reported 
that if God allowed them to live past the cancer, it was for a higher purpose. God had a 
plan for their lives. One survivor said, "That's how come God don't want to take you 
now. God meant for you to be here. He got something for you to do." Prayer, attending 
church, and being a source of support for others in the church with a cancer diagnoses were 
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described as factors that contributed to the physical and emotional healing of their cancer 
experience. 
Strength Comes Eventually 
Most survivors reported that strength came eventually and from other parts of life. 
After treatment, they described having to "push" themselves to get up in the morning, go 
out, and begin establishing a "normal" routine again. Strength came from keeping 
themselves busy including returning to work, volunteering, walking, and attending 
survivor programs at the cancer center. 
I get out. I go out. When I feel like it I babysit my granddaughter in the 
daytime .. .I take the kids to the bus stop. This is something I do because I 
want to do it. It gives me a motivation to get out of the house instead of just 
sitting here and getting all depressed and teary-eyed and this, that, and the 
other. So, I am able to get out and do things for myself: go shopping and go 
to the mall. And if I don't buy nothing, just go to the mall, walk around and 
whatever. It's just good. 
Most survivors felt that if they remained inactive, they would continue to think about the 
cancer and feel depressed. To them, it was about keeping the mind preoccupied and away 
from negative thoughts. This was a learning process for many survivors. 
I was depressed a lot after the treatment ... I ended up back in the hospital 
for about a week. After that, I started going out and I kind of picked myself 
back up ... I got back into the swing of things. Of going out, going back to 
church, hanging out with some of my best girlfriends ... Then I started yoga, 
and then I got back into the zumba classes, and then I began to go back to 
the support classes and stuff. That's where I'm at right now so I am doing 
much better than I was. 
Survivors also reported that it was only after they started feeling better physically, such as 
their hair growing back, that they began to feel confident and positive, and to gain strength. 
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Many also indicated that the troubles of life prepared them for dealing with cancer and 
coping with the hardships of cancer post-treatment, whether these hardships were medical 
in nature or simply difficulties of life like fmancial problems. For example, many 
survivors reported taking care of family members who had cancer or had passed away from 
cancer. They described this as a hardship but also a blessing in disguise because they were 
familiar with cancer diagnosis and knew how to cope and deal with it internally. One 
survivor said, "She [mother] had cancer so I dealt with her. And as I was growing up as a 
kid my grandfather had stomach cancer. So, I dealt with that. So, I already know how to 
deal with that within." 
Strength after cancer also came out of necessity to move on quickly and focus on 
other issues, such as competing health problems and family issues. Some survivors 
expressed that they had new health problems, multiple health conditions, like diabetes and 
heart disease, and needed to focus their attention on those areas now that they were free of 
cancer. Some of the health problems were old while others were new and had developed 
after cancer. Other survivors reported they had many family problems, including their 
children suffering from mental health issues, physical disabilities, and substance abuse. 
They described having to recover quickly after cancer so they could address their children's 
needs. One survivor said "I get up because I have a girl in a wheelchair. I have to think not 
of me, but of her first ... But it's hard, really hard. I have to fight for my life, the life I have 
because I have a girl in a wheelchair, she needs me." 
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Theme 2: Ideas about Providers 
Oncology Providers Continue to be Source of Encouragement and Counseling 
During the transition to survivorship care, survivors not only spoke about 
processing their cancer experience, but also about managing their relationships with the 
medical providers. Many of the survivors expressed completely positive feelings for the 
oncologist that treated their cancer. Most described the oncologist as a source of advice, 
encouragement, and cheerful support. 
The last visit with the doctor was good because she always , from the 
beginning, gave me lots of support, emotionally ... There were people that 
helped me a lot ... My children and I were given much support and that's 
one of the things that helps people with cancer, is to not feel alone. 
Some talked about the oncology team as a family that was present when most 
needed, or a consistent source of encouragement to stay with the treatment. This generally 
positive review was extended to all of the oncologists, the nursing staff, the office staff, 
and generally everyone that the patient contacted. Most patients attributed some of their 
strength to the ability of the oncology teams to help them through the process. 
The nurse they gave to me was taking care of me like a daughter. And all 
the people, even the secretaries in the front, they are so kind .. . They help me 
a lot over there. They give me all the support I need. I was so weak. I was 
so sad. I was so confused. I used to cry every minute but they tried to 
console me. They tried to give me all the support. They give me, urn, social 
worker. She was so friendly. She help me a lot ... and I start to feel 
comfortable ... like I found a family over there. 
While some survivors expressed a sense oflosing a family after completing treatment, they 
were happy to be done and moving on to the next phase of care. One survivor stated, " It 
was like I was losing a family because I had begun to get so close to the radiologist, my 
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doctors ... but yet it was like, I'm finished. This part of my life is over so I can move on to 
something else." 
Survivors also felt that their relationship with the cancer care team had not changed 
after treatment. The only aspect of the relationship that changed was how frequently they 
were seeing their providers. Survivors continued to report a strong relationship with their 
oncologist post-treatment. They described their doctors as "always being there for them" 
and "reaching out to them." Survivors described being comfortable calling their providers 
anytime with questions or concerns. They even reported visiting their doctors and nurses 
occasionally just to say hello. 
I felt comfortable with them. I could talk to them, ask them questions, they 
would answer, and they gave me their phone numbers. Call me anytime. 
Talk to me. That was like a pillar, a cushion for me to know that if I had 
any questions anytime that I could call the medical doctor, the oncologist, 
or nurse. [The nurse], I could call her and really talk to her about how I'm 
feeling, and she would understand. 
Disconnected from Primary Care Doctors 
Unlike their relationship with the oncologists, survivors consistently reported a 
poor relationship with their primary care doctors. They expressed that it was difficult to 
forge a relationship because they were assigned a new PCP every year. Survivors noted 
that PCPs were often medical residents that left the practice after a few years. For many 
survivors, the PCP they had during their cancer treatment was different from the PCP they 
had post-treatment. This led to survivors feeling disconnected and not really cared for. 
I did have one [primary care doctor] that understood. Actually, they even 
called and everything. But they retired. Maybe that is what happened. That 
when I began treatment, when I was diagnosed with cancer, I had that 
doctor. That I saw that was worried for me. After, when that doctor left, I 
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have not seen that they are worried. Like they care, but they don't care, 
actually sometimes I call to make an appointment and I have to fight for 
them to take me. 
Some survivors indicated that they never speak with their PCP about their past cancer 
diagnosis. One survivor stated, "We haven't spoken about that [cancer]. Because when I 
visit her, we talk about other things." 
Survivors also described their relationship with the PCP as "not in good terms." 
They felt that PCPs were not personable and did not get to know their patients. They also 
felt rushed during medical visits and treated like a "number." When patients asked PCPs 
questions about their cancer related needs, the PCPs often referred them directly to their 
oncologist. 
I didn't [have a good relationship], because we had went through a little 
something something. I don't know if we was on good terms ... I felt that, 
with my primary care that she was just in and out ... she'll come in, only for 
a split second. Then it's like, when we wanna talk, I wanna ask a question, 
she says, that's what you got a specialist for. We wasn't great and on good 
terms. 
Survivors described wanting the PCPs to be more involved in their cancer care post-
treatment. One survivor said, "My primary care doc, I would like for her .. . now that she 
knows that I had cancer, to say to me .. .ifyou have any issues ... you can come and talk to 
me. We can sit down and talk about it." 
They also reported trusting their cancer care team more than the primary care 
doctor. One survivor stated, "Well I trust my oncologist, surgeon, and radiation oncologist 
more than the primary care doctor; Because, I have felt more protected. In other words, 
better taken care of." 
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Not all experiences with the PCPs were negative. Several survivors indicated that 
the PCPs were very concerned and worried about their cancer. They mentioned their PCPs 
checked up on them periodically during their treatment by making phone calls to their 
home. Some described the PCPs as "caring", "attentive" and "advocating for their needs." 
After completing treatment, some survivors also reported that PCPs would remind them of 
things they needed to do post-treatment. One survivor stated, "He try to relate all the needs 
to my cancer. He try to remind me, listen you need to do this because of that situation. 
You need to do that." 
Language Cited as a Communication Issue 
Both Black and Hispanic cancer survivors reported language as a communication 
problem. Survivors spoke Spanish, French, Cape Verde, and Haitian Creole and expressed 
frustration not being able to communicate in English. One survivor stated, "I felt frustrated 
because I felt like I needed to tell my doctor everything. But, I cannot. That's why I 
struggle to learn English so I can communicate as soon as possible with my doctor." 
These survivors also reported not feeling comfortable with interpreters. They felt 
the communication was lost between the patient and provider when an interpreter was 
present. One survivor stated, "We have lots of translators, there are a lot. But I don't really 
like the translators because you lose that communication with the doctor or nurse. You 
lose that." 
Other survivors felt that interpreters withheld important information from them. 
One survivor said, "Yes, there was an interpreter and all, but that didn't satisfy me .. . 
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because there were things she didn't tell me completely ... that's the trouble with the 
interpreters here, sometimes they say some things and don' t tell you the others." They also 
described the process as being impersonal, especially when phone translators were used. 
Survivors also felt that while language presented some problems with 
communication, they did not feel "left out" or "discriminated." They felt they were able 
to communicate with the oncologists and PCPs and that their medical needs were being 
taken care of, regardless of the language spoken. 
Well, speaking English is a problem for me. But I believe that at no time 
have I been discriminated against or been left out. It' s just that it's not the 
same talking to a doctor who doesn't speak Spanish. Now there has to be a 
person in the middle, which is an interpreter, to assist a person, so it's not 
the same as when I explain it you in the way I am explaining to you now. If 
you ask me in English, I will not answer anything. 
Theme 3: Issues with Follow-Up Post Treatment 
Confusion between Primary Care Provider and Oncologist Roles 
Most survivors reported difficulties with the post-treatment period. Often survivors 
would express confusion at the communication gaps between their oncology team and their 
primary care doctor in terms of information about treatment, follow-up care, or long term 
and late effects. Some were confident that there was no communication between their 
oncologist and PCP while others were unsure if communication occurred. 
To be honest with you, I don't think they talked. They probably sent e-
mails .. . But in my gut feeling, I don't feel that they ever really talked .. . I 
don't think they actually .. . said well, "X is finished now and this is what you 
need to look for. And if she comes in with this type of sign, they need to 
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get back in contact with me or you need to tell her boom, boom, boom, 
boom." I don't think they did. 
Survivors also reported being the ones to facilitate communication between the oncologist 
and PCP by requesting that information be sent directly to their providers. 
A main issues was confusion between the responsibilities of the oncology team 
versus the primary care team. Survivors reported going to the PCP with a problem and then 
being referred to the oncologist, who would then send them back to the PCP. 
They would communicate; the surgeon with the oncologist with the 
radiation oncologist. .. but not with the primary care doctor. But them two 
should speak ... so them two can decide ... how to proceed. Not send me here 
and there. I want the games to stop. 
They expressed wanting clear information about who to call and wanted this 
information to be communicated to all doctors, including specialists for other diseases. 
Survivors were also unsure what role, if any, the PCP played in their cancer care. 
One survivor said, "I honest to God thought that they [oncologists] would tell her [about 
the cancer] and send her reports and stuff... when I went back to her ... she was really 
upset .. .I said, what were you gonna do? I was already dealing with it. What were you 
gonna do?" 
Others indicated that when communication was positive and frequent between the 
two provider groups, it helped them to feel secure and comfortable. One survivor stated, "I 
think it's a good thing ... that everybody is on one accord. Everybody is on one page and 
everybody knows what your treatment plan is." 
Burden of Follow-Up Appointments 
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Another issue reported by survivors was the burden of follow-up appointments. 
Some survivors indicated that once treatment was over they were happy to never see the 
oncology team, the facility, or the entire cancer process again. They welcomed the ending 
of the often frightening and anxiety producing process of diagnosis and treatment, and 
moving to a reduced schedule of follow-up. 
Other cancer survivors, however, felt that once treatment was over, they wanted 
their medical appointments to be over as well. For some, follow-up appointments were 
seen a constant reminder of their prior cancer diagnosis when all they wanted to do was 
forget they had cancer and move on to the next stage of their lives. These feelings led some 
survivors to skip their follow-up appointments. 
I finished my treatment in 2011 .. .I finished my treatment and I left there. In 
July, I was supposed to go to the doctor .. .I didn' t go, it is going to be two 
years, one year of treatment and one year that I have not gone .. .I don't want 
to return. 
Follow-up visits were described as "tiresome" and a burden, especially because of 
the financial difficulties of getting to appointments. 
I was tired. I hate going to the hospitals ... , especially when I have to drive 
down there. I don't like driving that much. It kinda bothersome to me. 
Then, too, you have to pay that money to get outta there. Every time I go 
down there, every three months ... I'm on a fixed income. I don't have the 
money to be spending that for doctor visits and stuff like that. 
Survivors also reported wanting the follow-up visits to be less frequent. One survivor said, 
"She [oncologist] said ... just come back every 3 months. That was a problem. Every 3 
months I had to go back for follow-up appointments. I didn't like that. I was trying to rush 
it out to 6 months." 
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Only one survivor mourned the end of the reassuring contact with the oncologist 
and nursing staff, and described their last treatment visit as a frightening moment. They 
described feeling without a "place" or "horne" and needing reassurance from the cancer 
care team. 
It's been difficult adapting to the fact that I don't have cancer anymore. 
That I'm not going to the hospital. I always think I have an 
appointment ... Because after going so much, I got used to it. I got use to 
going to the hospital. Going to the clinic. That was my life, appointment, 
appointment, appointment ... Now I find myself without a place. You see, 
like if that was my salvation ... Like you leave there, and it's like, wow I'm 
being saved. Because you feel like every time you go there they are helping 
you get better. To remove the cancer. Or to improve your health, and now 
here you feel all alone. 
Reducing Risk is Important but Confusing 
For many survivors, changing behavior and reducing risk of future cancers was 
seen as important, but confusing. Confusion arose from not knowing how to reduce their 
risk and not understanding how changing behavior, like eating well and exercising, can 
reduce your risk of a cancer recurrence or secondary cancers. Survivors often mentioned 
that maintaining a healthy lifestyle was important for their general health, but it wasn't 
clear what effect that had on the cancer. One survivors mentioned, "I don't know how it 
[exercise] affects cancer. . .I don't have that information." Some survivors indicated that 
they had not changed anything to do with their health, although some said that they had 
made small changes or they were trying to do more healthy things, like eating right or 
taking care of stress. One survivor said, "I eat healthier. I eat vegetables. I cut down on 
my McDonald's intake." 
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Follow-Up Appointments Important but Surveillance is "Scary" 
Most survivors expressed that follow""UP visits were important to keep and helped 
with long term recovery. They talked about the importance of taking their medications, 
getting appropriate tests and scans, and not missing appointments. Survivors were also 
knowledgeable and well informed about their next appointment date and how often they 
should see their oncologists (e.g., every 3 months for the 1st year). However, they noted 
that routine surveillance scans and tests caused them fear and anxiety. 
When I had my test [colonoscopy], the technician, I talked to him. Oh I 
remember I was so nervous. I cried. They asked me why you cry. I said 
cause I'm so nervous, can you pray for me please? .. .! was so nervous. I 
remember the first time, I did my test. I needed to call my brother in Rhode 
Island so he can go with me to the hospital. And then, I asked the technician 
can you tell me what that say. He said, I can't tell you that but believe me, 
this test is going to be okay. Don't worry about it. And then I went home 
and I wait. 
Survivors were afraid that test results would show a cancer recurrence and some 
preferred not to know if the cancer had returned. Therefore, some survivors would 
intentionally miss their appointments. One survivor stated, "I had to go for a mammogram 
last week, but I kinda of like freaked out about it. I just got flashbacks from everything 
that I went through. I've been through a lot. And I freaked out and I didn't show up for 
the appointment." 
Fear of Recurrence 
For many, fear of recurrence was a regular part of post cancer functioning. One 
survivor described it as " ... something black that you have there. It's fear that just shows 
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up." Survivors thought about this constantly, and carried the thoughts with them without 
abatement across time. It was a regular and negative experience. 
The only worry that I had was will the cancer come back. I worried about 
that a lot. And even though I had the treatment, I worried. I think a lot of 
cancer patients worry about that because we know in our [support] group, a 
lot of our women have had it. Some [cancers] never came back. Some 
[cancers] came back different places. That worried me for a while. 
Any pain or discomfort was also automatically associated with a recurrence of 
cancer. One survivor stated, "Sometimes I get that feeling like something be hurting me. 
I get kinda scared. I wonder, because that' s how I find out about my cancer, by hurting." 
Additionally, some survivors felt that they were "prone" to cancer and that getting cancer 
again was inevitable. 
I know I'm prone to cancer ... I already figured that part out a long time. 
Cancer is in your body. It has to have something that triggers it off; no 
matter how you look at it. You can do all the exercise. You can do all the 
eating but something has to trigger it off. It's in the body no matter how you 
look at it. . .It's like prolonging the inevitable. 
Survivors reported that God and prayer were their main coping strategy. Others talked 
about support groups being instrumental in dealing with the fear of recurrence. 
I just got to the point and I just said, you know God, you know the lord. 
God said he wouldn't put no more on us than we could bear. So, therefore, 
let it go. Put it in God's hands. Live for today as if it was your last, and if 
the cancer should come back, deal with it when it comes. But right now, 
you are cancer free. Take the medication and go on and do what you gotta 
do. And that's been what I have been doing ever since. 
Support Groups Helpful for Some, Not Others 
Some survivors emphasized the importance of support groups in helping them 
transition to survivorship. Support groups offered at the hospital setting were described as 
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helpful and serving multiple purposes. Survivors saw support groups as an opportunity to 
"heal", "meet new people", and "learn from other's experiences." 
The truth is that in the support group ... I've felt better ... What I couldn't say 
before, I say it there. And I feel good talking to them. I know we are all, 
not all of us have the same problem. All cancers, but different types of 
cancer. But we all want to move ahead. 
Survivors also reported that it was during support groups meetings that they learned to 
advocate for themselves and learned what questions to ask their doctors. 
Because you'll hear some of the women in groups saying, "I'm not taking 
that." And, "If I have to take it, why am I taking this?" or "Why are you 
doing this test?" I never asked those questions. I just went with the flow. 
Now I know when I go into the doctor's office, if I am not comfortable with 
something, well, I'm not saying I am not going to take it, but I want to know 
the reason why I have to take it. What are the side effects behind it? If 
something else comes up, what are we going to do about this before we do 
anything else? What is your decision? 
Support groups also presented the opportunity to learn about post-treatment issues such as 
the risk for other types of cancers and late and long-term effects. Survivors reported that it 
was through listening to other survivors and information exchange that they learned about 
other cancers and side effects, like lymphedema. One survivors said, "Sometimes we don't 
know until we listen to other people's problems. Then we realize, hey listen, you can come 
up with that." 
For other survivors, especially Hispanics, the support groups were seen as positive 
but they did not take part in them. Survivors did not want to keep speaking about their 
experiences and remembering what they went through during treatment. They felt support 
groups were not helping them move on, instead they were reliving that scary period in their 
life over and over again. 
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Well, I'm not saying they are not good. What is not good is to be 
remembering every week what happened to you ... Instead of taking that out 
of your mind they are driving you crazy ... because you tell me, if you have 
something and you are healed ... and I am going to be pounding it every 
day, the same thing over and over and over again, you're never going to get 
out of that trauma. 
Instead of support groups, Hispanic survivors preferred programs and resources focused 
on improving your self-esteem, body-image, and mood. One survivor noted that after 
treatment she wanted programs that "lift you up and give you strength." 
Becoming One's Own Advocate 
Survivors reported that treatment and follow-up care became the motivator to 
become one's own advocate for appropriate and timely care. Survivors spoke about 
learning to speak up for what they needed, and having to ask for help from multiple people 
in their lives. Many described this process as growth oriented and positive; even though 
it was hard it was necessary. 
Nobody else explained anything. I just went with the flow. Whatever they 
told me to do that's what I did. Now I know that I have a voice and I am my 
own advocate. I know that if something is going on, I have a right to ask 
questions and not to leave the office and not allow them to just do anything 
they need to do because they are the doctors, but I have a right to say, "Wait 
a minute. What is this for? And why are you doing this?" instead of saying, 
"Okay, I'll just take the treatment and then I'll go home without any 
questions at all." 
At first, some survivors reported they felt it was disrespectful to ask their doctors questions 
or occasionally question their recommendations. However, survivors soon learned, 
through their interactions with other survivors and their lived experiences, that it was okay 
to ask questions and to actively engage in their care. 
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You know, I was a little wimp ... and I would be hearing these women saying 
oh, well you know you got to do this or you got to do that. Because I thought 
it was disrespectful, talking to the doctors like that. It wasn't that they were 
being disrespectful, they were actually concerned about what was going on 
with their own bodies. So if I should ever, anything; not only cancer, if 
anything in my life should come down I should have a say in it from now 
on. I'm not going to just be brushed and pushed to the side and just say, 
okay, okay, okay. 
Theme 4: Family Interactions 
Family Critical for Some 
The responses to questions about family support were mixed across the participants. 
Some participants reported very supportive family members. Often the remarkable family 
members were not only spouses or children, but family members once removed, like sister-
in- laws or cousins. These supportive family members were critical to the survivor's ability 
to get through the cancer experience and transition to survivorship. A few survivors moved 
in with family members during their cancer and remained living there until they were 
physically and mentally ready. Families were helpful in many areas including cooking, 
household chores, accompanying survivors to follow-up appointments, serving as 
interpreters, and being a source of comfort when survivors were due for surveillance tests. 
Oh, they were such a great help! Everybody in my family was reaching out 
to me ... they were saying positive words, kind words, to encourage me ... I 
had my father that at that point was dying from colon cancer was giving me 
strength ... I felt that I had my sister. She's a nurse ... I also have my next 
colonoscopy scheduled for next Thursday. I told my mom in advance I have 
a test on that day you need to go with me. She said okay. Every time I have 
a test I need to have somebody and I need to call my sister in Cape Verde. 
Family is a Burden 
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Other survivors expressed negative feelings about family support. Some indicated 
that their family members were often too busy to help them or listen to them. They 
reported that family members did not understand what they were going through and made 
them "sicker" rather than better. 
And as much as I feel like we've got a lot of family folks around. I don't 
mean to disrespect the family people, but sometimes I think they make you 
more sick than what you are. They make you feel bad about this and that 
and you know. Sometimes I don't think people heal properly because of all 
the heavy stuff that they got on them. 
Survivors reported that family members were an additional burden; often having to 
serve as caregivers for them while also trying to take care of themselves. One survivor 
stated, "Now here I am trying to take care of a sister, my older sister with Alzheimer's, and 
my brother that's blind ... [and] I'm in the middle doing what I have to for myself." Taking 
certain medications was also an issue for a few survivors due to substance abuse problems 
in their family. One survivor reported, "I refuse any kind of pain medication .. .I don't want 
nothing to be narcotic .. .! have issues in the family, and I couldn't be able to put 'em down 
nowhere, and I don't feel comfortable." 
Family support also seemed to diminish after treatment was complete. Survivors 
felt that their families lacked awareness of their post-treatment needs and indicated that 
they still needed family support after cancer; physically and emotionally. 
I say [to my family], It ain't over yet. I'm still on medication. They felt 
like after the treatment, the surgery . .. that I was complete. Everything was 
back to normal again. I say, No. It' s not back to normal because I can't do 
any lifting. Because of the swelling on the arm. I still need help doing some 
things, you know. Sometimes I need help. 
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Survivors also reported a lack of support from husbands, who often left them because of 
their cancer diagnosis. 
Did Not Tell Family about the Cancer 
Some survivors did not tell their family members, even those living in the same 
city, about their cancer diagnosis. Reasons for not telling their family members included 
not wanting to worry them, not having a strong relationship with them, and feeling that 
they were not going to be supportive. One survivor said, "There are certain things you 
can't tell you loved ones, your family and friends. Good thing about seeing a therapist, 
you sit there ... no one is going to criticize you or ridicule." 
Some survivors also reported that cancer was still considered taboo in their 
communities and therefore, preferred not to speak about it. One survivor indicated, "Well, 
for us Latinos, when we mention cancer, we saw it as a taboo, something big, as death ... 
because we weren't well oriented. They didn't teach us what cancer really means. We did 
not have information. We did not know anything about cancer." Other survivors, on the 
other hand, were empowered to speak to other cancer patients in their communities, 
especially through their churches, about their cancer experience and survival. They felt 
that by speaking to Black and Hispanic patients in their community, they could help 
demystify that cancer was a death sentence. 
Immigrants were also more likely to report not telling family members about their 
diagnosis. One survivor said, "I would have liked to have the support of my family. But I 
didn't have it. Unfortunately, my mom is in El Salvador. My sister too ... So, it's better 
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not to say anything." These survivors described their cancer expenence as lonely. 
However, regardless ofhowthey felt emotionally, they were incredibly grateful to the U.S. 
healthcare system and the doctors for the care they received. One survivor stated, "I give 
a million thanks to God, because it's an advantage to be in this country. I've had treatment. 
I've had the medicines. Ifl was in El Salvador, I probably would have died. Because from 
where do I find money to pay for treatment or a surgery?" 
Theme 5: Unmet Needs during the Process 
Medical & Psychological 
Many survivors had unmet needs after cancer. Those listed included both health 
related and non-health related. Financial, educational, and psychological needs were 
among the most common issues expressed in the interviews. In terms of medical and 
psychological concerns, survivors reported a host of complications post-treatment, 
including neuropathy, lymphedema, pain, tiredness, problems with sexual intimacy, 
infertility, trouble sleeping, and weight loss or weight gain. 
I thought once the treatment was over, that I was going to be okay. I didn't 
know how fatigued, not only fatigued during the treatment, but I was still 
just as fatigued after the treatments were over. . .I thought I was fixed, you 
know. [I thought] once they did that [treatment], it was all going to be over, 
but it takes time. 
Some survivors felt that some of these needs were not being addressed by their care 
team. They expressed that providers did not follow-up on the health issue or that the 
providers would give them the "run around" and never find a solution to the problem. 
I was a bit. .. concerned about ... sex ... my erection ... then I spoke with him, 
then he gave me a prescription for Cialis. I was taking them for some time 
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and I talked with him later on. I told him that they did not help me. I know 
that the surgery [caused this], I understand about the surgery, but then he 
gave me a pamphlet about a surgery, like prosthesis or something and that's 
where it ended. Since then I have had other visits but we have not spoken 
about this again. 
When their needs were not being addressed (e.g., changing prescription 
medications to reduce side effects), some survivors reported they stopped taking the 
medication. Survivors also reported that physicians did not inform them of the late and 
long-term effects of treatments. This led to unnecessary anxiety and emergency room 
visits. 
I went to the hospital needlessly ... because after ... I started having pains in 
this arm. And I didn't know what was going on. And so I went to the 
emergency because for three days I couldn't lift the arm ... but if somebody 
had told me that you would get pain from the lymph node then I would have 
known you don't go to the hospital for that .. .If you don't know what's going 
on with your body, and nobody tells you .. .it would have been helpful if 
they'd just said, these are some of the signs that you are going to get when 
you go home. So don't be alarmed that when you have these signs ... You 
don't have to get up and run to the emergency room because these are some 
of the signs that you are going to have. These are some of the things that 
you need to look out for, so if they do happen, be aware. 
Survivors also spoke about the importance of mental health. Mental health was 
viewed as important and sometimes more important than physical health. They expressed 
wanting referrals to "counselors" or "psychologist" but not being offered these services by 
the care team. They were told about the support groups but wanted more expert and one-
on-one support. Survivors also wanted mental health providers who spoke their own 
language, as it could facilitate better communication of feelings and concerns. 
[I wanted] a little more psychological help, because I feel like people who 
have finished treatment, there's something big that they still have inside of 
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them. The groups are good but it would be good to have a psychologist who 
speaks both languages. 
Knowledge 
Many survivors indicated that they felt in need of more knowledge and information 
about cancer. Survivors reported knowledge gaps in a variety of areas including: not 
knowing what cancer is, where it comes from, what the stage of the disease means, what 
their chances of recurrence are, what symptoms are considered normal and which are not, 
and how to prevent the cancer from returning. 
As for the lymphoma goes, I really would like to know what causes that. It 
just came up all of a sudden. I know that, when I was going to other 
hospitals, the doctor was looking at your blood. It's a blood disease. I'd 
like to know where it come from .... Maybe is it have something to do with 
when I fell? .. .l [would] just really like to know ... Why? I don't understand 
why. Where does it come from? 
Survivors also expressed confusion as to why they were experiencing late and long-term 
effects, if they were cancer free. One survivors said, "He [oncologist] said, it takes a 
while for that chemo to work out of your system, so all these little things that you're 
going through right now is what you're supposed to be going through. I'm like, Why? 
The cancer's out." 
The information and instructions provided to survivors post-treatment varied 
widely and included information on hormone therapy, follow-up appointment dates, 
surveillance, diet and exercise, and instructions on taking care of affected areas (e.g., 
radiation burns). Some survivors reported that their oncology team provided them with an 
assortment of reading materials and websites to look at and explore. However, survivors 
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wanted this information explained to them in person first. The pamphlets and reading 
materials could then serve as a supplement to the information provided by the physicians. 
What would have been helpful. . .is, if they sat down, and told you well this 
is what you're going through. And then ... then you' re going to experience 
this this [and] this. Even though they gave you a whole bunch of papers to 
read and what not. I didn't feel like reading no papers. 
Survivors also reported wanting this information in a language that was not replete with 
medical terminology. 
[I want providers] to take the time. Don't rush into thing, and don't be 
talking with all that terminology. If you talking to somebody and we talking 
to this person, explain to me what you're talking, because you talking about 
my body .. . I want to know. I don't want you to just say, okay? 
More importantly, survivors stressed wanting clear information about what to 
expect after cancer treatment and wanted this information to be tailored to their specific 
cancer. They spoke about wanting information on diet, exercise, symptoms to look out 
for, late effects, survival rates, and mental health. 
[I want] clear information of what to expect. Although we know that they 
aren't soothsayers that know what's going to happen. That they give me 
something in my hands. That I come out of the office with something in 
writing ... That I can understand what to expect after chemotherapy. After 
radiation. With my specific cancer. 
Survivors also acknowledged that the oncologists were very busy saving other people's 
lives, and therefore some of this information could occur in the form of classes or 
educational groups or be facilitated by patient navigators and social workers. 
You know what program would be good. I say this because ... some people 
think that the chemotherapy is a machine that shakes you and does stuff to 
you. We are not education that chemotherapy is something, is a medicine 
that comes in an IV. So, a class or educational group for survivors [would 
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be helpful]. 
Financial 
Financial issues were also a concern and included needing money for medical care 
and associated costs, and needing money for basic existence, like food and transportation. 
Some survivors reported that they did not have enough money to pay for their prescription 
medications and sometimes had to do without. 
If it gets too bad, where I can't pay for the medicine, then I weigh my option 
as [to] what I can get away with and what I can't. Then I pay for what helps 
me more ... My fmances have drastically changed a lot. That kinda weighs 
on me a lot. 
Cost and access to transportation were also a concern. Survivors reported having 
difficulties paying for parking (even at a reduced rate), gas, or the MBTA bus. Poor MBTA 
service in certain communities was also cited as a problem with survivor's spending 2 to 3 
hours trying to get to the cancer center for an appointment. 
Almost all survivors reported that food availability and cost of fruits and vegetables 
were an issue and were barriers to maintaining a healthy lifestyle. One survivor stated, 
"The only thing that keeps me from eating healthy is not being able to buy the food." For 
some, food pantries were also their main source of getting food. 
I go to the food pantries and two dollar bag trucks. I have to work it like 
that, being on a fixed income. I don't get much. I get like 54 dollars' worth 
of food stamps. This isn't how I like to live my life, but right now, I am in 
recovery of not only cancer but also schizophrenia. 
Finding housing and employment were also described as stressors that negatively impacted 
their emotional health. 
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Legal needs were mostly expressed among survivors that were immigrants. They 
spoke about the difficulties of applying for permanent residence and not having access to 
many government resources, such as assistance with housing and obtaining employment. 
This affected their overall mental health. One survivor said, "One thing is the physical and 
also the mental health. Being healthy. It's important to have that good mental health. It's 
difficult to maintain it. Because being an immigrant. Not having family. There's a lot." 
Two survivors also felt they were going to be discriminated at work and therefore, did not 
tell anyone about their cancer diagnosis. 
I felt, how can I tell you, bad. Because when you get that news you have 
cancer. .. how do I tell you, I'm not able to speak to anyone that I had 
surgery for cancer. Because, I don't feel well. I feel like they're going to 
discriminate me. 
Hispanic specific information/resources 
Hispanic survivors also expressed wanting programs in Spanish and specific to 
Latinos. They felt there were plenty of educational materials (e.g., pamphlets) available in 
their language. However, most of the survivor programs available were held in English. 
One survivor said, "Those programs there are more focused for people who speak English. 
There are almost no programs for people who speak Spanish. Anyway, there I needed a 
program that in reality I did not get." Specifically, survivors wanted Spanish speaking 
support groups and for these groups to be facilitated by providers (e.g., patient navigators, 
social workers) that spoke the language. One survivor also expressed how in an ideal world 
there would be a Latino clinic, where all the survivor resources and clinical information 
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was available in their language. Survivors also reported they would be more willing to 
attend survivor programs (e.g., Zumba, arts and crafts) if they understood English. 
I would like to go because a lady [from the cancer center] was calling me, 
but she mostly spoke English .. .! don't know what, maybe it's for exercises 
in the basement, like yoga. And another one that's like in Chinese. Tai Chi. 
And I don't understand, I only understand two or three words. But I don' t 
understand everything. And if there giving the instructions in English, then 
I'm not going to understand it. 
4. Summary 
This study supports prior fmdings that the transition from treatment to survivorship is 
challenging. Among Black and Hispanic cancer survivors interviewed, there were mixed 
emotions expressed about ending treatment and specifically ending regular contact with 
the oncology team. Some survivors indicated that once treatment was over they were 
happy to never see the oncology team, the cancer center facility, or the entire cancer process 
again. Survivors welcomed the ending of the often frightening and anxiety producing 
process of diagnosis and treatment, and moving to a reduced schedule of follow-up. Others 
mourned the end of the reassuring contact with the oncologist and nursing staff, and 
described their last treatment visit as a frightening moment. 
Many survivors reported difficulties with the post-treatment period. A main 
difficulty was the confusion between the responsibilities of the oncology team versus the 
primary care team. Often the survivor would express confusion at the communication gaps 
between providers in terms of information about treatment and follow-up care. Others 
would indicate that when communication was positive and frequent between the two 
provider groups, it helped them to feel secure and comfortable. For the most part, survivors 
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described the oncologist as source of advice, encouragement, and cheerful support. Some 
talked about the oncology team as a family that was present when most needed, or a 
consistent source of encouragement to stay with the treatment. Most patients attributed 
some of their strength post-treatment to the ability of the oncology teams to help them 
through the process. However, survivors reported a disconnect with primary care providers, 
who they rarely saw during their treatment. 
Some survivors also expressed that follow-up visits were important to keep and 
helped with long term recovery. However, many other expressed confusion about the 
purpose of these follow up visits. Many survivors indicated that they felt in need of more 
knowledge and information about cancer and that they were always at the mercy of their 
providers to explain and review this information with them. For many fear of recurrence 
was also a regular part of post cancer functioning. Survivors thought about it regularly and 
carried the thoughts with them without abatement across time. For some, fear of recurrence 
was a regular and negative experience. However, God and spiritual activities, such as 
prayer provided strength and comfort. 
Family dynamics was also critical in the transition to survivorship. Some survivors 
reported very supportive family members like spouses and children. These supportive 
family members were critical to the survivor' s ability to get through the cancer experience 
and move to survivorship. Others expressed negative feelings about family support. Some 
indicated that their family members were a burden and often too busy to help or listen to 
them. Others simply did not tell their family members, even those living in the same city, 
about their cancer diagnosis because of cultural taboos. 
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Many survivors also had unmet needs after their cancer experience. Those listed 
included both health related and non-health related needs. Financial issues were among 
the most common, including needing money for medical care and associated costs, and 
needing money for basic existence, like food and transportation. Survivors also reported 
that treatment and follow-up care became the motivator to become one's own advocate for 
appropriate and timely care. Survivors spoke about learning to speak up for what they 
needed, and having to ask for help from multiple people in their lives. Many described 
this process as growth oriented and positive; even though it was hard it was necessary. 
For many survivors, changing behavior and reducing risk of future cancers was also 
viewed as important but challenging. Some survivors indicated they had not changed 
anything to do with their health, while others said they had made small changes like eating 
healthier. For some, support groups offered at the hospital setting were seen as helpful. 
For others, it was seen as positive that such things existed but they did not take part in 
them. Instead they preferred programs that moved away from talking about cancer and 
focused on building self-esteem and good health mental. 
Implications for Survivorship Care Planning 
The primary focus of the interviews was to understand the experiences and 
challenges experienced by low-income Black and Hispanic cancer survivors as they 
transitioned from treatment to survivorship. This information was then used to identify 
gaps and needs that could be addressed by an SCP. After a thorough review of the findings, 
there were a number of areas that were important to consider when adapting the Journey 
Forward Survivorship Care Plan for low-income Black and Hispanic cancer survivors. 
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These areas are listed below: 
• Include purpose of follow-up visits in SCP and the importance of not missing 
appointments 
• Include strategies/interventions to reduce anxiety related to surveillance testing 
• Include strategies/interventions to reduce fear of recurrence 
• Facilitate assessment of distress and depression by PCP or oncologist 
• Facilitate referral to mental health services if needed 
• Outline specific action steps for survivors of what they need to do to reduce 
their risk of a recurrence and live a healthy life after treatment 
• Include information and resources on spirituality, financial, legal, and career 
• Include additional support services for immigrant survivors 
• Include section on family support. Section could include 2 to 3 basic items 
families can do to support someone after cancer. 
In terms of the delivery of the SCP, there were 4 important components to consider. First, 
survivors reported wanting written information about what to expect after cancer treatment 
in addition to wanting someone to review this information with them. Therefore, when 
delivering the SCP, it will be important to have the SCP already printed and readily 
available for the patient to review with cancer center staff. Secondly, survivors reported 
that post-treatment information could be delivered by someone other than the oncologist. 
This is important, considering that oncologists are limited on time and may not have the 
ability to sit with a patient and explain all the components of an SCP. Therefore, it may be 
acceptable for other cancer center staff members to deliver the SCP such as nurses and 
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patient navigators. Thirdly, survivors reported that they wanted their doctors to speak to 
them in laymen terms and not use a great deal of medical terminology. For this reason, the 
SCP will need to contain patient friendly terminology with limited clinical details. 
Fourthly, survivors reported wanting their PCPs to be involved in their care from the onset 
of their cancer diagnosis. The SCP will need to be designed to facilitate communication 
and partnership between the oncologist, PCP, and patient from the beginning of diagnosis 
through treatment and survivorship. Lastly, the SCP will need to consider the various 
languages spoken by Black and Hispanic cancer survivors and how best to deliver this 
information to non-English speaking patients. 
Limitations and Strengths 
There were several limitations in this study worth considering. First, the fmdings 
in this study may be generalizable to other populations and settings. Survivors who 
participated in this study were from Massachusetts; a state that has had universal health 
care coverage since 2006. The transition experiences of low-income Black and Hispanic 
survivors in MA may be completely different from survivors in other states who do not 
have access to health insurance and face additional barriers to care. Additionally, most of 
the survivors in this study were patients at Boston Medical Center. This is a hospital that 
serves predominantly minority populations and really gears their cancer care to address the 
needs of diverse populations. For example, in 2010 Boston Medical Center launched the 
Minority-Based Community Clinical Oncology Program to ensure that minority 
populations have access to cutting edge cancer clinical trials and the best medical care. 
Boston Medical Center also has a cancer survivorship program with several full time staff 
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members. They offer any array of programs that are culturally appropriate including a 
Spirituality Group and a Spanish speaking support group. Minority survivors in other 
cancer centers may not be exposed to such resources and programming and may have 
different needs as they transition from treatment to survivorship. Despite these limitations, 
it is important to note that qualitative research is not meant to be generalizable. The purpose 
is to gain an in-depth understanding of a particular phenomenon. Therefore, while the study 
findings may not apply to other low-income Black and Hispanic survivors or other 
survivors in general, they still provide some valuable information on the transition 
experiences of this group. 
A second limitation in this study was selection bias. The participants who agreed 
to take part in this study may have had more positive or negative experiences than survivors 
who chose not to take part in the study or were unable to be reached via the telephone. 
There is also the possibility of recall bias. Participants were asked questions that pertained 
to the period immediately following completion of treatment. It is possible that participants 
were not able to accurately recollect their past experiences. 
In spite ofthese limitations, this study also had several strengths. First, this is one 
of a few studies investigating the transition experiences of low-income Black and Hispanic 
cancer survivors and non-English speaking groups. This provides an important first step 
in understanding the transition needs ofunderserved populations post-treatment. Secondly, 
this study highlights some of the issues and areas that are important to consider when 
developing and delivering Survivorship Care Plans to low-income Black and Hispanic 
cancer survivors. These fmdings contribute to the limited literature available on 
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survivorship care plans and their use and acceptability among diverse cancer populations. 
Lastly, this study helped set the foundation for adapting the Journey Forward Survivorship 
Care Plan for low-income colorectal cancer survivors at Boston Medical Center. 
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CHAPTER3: 
CREATING THE SURVIVORSIDP CARE PLAN 
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1. Introduction to the Chapter 
A survivorship care plan (SCP) is recognized as an important tool for assisting 
cancer survivors in their transition from treatment to survivorship.24 One ofthe goals of an 
SCP is to help ensure that patients receive appropriate follow-up care by facilitating 
communication and shared coordination among oncologists and primary care providers. A 
second goal is to help reduce the stress and anxiety that cancer patients feel when they 
complete treatment and transition to survivorship. A third goal is to increase patient 
knowledge of their long term needs and the steps they need to follow to maintain a healthy 
life after cancer. Despite the potential of SCPs to facilitate care and ease the challenges 
associated with the transition to survivorship, they have not been designed with diverse 
cancer populations in mind. 
African Americans and ethnic minorities comprise 12% of the survivor population; 
yet, they are underrepresented in studies of survivorship care plans. 155 Low-income 
minority survivors are a unique group because they have lower levels of health literacy, 
lack knowledge of treatment received, experience poorer coordination of care, have 
competing demands, and have greater mistrust of medical providers. Studies exploring the 
use and acceptability of SCPs among minority survivors have also found that they contain 
too much medical terminology, are written at a grade level too high to understand, and do 
not take into account the cultural, social, and socioeconomic factors that are important to 
this group.39•40 Thus, research suggests that SCP templates that are currently available 
may not be appropriate for low-income minority populations. A well designed, culturally 
appropriate SCP is needed and may be an important tool for addressing their specific needs 
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and ensuring a successful transition to follow-up care. This study aims to address this gap 
by adapting an SCP template that will be appropriate for low-income colorectal cancer 
survivors at Boston Medical Center (BMC). 
At Boston Medical Center, colorectal cancer (CRC) is the 4th most commonly 
treated cancer. Although prostate, breast, and lung cancers are more common the focus on 
a survivorship care plan for colorectal cancer survivors stems from several reasons. First, 
there are significant disparities in rates of CRC surveillance among racial/ethnic survivors. 
Colorectal cancer surveillance rates have been found to be lower among non-White 
survivors and survivors of low SES. 109,156,157 Lack of surveillance could potentially lead to 
high mortality rates. In addition, low-income survivors are less likely to adhere to follow-
up care visits. 155 Secondly, up to 40% of CRC survivors suffer from a recurrence of the 
disease making it a priority to address their follow-up care needs. 158 Thirdly, CRC affects 
both men and women equally allowing for input on the SCP from both groups. Lastly, 
survivorship care should be based on evidence-based clinical guidelines. Currently, 
evidence-based guidelines for follow-up care only exist for colorectal and breast cancer. 
In the sections that follow, I describe the process that was undertaken to adapt an 
SCP for low-income colorectal cancer survivors at Boston Medical Center using a Quality 
Improvement (QI) approach. I also present the final suggested changes to the SCP. 
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2. Methods 
Research Design 
Quality Improvement (QI) methods were used to adapt the Journey Forward 
Survivorship Care Plan for low-income colorectal cancer patients. Quality Improvement 
has been defined as a systematic and continuous approach to improving the quality and 
performance of an organization and their services in order to improve the health of the 
community. 159 QI uses specific techniques and methods to improve quality, such as Lean 
and Six Sigma. 160 In public health, the Model for Improvement, illustrated in Figure 2, is 
the most widely used. 161 
----------
Figure 2: Model for Improvement 
Aim ___. l~ _______ w __ ha_t_ar_e_w_e_~~in~g_ro_a_c_oo_m~p_lis_h_? ______ ~ 
u 
Measure ____. How will we know that a change is an improvement? ~--------------~~------------~ 
Change What change can we make that will result in an Improvement? 
Source: After Langley, eta/. ( 1996) 
- --·---------
Source: Langley, G. J. et al. The improvement guide: a practical approach to enhancing 
organizational performance. (John Wiley & Sons, 2009) 
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The Model for Improvement, developed by the Institute for Healthcare 
Improvement in the 1990s, is a framework for testing and implementing changes on a small 
scale that can ultimately lead to improved processes and outcomes. 161 The model aims to 
make an improvement by asking three specific questions and using the Plan-Do-Study-Act 
(PDSA) Cycle. 162 The three questions are: 
• What are we trying to accomplish (Specific Aims)? 
• How will we know that a change is an improvement (Measures)? 
• What changes can we make that will result in improvement (Change 
Concept)? 
The first question, what are we trying to accomplish?, addresses what the problem 
or issue is that needs of fixing. The specific aim statement usually includes a description 
of the target population, measurable goals, and is time specific. For this QI study, the aim 
was to adapt the Journey Forward Survivorship Care Plan for low-income colorectal cancer 
survivors at Boston Medical Center in order to improve their transition to follow-up care. 
The second question, how will we know that a change is an improvement?, uses quantitative 
and qualitative measures to determine if improvements actually occurred as a result ofthe 
intervention or change that was implemented. In this study, qualitative methods were used 
to collect data on the usability of the hypothetical SCP appropriate for low-income CRC 
survivors. Specifically, in-depth interviews were conducted with survivors and providers 
and a brief survey was administered to survivors only. The last question, what changes 
can we make that will result in an improvement?, involves testing different ideas and 
interventions through the Plan-Do-Study-Act Cycle. The idea being tested was the Journey 
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Forward Survivorship Care Plan. 
The second component of the Method of Improvement is the PDSA Cycle. The 
purpose of the PDSA cycle is to test a new change (e.g., survivorship care plan) on a small 
scale using multiple rapid cycles.42 This allows QI teams to learn from each test, refine 
the change, and get the change ready for full implementation. 163 Specifically, there are 
four steps in the PDSA Cycle: 1) Plan, 2) Do, 3) Study, and 4) Act. 
The purpose of the Plan phase is to understand the root of the problem, develop a 
potential solution to address the problem, and develop a plan for testing it. In the Do phase 
the proposed plan is implemented and data is collected. The Study phase entails evaluating 
the data collected to determine if an improvement was made. The fmal step of the PDSA 
cycle is to Act. There are three alternatives in acting: 1) the cycle can be repeated in order 
to incorporate what was learned in the previous cycle, 2) the proposed solution can be 
abandoned and the team will return to the planning phase and develop a new solution, or 
3) if significant improvements were made and the goal was reached, the intervention can 
be implemented system wide. For this QI study, one PDSA cycle was conducted to evaluate 
the usability of the Journey Forward Survivorship Care Plan. In the future, it is 
recommended that a second PDSA cycle be conducted to test the implementation of the 
Journey Forward Survivorship Care Plan with low-income colorectal cancer survivors. 
Description of PDSA Cycle at BMC 
The Quality Improvement project at Boston Medical Center began with the 
Planning phase. During the Planning phase, meetings were held with several BMC Cancer 
Care Center staff members. This included the Director of Clinical Trials and Cancer 
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Support Services; the Interim Director of Radiation Oncology; the Manager of Clinical 
Trials and Cancer Support Services; and the Cancer Survivorship Program Coordinator. 
During the meetings, the team discussed how the survivorship care plan would be tested, 
recruitment strategies for survivors and providers, and methods for data collection. 
Additionally, a large group meeting was held with medical oncologists, radiation 
oncologists, surgeons, nurses, social workers, patient navigators, and cancer center 
administrators to introduce the SCP initiative and obtain their feedback and thoughts on 
the project. 
In preparation for the Do phase of the PDSA cycle, the Journey Forward 
Survivorship Care Plan template was adapted by adding a one page summary page for the 
patient. The fmding from the qualitative study in Chapter 2 and a review of the 
survivorship literature were used to inform the development of the summary page. 
Together, the summary page (Appendix K) and the Journey Forward Survivorship Care 
Plan template, comprised the adapted version of the survivorship care plan. 
In the Do phase of the PDSA Cycle, in-depth interviews were conducted with 26 
low-income colorectal cancer survivors, primary care physicians, and oncology health care 
providers. The goal of the in-depth interviews was to evaluate the usability of the adapted 
version of the Journey Forward SCP. In the Study phase, the qualitative data was analyzed 
using Framework Analysis. In the Act phase, final changes were made to the Journey 
Forward Survivorship Care Plan based on what was learned from the interviews. Table 3 
provides a summary of the PDSA Cycle for this QI Project. 
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Table 3: PDSA Cycle for Survivorship Care Plan Project at Boston Medical Center 
PDSACycle 1 
Plan The QI plan was discussed with the cancer center leadership staff. This included: 1) 
how the survivorship plan would be tested, 2) what the major steps were, 3) who 
would be involved, 4) recruitment of participants, and 5) methods for data 
collection. 
Do In-depth interviews were conducted with the following groups : 
• Low-income colorectal cancer survivors 
• Primary care physicians 
• Oncology health care _£roviders 
Study The qualitative data was analyzed and the results were studied. 
Act The survivorship care plan was refined based on what was learned from the test. 
Translating and Adapting the SCP for Hispanic Survivors 
A process called transcreation was used to translate and adapt the summary page of 
the SCP for Hispanic colorectal cancer survivors. Transcreation has been defmed as "the 
process of not only translating the text of written materials into another language, but also 
infusing culturally relevant context, photos, and themes."164 Transcreation has been used 
successfully in multiple public health projects. For example, the National Cancer Institute 
(NCI) engaged in the process of transcreation to adapt the Facing Forward: Life After 
Cancer Treatment booklet for Latino cancer survivors. 150 As part of this project, NCI 
recommended several major steps in transcreation. The transcreation approach developed 
by NCI was used as model for this QI project. 
The transcreation process began with the translation of the SCP by a certified 
professional translator of Spanish descent. Because there are differences in the Spanish 
language based on an individual' s country of origin, the SCP was also reviewed by two 
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native Spanish speakers of Puerto Rican and Ecuadorian descent. 164 The largest Hispanic 
groups in Massachusetts are Puerto Rican, Dominican, and Salvadorian. As a result, a 
diverse group of translators were used. 182 Any discrepancies in the translation were 
addressed by the three translators and a pre-final version was created. Latino colorectal 
cancer survivors were then recruited for the QI project. The appropriateness of the 
translation and usability of the SCP (e.g., informativeness, understandability, and 
readability) was evaluated among these Latino survivors through one-on-one interviews. 
Survivors were interviewed in Spanish and were asked a series of questions. For example, 
survivors were asked about their understanding of each of the components of the SCP and 
were asked for suggestions on items they did not understand. The data from the interviews 
was analyzed using framework analysis. Final changes were then made to the SCP to reflect 
the findings from the interviews. 
Participant Selection 
Colorectal Cancer Survivors 
Participants for this QI project were selected through purposeful sampling. 
Specifically, criterion sampling was the technique used to select individuals for 
participation in the in-depth interviews. This type of sampling is described in detail in 
Chapter 2. Survivors were eligible to participate in this project if they met the following 
inclusion criteria: 
1. Had been diagnosed with colorectal cancer at any stage 
2. Self-identified as low-income 
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3. Completed active cancer treatment (e.g., surgery, chemotherapy, and radiation) 
4. Cancer was in remission (i.e., absence of disease) 
5. Diagnosed with cancer less than 5 years ago 
6. Spoke English or Spanish 
7. Were 18 years of age or older 
Participants were excluded if: 
1. They failed or were unable to give informed consent. 
2. Completed treatment more than 5 years ago. These individuals are entering long-
term survivorship and their post-treatment needs might differ from survivors who 
are recently transitioning out of care. 
Participants in the QI project were a different set of survivors than the group of survivors 
in Study 1. Because the adapted SCP template would ultimately be given to all survivors 
of colorectal cancer at BMC, all races/ethnicities were eligible to participate in the QI 
project. However, efforts were made to recruit more Black and Hispanic cancer survivors 
in order to obtain input and feedback on the SCP from the minority survivorship 
experience. 
Primary Care Physicians and Oncology Health Care Providers 
Primary care physicians were eligible to participate if they were practicing PCPs at 
Boston Medical Center or one of the affiliated 15 Community Health Centers. Oncology 
health care providers were eligible to participate if they were directly involved in the care 
of the patients, were key decision makers at the cancer, or were involved with the 
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survivorship care program. Individuals who constituted part of the oncology care team 
included medical oncologists, radiation oncologists, surgeons, social workers, patient 
navigators, nurses, cancer center administrators, and survivorship staff. 
Sample Size 
Sampling in QI projects differs from sampling strategies in traditional research 
studies. In QI, sample size is not calculated or founded on data saturation. Based on the 
work of Lewis, Shewhart, and Deming the underlying assumption is that "just enough" 
data needs to be collected. 165.l66 Sample size in QI should be small and sequential and 
determined on past experience with the subject matter and QI projects. 165.l66 As a result, 
sample size was determined by estimating the number of interviews that would be needed 
to produce enough data. Sample size for this QI project was set at: 
• 10 interviews with low-income colorectal cancer survivors 
• 5 interviews with primary care physicians 
• 5 interviews with oncology health care providers 
This sample size was large enough to gain both detail and depth, and to make meaningful 
comparisons. 
Participant Recruitment 
Colorectal Cancer Survivors 
Recruitment of survivors at Boston Medical Center occurred through the 
survivorship staff at BMC. The survivorship staff, as well as patient navigators and nurses, 
approached cancer survivors for participation at several different venues, including post-
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treatment visits, follow-up visits, and other clinical contact visits. Survivors were told about 
the purpose of the interview, which was to obtain their opinions and perceptions on a new 
tool for cancer survivors called an SCP. If interested in participating in the QI project, 
BMC asked the survivor for permission to pass along their name and contact information. 
The survivors were then contacted and an interview was scheduled. Interviews took place 
at the patient's home or in private offices at the Boston University School of Public Health 
(BUSPH). All participants received a $25 gift card for participating in the interview. 
Primary Care Physicians and Oncology Health Care Providers 
To recruit primary care physicians and oncology health care providers, a list of 
providers was generated by the cancer center staff involved in the QI project. This list 
contained the names of 30 healthcare providers who played a critical role in survivorship 
care. Based on previous discussions with cancer center staff, it was deemed that email was 
the best approach to reaching providers. Therefore, all providers were emailed an 
invitation to participate in the QI project. Of the 30 providers contacted, 18 agreed to be 
interviewed. 
Data Collection Instruments 
There were three data collection instruments used in this QI project: 1) a short 
demographic form, 2) a semi-structured, open ended interview guide, and 3) a brief survey 
for survivors. Table 4 provides a summary of these instruments. 
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Table 4: Overview of Quality Improvement Project Data Collection Instruments 
Data 
Collection 
Instrument 
1 Demographic 
Form 
Purpose 
Designed to 
elicit survivor 
demographic 
data 
Domains 
• Race/ethnicity 
• Gender 
• Age 
• Education level 
• Marital status 
• Employment status 
• Type of cancer 
• Stage of cancer 
• Number of times diagnosed 
with cancer 
• Date of diagnosis 
• Type of Treatment received 
• Year treatment was 
completed 
2 Semi-structured Designed to Usability measures: 
open ended test the • Informativeness 
interview usability of the • Understandability 
guide25 adapted • Readability 
version of the 
Journey 
Forward 
Survivorship 
Care Plan 
No. of 
items 
12 
3 
3 Survivors 
Knowledge of 
Disease and 
Treatment 
Questionnaire* 
Designed to Knowledge on: 7 
assess • Stage of cancer 
survivors' • Symptoms to report 
perceived • Health risks 
knowledge of • Management of health risks 
their treatment • How to schedule follow-up 
and follow-up visits 
care. 
• Cancer doctor's contact 
information 
• Make an appointment with 
social worker or patient 
navi ator 
Administered by 
Interviewer 
Administered 
Interviewer 
administered 
Self-administered 
*Questionnaire adapted from the Breast Cancer Survivors Knowledge of Disease and Treatment 
Questionnaire developed by Carrie Stricker at the University of Pennsylvania 
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Questions in the interview guide were designed to evaluate the usability of the SCP. 
Usability is a construct comprised of the user's perceptions of product effectiveness, 
efficiency and satisfaction. 167- 169 Usability testing is typically conducted to determine 
whether information is necessary or useful, if the format is appropriate, and if the audience 
understands the message and information. To evaluate the usability of the SCP, the 
measures below were tested through specific interview questions. These three measures 
have been commonly used in other usability studies. 170,171 
• Informativeness: How informative was the information provided in the SCP? 
Was the information useful and helpful? Did the SCP contain information 
important for follow-up care? 
• Understandability: How understandable was the information in the SCP? Was the 
SCP easy or difficult to understand? Was the SCP written in a language that was 
well understood? 
• Readability: What did survivors and providers think about the format, length, 
layout, and organization of the SCP? 
Both the brief survey and interview guide were translated to Spanish for use with 
Spanish-speaking cancer survivors (Appendix 0 and Q). 
Interview Process 
Colorectal Cancer Survivors 
The interviews with CRC survivors were conducted in the language preferred by 
the participant; English or Spanish. At the time of the scheduled interview, participants 
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were told about the purpose of the QI project and were instructed to complete a short 
demographic form. After completing the form, participants were given a sample of the 
adapted Journey Forward Survivorship Care Plan; which included the original Journey 
Forward SCP for colon cancer and the Survivorship Care Plan Summary Page. All 
survivors were told that the SCP was based on a fictitious colorectal cancer survivor. 
Participants were given 5-l 0 minutes to review the SCP and summary page before the 
interview questions began. Participants were also informed that the interview would be 
recorded but they would not be identified by name on the tape. All participants agreed to 
the interview being recorded. After the interview was completed, survivors were given a 
brief survey to complete. 
Of the 8 interviews, 4 were conducted in Spanish. Because the Journey Forward 
Survivorship Care Plan is only available in English, it was still given to the survivors, but 
the information was verbally translated during the interview. This was done to reflect a 
real life scenario where an interpreter would sit with the patient and explain the information 
in the SCP. The interview questions were then asked in Spanish. 
Primary Care Physicians and Oncology Health Care Providers 
The interviews with primary care physicians and oncology health care providers 
took place at BMC or the community health centers. Three of the interviews were 
conducted via telephone due to the physicians' request. All providers were given the same 
sample of the Journey Forward Survivorship Care Plan and the Survivorship Care Plan 
Summary Page as survivors. Providers were also informed that the interview would be 
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tape recorded. Five interviews were not recorded because permission was not granted. 
Field notes were taken for the interviews that were not recorded. 
Data Analysis 
Data analysis began with the transcription of the interviews. All interviews were 
transcribed verbatim by a research assistant and myself. The interviews in Spanish were 
both translated and transcribed. Once transcribed, all transcripts were uploaded to Nvivo; 
a qualitative research software program. Framework Analysis was then used to analyze 
the data from the in-depth interviews with cancer survivors, PCPs, and oncology health 
care providers. As described in Chapter 2, Framework Analysis consists of 5 steps: 
Familiarization; Identification of a thematic framework; Indexing; Charting; and Mapping 
and Interpretation. During the familiarization stage, the PI became immersed in the data 
by conducting the interviews, listening to the audiotapes, and reading the transcripts at least 
2 times in their entirety. Through this process, recurring themes and concepts were 
identified. In the thematic framework and indexing stage, the research assistant and PI 
selected 3 transcripts and developed a codebook through line-by-line coding. After the 
codebook was finalized, all interviews were coded. As new codes emerged in the data, the 
final code book was refined and transcripts were recoded. In the charting stage the coded 
text was pulled from the transcripts and organized into charts. In the final stage of mapping 
and interpretation, themes across the data were identified in order to draw conclusions ad 
inferences about the SCP. 
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Ethical Considerations 
The Boston University Medical Campus Institutional Review Board (IRB) does not 
require approval for QI activities. Therefore, this QI project was not submitted to the IRB. 
However, several steps were taken to ensure confidentiality and privacy of survivors and 
providers. First, all the data was maintained in a secure building in a password-protected 
computer and in a locked file cabinet. This data included demographic surveys, audio 
recordings, and transcriptions. Only study personnel had access to this information. 
Secondly, no identifiers were recorded during the one-time interviews. There was also no 
identifying information included m interview materials including interview 
transcripts, demographic survey questions, or audio recordings. Lastly, all efforts were 
made to ensure that survivors and providers felt comfortable during the interviews. 
3. Results 
In the next section, the findings for the QI project are presented. The section begins 
with an overview of the demographic characteristics of the participants. Then the suggested 
revisions to the Journey Forward Survivorship Care Plan and Summary Page are presented. 
Examples of quotes from interviewees are also presented. 
Participant Characteristics 
Colorectal Cancer Survivors 
A total of eight low-income colorectal cancer survivors participated in this QI 
project. Initially, the goal was to recruit a sample of 10 survivors. Unfortunately, there 
were some difficulties during the recruitment process. First, cancer center staff were busy 
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during clinic hours and were unable to dedicate time to recruiting participants. Secondly, 
some participants were not eligible to participate because they were still undergoing cancer 
treatment. Thirdly, some participants were not interested in participating because of time 
constraints or not feeling comfortable providing feedback on the SCP. 
Five of the interviews occurred at the participant's home while three of the 
interviews occurred at private offices at the BUSPH. Interviews ranged from 33 minutes 
to 1 hour and 12 minutes in length. Of the 8 survivors interviewed, 2 self-identified as 
Black/African American, 2 as White, Non-Hispanic, and 4 as Hispanic. Four of the 
participants were male while 4 were female. The age of participants ranged from 46 to 72 
years old. The majority of survivors interviewed had been diagnosed with stage 2 (n=3) or 
stage 4 (n=2) colon cancer. Five had received chemotherapy and surgery while 3 had 
received a combination of chemotherapy, surgery, and radiation. Participants were 
predominantly unemployed (n=5), married (n=6), and reported completing at least a high 
school degree (n=4). The demographic characteristics of the cancer survivors are presented 
in more detail in Table 5. 
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Table 5: Demographic characteristics of colon cancer survivors who participated in the 
Survivorship Care Plan Quality Improvement Project at Boston Medical Center 
Characteristics Variables n (%) 
Gender Male 4 (50) 
Female 4 (50) 
Race/Ethnicity White Non-Hispanic 2 (25) 
Black/ African American 2 (25) 
Hispanic!Latino 4 (50) 
Age 40-49 2 (25) 
50-59 3 (38) 
60-69 2 (25) 
>70 1 (12) 
Date of Diagnosis < 1 yr 1 (12) 
2 yrs ago 0 
3 yrs ago 6 (75) 
4 yrs ago 1 (12) 
5 yrs ago 0 
Stage of Colon Cancer 1 1 (12) 
2 3 (38) 
3 0 
4 2 (25) 
Unknown 2 (25) 
Treatment Received Chemotherapy & Surgery 5 (63) 
Surgery, Chemotherapy, and 3 (38) 
Radiation 
Marital Status Married/Domestic Partners 6 (75) 
Never Married 0 (0) 
Divorced 2 (25) 
Education Less than high school 1 (12) 
High school or GED 4 (50) 
1-4 years at university/college 3 (38) 
Bachelor's degree 0 
Master' s degree 0 
Employment Status Full Time 1 (12) 
Part Time 2 (25) 
Unemployed 5 (63) 
*Numbers may not add up to 100% because the numbers were rounded to whole percentages. 
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Primary Care Physicians and Oncology Health Care Providers 
Five primary care physicians and 13 oncology health care providers agreed to 
participate in this QI project for a total of 18 participants. Interviews ranged from 20 
minutes to 1 hour and 33 minutes in length. Of the five PCPs, 3 were recruited from 
community health centers affiliated with BMC. All oncology health care providers were 
recruited from the BMC cancer center. Three were medical oncologists, one was a surgeon, 
and one a radiation oncologist. Others represented in the oncology team included nurse 
practitioners (n=4), patient navigators (n=3), and cancer center administrators (n=1). The 
providers' cancer specialties included breast, head and neck, colorectal, gastrointestinal, 
and genitourinary. The majority ofPCPs and oncology health care providers were females 
(n=16) and White, Non-Hispanic (n=16). The demographic characteristics of PCPs and 
oncology health care providers are presented in more detail in Table 6. 
Table 6: Demographic characteristics of medical providers who participated in the 
Survivorship Care Plan Quality Improvement Project at Boston Medical Center 
Characteristics 
Gender 
Race/Ethnicity 
Provider Type 
Variables 
Male 
Female 
White Non-Hispanic 
Black/ African American 
Hispanic/Latina 
Asian/PI 
Primary Care Physician 
Medical Oncologist 
Radiation Oncologist 
Surgeon 
Oncology Nurse Practitioner 
Patient Navigator 
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n (%) 
2 (11) 
16 (89) 
16 (89) 
0 
0 
2 (11) 
5 (27) 
3 (17) 
1 (6) 
1 (6) 
4 (22) 
3 (17) 
Provider Specialty 
Year of medical school 
graduation 
Cancer Center Administrator 
Adult Internal Medicine 
Family Medicine 
Breast 
Colon 
Gastrointestinal 
Genitourinary 
Head & Neck 
None/Not Applicable 
<1979 
1980-1990 
1991-2000 
>2000 
Not Applicable 
1 (6) 
1 (6) 
2 (11) 
5 (28) 
2 (11) 
1 (6) 
1 (6) 
2 (11) 
4 (22) 
1 (6) 
2 (11) 
3 (17) 
4 (22) 
8 (44) 
Practice Site Boston Medical Center 15 (83) 
BMC Affiliated Community Health Center 3 ( 17) 
*Numbers may not add up to 100% because the numbers were rounded to whole percentages. 
Findings of QI Project 
Findings from the QI project are organized into 6 major themes: 1) Medical 
terminology difficult to understand and geared towards oncologists, 2) Follow-Up Care 
Plan does not meet information needs, 3) Summary page "alone" is better for the survivor, 
4) SCP can lead to better care, 5) Important for information sharing 6) Format and layout 
in need of improvement. These themes are listed in Table 7. 
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Table 7. Findings from QI Interviews with Survivors and Medical Providers 
Survivor Primary Care Oncology Healthcare 
Phisician Providers 
Themes 
Medical terminology • Challenging • Not patient and PCP • Too advanced for 
difficult to • Confusing friendly survivors 
understand and • Important for PCPs to • Clinical information • Challenging for 
geared towards know overwhelming non-literate 
oncologists 
• Interpreters needed populations 
Follow-Up Care Plan • Personalized nutrition • More information on • Detailed clinical 
does not meet and diet information follow-up care trial information 
information needs • Mental health referrals instructions needed 
• Hospital and • Long-term follow-up • Address/location for 
community based critical ( <5 yrs) medical providers 
resources • Clearer delineation important 
• Patient navigators of roles 
critical • Greater mental health 
and nutrition 
information 
• Voice of Survivor 
Important 
Summary page • Want both Summary • Simple • Contains enough 
"alone" is better for Page and Journey • Patient friendly information for 
the survivor Forward patient 
SCP can lead to • Increased knowledge • Clarity of provider • Facilitate 
better care • Reaffirm importance roles discussions about 
of follow-up visits • Increased knowledge transition 
• Reduce • Reaffirm primary 
underutilization care as medical 
home 
• Better integration of 
PCPs 
• Standardize 
survivorship care 
Important for • Portable • Increase • Increase 
information sharing • Share with Family communication with communication 
oncologist with PCP 
• Share with Family 
Format and layout in • Length appropriate • Headings need • Separate by major 
need of improvement • Tables/sections need clarity treatment type 
better labels • Too long • List treatment dates 
• Condense clinical first 
information 
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Theme 1: Medical Terminology Difficult to Understand and Geared Towards 
Oncologists 
Survivors 
Survivors expressed difficulties understanding medical terms in the Journey 
Forward Survivorship Care Plan. They understood some basic medical terms such as 
"patient's weight," "chemotherapy treatment dates," and "possible side of effects of 
regimen." However, the rest of the medical terms were a challenge. Examples of these 
words included "pre-op colonoscopy to cecum" and "notable pathologic findings." While 
survivors thought these terms could be worded differently, they wanted the clinical 
information to remain included in the care plan. They expressed that while they may not 
be able to understand the medical terminology, it was important for their primary care 
providers to know. One survivor said, "That needs to stay there. So, that way my primary 
care doctor knows because your doctor needs to know this." Their recommendation was to 
include a glossary at the end ofthe Journey Forward Survivorship Care Plan or underneath 
each of the sections. The glossary could serve as a quick reference for medical terms they 
were not familiar with. 
Spanish speaking survivors reported the most difficulties understanding the 
medical terminology in the Journey Forward Survivorship Care Plan. While the Summary 
Page was provided in Spanish, the Journey Forward Survivorship Care Plan was given to 
all survivors in English; making it difficult to understand the content. Hispanic survivors 
expressed they would prefer to receive the Journey Forward Survivorship Care Plan in 
Spanish. However, they also reported that the SCP did not necessarily have to be translated. 
Having an interpreter go over the information in the SCP was acceptable as it was the same 
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procedure they used for hospital visits and gomg over other hospital 
documents/instructions. 
Well, I would like it to be in my language. It should be in different 
languages for everyone. But you don't have to necessarily translate the 
whole thing to Spanish. You can have some interpret the information; 
what's on here. Like what you're doing with me right now. 
However, it was important for the survivors to have interpreters that could 
accurately explain the information in the SCP, without leaving essential pieces out of the 
discussion. They also noted they had family members, such as sons and daughters, who 
could translate and go over the SCP with them. The one concern among Hispanic survivors 
was that if the Journey Forward Survivorship Care Plan was translated, some of the Spanish 
words and phrases used would not be understood due to variations in vocabulary among 
people from different Spanish speaking countries. For example, primary care doctor can 
have multiple translations such as "medico primario" or "medico de cabecera." 
Primarv Care Physicians 
PCPs also reported that some medical terms in the SCP were not patient or PCP 
friendly and that there were various acronyms that needed to be clearly spelled out and 
explained. For example, "ECOG Performance Status" was confusing to PCPs and many 
were unsure of its meaning. PCPs expressed that adding a few additional words in certain 
sections could significantly improve how patients understand the information. For 
example, in the SCP "cancer detection" could be replaced with "how was your cancer 
detected?" 
PCPs also felt the SCP contained "too much" clinical information for their patients, 
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adding to the complexity of the document. Several components in the Journey Forward 
Survivorship Care Plan were recommended for removal such as treatment tolerance, 
hospitalizations for toxicity, and genetic testing. These were recommended for removal 
because providers did not fmd the information "helpful" for themselves or for their 
patients. Instead, PCPs felt the information in the SCP was geared more towards 
oncologists and medical information that was important to them. One PCP stated, "I think 
this was written from the perspective of other oncologists. So, again, it becomes 
confusing." 
PCPs also expressed that some of the clinical information in the treatment summary 
section was overwhelming. They felt the information was important to know during the 
patient's treatment, but not pertinent to a patient's care post-treatment. For example, PCPs 
consistently asked, "Why do we need to know what side effects they experienced during 
treatment, if the patient has already completed treatment and these issues have been 
resolved?" What PCPs considered important was what was going on with the patient after 
treatment. One PCP stated that "it's the active stuff that matters." 
What I as a provider, who gets a ton of paperwork, I pick up the paper and 
I eyeball it, and I look through the things that matter. And the things that 
matter is how can I contact them, who are the providers, that's really helpful. 
When were they diagnosed, what was there stage, what date they had 
chemo, radiation, surgery, [and] what are the long term things that I need to 
look for. That's all I care about. 
Oncologists 
Oncologists also expressed similar concerns. They noted that the clinical 
information provided in the SCP was important for oncologists to know (e.g., dose 
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reduction) but not relevant to survivors and PCPs. One oncologist stated, "If this is meant 
to communicate with another oncologist ... then they would need to know all of this but if 
this is information for the primary [care doctor], they don't need to know that." 
Oncology health care providers also reported that the terminology in Journey 
Forward Survivorship Care Plan may not be appropriate for their patient population. They 
expressed that a lot of their patients at BMC were underserved, had low-levels ofliteracy, 
low educational attainment, and did not speak English. They felt that their patient 
population would not be able to understand the Journey Forward Survivorship Care Plan 
and as a result would not know what to do with it. 
I think this is great in the perfect world. In the imperfect world, they are 
going to walk away with this ... and not know how to read it. And the more 
you put on it, the more dizzying this is. A lot of what I find among low 
income patients is that they'll fold it up with all their other paper work. And 
it'll be put into an ... envelope in there drawer in their kitchen. It'll sit there. 
And when they have something happen they'll grab everything out of that 
envelope [and] will come to my office. And in it will be this survivorship 
care plan. 
The expressed that the SCP was "information overload" for the patient and that it was 
written at a grade level that was too advanced. They also felt that it would be difficult to 
simplify the medical terminology any further, especially if the SCP was meant to be used 
by PCPs as well. 
Lastly, oncologists discussed that it would be difficult for non-English speaking 
survivors to understand the SCP. Even if the SCP was translated to multiple languages, 
like Spanish, there were still a considerable number of Spanish speaking patients that were 
not literate in their own native language. Therefore, to be effective, oncologists expressed 
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the SCP would need to be thoroughly explained to the patient by a translator or patient 
navigator who spoke their language. Both PCPs and oncologists also suggested that family 
members who spoke English accompany the patients to the last treatment visit to increase 
understanding of the SCP. 
I think one of the challenges here, [at BMC] is that a lot of our patients have 
pretty low literacy. And just looking at this now most of my patients 
wouldn't be able to read or understand it. One issue is just translating it into 
other languages. Like almost my whole patient population is Latino. And a 
number of them, at least half of them, didn't really do that much school in 
their home country. And so while they speak Spanish, preferentially they 
couldn't read this much level of detail even in their native language. So, 
that's the tricky part. 
Theme 2: Follow-Up Care Plan does not Meet Information Needs 
Survivors 
After reviewing the SCP, survivors conveyed a desire for more information on diet 
and nutrition. They expressed that for colorectal cancer survivors, diet and nutrition were 
important for their health. They recommended that the Journey Forward Survivorship Care 
Plan include personalized nutrition and diet information, especially types of foods to eat. 
A majority of survivors also reported feeling sad, depressed, and unable to cope or deal 
with their cancer. They wanted referrals to a psychologist or resources to help address their 
mental health needs. 
I am worried. I need to go to a psychologist. I need to be referred to a 
psychologist and that should be on here. I think everyone, who goes through 
this, should be referred to a psychologist to talk to. 
Survivors also indicated that the Journey Forward Survivorship Care Plan should include 
a list of hospital and community-based resources available to support them post-treatment, 
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such as support groups and assistance with transportation, food, and housing. A few 
survivors noted that they did not know about the availability or existence of support groups 
in other languages. They also reported not having a patient navigator or social worker to 
assist them with everyday challenges, like transportation. They thought the SCP could 
serve as a resource for referrals to a navigator or social worker, especially if a contact name 
and phone number were included as part of the care team information. 
There were also other elements reported missing from the SCP. Survivors 
recommended that their health care proxy and patient navigator be included as part of the 
care team. They viewed the patient navigator as an important player in their cancer care. 
Survivors also expressed a desire to have their stories told as part of the Journey Forward 
Survivorship Care Plan. Specifically, they requested that the oncology team include in 
narrative form, how their cancer was detected (e.g., symptoms they presented with) and 
how they were doing post-treatment. Survivors also thought it would be helpful to have a 
list of their medications (cancer and non-cancer related) and other health problems included 
in the SCP in order for "other doctors to know about it too." 
Primary Care Physicians 
The follow-up care section of the Journey Forward Survivorship Care Plan did not 
meet all the needs ofPCPs. PCPs reported that it lacked specifics about a survivors follow-
up care such as: 1) What was the patient's risk for recurrence or secondary cancers; 2) 
should they be screening more frequently for other cancer types; 3) how worried should 
they be about certain symptoms the patient presents with; 4) what late and long-term effects 
should be monitored; 5) what action steps do oncologists recommend they take to monitor 
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for these effects; and 6) who is responsible for addressing their psychosocial needs. PCPs 
reported that the Journey Forward Survivorship Care Plan could be improved by including 
this information. Additionally, PCPs indicated that the SCP only provided a plan for the 
first five years post-treatment. They desired information on what happens after the five 
years when patients are no longer seeing their oncologist. Specifically, they wanted to 
know who was responsible for the patient's long-term care. 
This doesn't address what happens after she stops seeing her oncologist .. .It 
gets up to year 5. Well, I'm going to have her for the next 30 [years] .. . So, 
if there is any deviation from the standard type of screening that I would 
normally do, I want to know ... Also, I want to know due to their treatment 
what they are at higher risk for . .. Just very specifically how do I screen this 
patient and what are they at higher risk for that people their age and sex are 
not. . .I mean, I'll default to what I usually do, but specifics are nice. 
They also wanted to know the expectations of the oncologist for the PCP. One PCP said, 
"I think what would be helpful is understanding the expectations of the oncologist. 
Because every one ofthem is different. I may say [to the patient] come back to see me for 
your annual mammograms and they say oh, I already have an appointment with the surgical 
oncologist for that." 
Some PCPs also felt the needs/concerns section of the SCP should be expanded and 
include additional resources for mental health and nutrition/diet, especially since these 
were cited by providers as major concerns among their colorectal cancer patients. It was 
also recommended that the patient needs/concerns section indicate which provider would 
be responsible for speaking with the patients about these issues and making referrals to 
appropriate services. 
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PCPs recommended that the primary point of contact at the cancer center for the 
patient and PCP be clearly identified on the Journey Forward Survivorship Care Plan. PCPs 
noted that often times their patients had multiple cancer specialists and they did not know 
who the primary contact was. PCPs reported wanting clear information about who to call 
at the cancer center if they had questions regarding their patient' s follow-up care. They 
also felt that patients would benefit from knowing their primary point of contact. 
So, when I'm looking at these [phone] numbers, I guess what I want to know 
is are these the people that we are calling now. It's fme to have the 
information of everyone who took care of them, but is there an oncology 
number we can call with ongoing questions. Lots of time their surgeon is 
done early in the process you know. And often times it's the oncologist we 
are calling with follow-up questions. But maybe just to make that more 
clear. 
Similar to finding from survivors, PCPs felt the voice of the survivor was missing 
in the Journey Forward Survivorship Care Plan. They expressed wanting to know how the 
patient was diagnosed. They felt this could be particularly helpful to PCPs who acquire 
new patients and are not familiar with their cancer history. PCPs suggested adding a 
narrative box where oncology providers could write two to three sentences on the patient' s 
story; including how they were diagnosed, how they dealt with their cancer diagnosis, and 
how they were coping as a survivor. 
[The SCP] doesn' t really tell the story of how the patient was diagnosed. 
And sometimes that story is really important. It's different too, if it's 
somebody that I diagnosed them with colon cancer and sent them off and 
now I'm getting them back, it's a lot easier. But I could envision patients 
coming out of cancer treatment without a PCP and getting stuck to a new 
one. And if it's a new one you need to know a little more about the story of 
how it was diagnosed and stuff. 
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Oncologists 
Oncologists expressed that certain components of the SCP needed to be expanded 
to help meet the needs of patients and PCPs. For example, oncology providers felt patients 
needed detailed instructions on cleaning and changing their ostomy pouch. They also 
thought that survivors and PCPs could benefit from more details on clinical trials such as 
start and end dates, name of the clinical trial, and contact information for clinical trial nurse. 
Oncology providers also thought several critical care team members were missing from the 
care team contact list. This included the patient's healthcare proxy, patient navigator, and 
gastroenterologist. These three individuals were viewed as important to a survivor's 
follow-up care. The address/location for each medical provider was also recommended for 
inclusion as not all providers were part of the BMC network. 
Theme 3: Summary page "alone" is better for the Survivor 
Survivors 
Spanish speaking survivors preferred the Summary Page over the Journey Forward 
Survivorship Care Plan because it was available in their language. They appreciated that 
the Summary Page provided highlights of their cancer treatment and included the 
symptoms to watch for in Spanish. However, they still wanted to receive a copy of the 
Journey Forward Survivorship Care Plan, even if it was not available in their language. 
Conversely, English speaking survivors preferred the Journey Forward Survivorship Care 
Plan. They thought the Summary Page was not as detailed and did not include all the 
important information that the Journey Forward Survivorship Care Plan did. Survivors 
took comfort in the level of information provided by Journey Forward. They were strongly 
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adamant about receiving the Journey Forward Survivorship Care Plan in addition to the 
Summary Page. 
Primary Care Physicians 
Unlike the survivors, both PCPs and oncology health care providers felt that the 
SCP for patients should look different than the SCP for medical providers. The vast 
majority of PCPs liked the idea of having a Summary Page to accompany the Journey 
Forward Survivorship Care Plan or even replace it for their patient population. They 
thought the Summary Page "looked better than the Journey Forward Survivorship Care 
Plan for the patient." They described the Summary Page for this QI project as "perfect," 
"patient friendly," and "simple" enough. There were, however, some recommendations to 
improve the content of the Summary Page. This included simplifying the language further, 
rewording some of the headings, including the PCPs name and contact information, writing 
a short meaning of the cancer stage, and including extra space for the oncology team to 
input additional information or instructions for follow-up care. It was also suggested that 
examples of support services at BMC, such as support groups, be listed on the Summary 
Page. 
Oncologists 
Oncologists shared similar sentiments as the PCPs. They found the Journey 
Forward Survivorship Care Plan to be acceptable for use by the PCPs but not necessarily 
for the survivor. This was due to oncologists feeling that survivors would not be able to 
understand the level of details and information provided in the SCP. Oncologists felt 
strongly that PCPs should receive the Journey Forward Survivorship Care Plan while 
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patients should only receive the Summary Page. The Summary Page contained highlights 
of the patient's cancer treatment and post-treatment care and this was considered enough 
information for their patient population. Oncologists did recommend incorporating a 
"checklist." The checklist would outline key steps to take after completing treatment. 
They thought a checklist would be helpful for survivors with low levels of health literacy 
and who speak a language other than English. 
I feel like there should be 2 different documents; one for the patient and one 
for the doctors. All this information in the care plan would be appropriate 
for the primary care doctor ... So, here is what I think. More detailed 
information to the primary care doctor in a form of something like this 
[Journey Forward Survivorship Care Plan] is more reasonable with some 
tweaking. I think that with the patient, having the contact information, the 
care team, and then having a very basic ... of you know what type of cancer 
did you have, what stage was your cancer, when was it diagnosed, what 
basic things did you have done for this cancer ... and then sort of like a 
checklist ... Something very simple. And it doesn't have to convey as much 
information as this. This seems too complicated and overwhelming. 
Theme 4: SCP can lead to better care 
Survivors 
Survivors reported a lack of knowledge and understanding of their cancer. Even 
after completing treatment, survivors reported not knowing what cancer is or understanding 
the stage of their disease. After reviewing the SCP, survivors felt the SCP could help them 
and their families better understand their cancer. To help accomplish this, they requested 
brief definitions and explanations for staging of the disease as well as late effects of cancer 
treatment. Survivors also expressed confusion about the importance of follow-up visits. 
They felt the SCP could help them understand why they still needed follow-up visits and 
tests after completing treatment if they were cancer free. 
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I like this because many times a patient has cancer and the doctor tells you 
about it. But the patient is sometimes still disoriented. They don't know in 
reality what they had. What it was they had done. What you're going to do 
after the cancer. You are always worried and concerned. Also, the follow-
up visits. That's important after a disease. The appointments. So, I'm always 
saying, why do I still have so many appointments if I'm cured. So, it's good 
to know why. That's why this document is so important. 
Of all the sections in the SCP, survivors thought that the "symptoms to watch for" was the 
most important. They described wanting to know what they should be looking out for and 
what they should be doing to prevent their cancer from coming back. One survivor, who 
had a recurrence of colon cancer, shared that she had been experiencing significant weight 
loss for months and had she known that this was one of the symptoms she would have 
reported it to her doctor earlier. 
Survivors also thought the SCP could serve as a "calendar" of their follow-up 
appointments. They reported it could provide guidance on what they should be doing post-
treatment, could serve as a reminder of future appointments, and could prompt them to 
schedule an appointment if they missed a previous visit. One survivor said, "I like 
this ... because I know what I should be eating, doing, and how often I should come in to 
see my doctors." 
Primary Care Physicians 
PCPs reported that the Journey Forward Survivorship Care Plan could be effective 
in a number of areas. PCPs thought the SCP could help clarify the roles and responsibilities 
of the PCP, patient, and oncology providers. One PCP said, "I think elements of the care 
plan can make it really clear what the patient should do ... And what the oncologist should 
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do or expect to do ... and what they want to the PCP to do and follow-up with .. .it's really 
critical." 
PCPs indicated that ensuring that roles were clearly delineated among providers 
could help guarantee that follow-up care is not "dropped" and that providers are not giving 
patients "mixed messages." PCPs shared several stories of survivors whose care got 
dropped because oflack of communication in regards to provider roles and responsibilities. 
I have a woman who has endometrial cancer now. Who was treated for 
cervical cancer like 10 years before and she was seen in oncology for 
follow-up for a long time. And they were doing pap smears and stuff for 
surveillance purposes. And when I picked her up as a patient, it had 
probably been 5 to 6 years, since her cervical cancer treatment. And what I 
understood from her was that they were doing all of their paps ... And what 
they thought [oncology] was they had finished doing her paps. . So, 
anyways, she ultimately developed some symptoms ... and was diagnosed 
with endometrial cancer. Which I felt like, if the communication around 
who was doing the pap had been clearer, like maybe she would have 
diagnosed earlier. 
The Journey Forward Survivorship Care Plan was also seen as an opportunity to educate 
PCPs about follow-up care. PCPs often expressed that they saw a small number of cancer 
patients and just didn't have that kind of "expertise." 
I would like to know treatment effects. And whether the person needs to 
have enhanced surveillance for other cancers. So like, obviously, if 
someone had breast cancer they may need more mammograms but I don't 
know whether they need an earlier colonoscopy now to. I do know that in 
many cases if someone has been diagnosed with once cancer there risk for 
other cancers goes up. But I don't know what their recommendations are 
for other cancers. But it sounds like they would have that in here [in the 
SCP]. 
Oncologists 
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Both oncology health care providers and PCPs reported that patients had poor 
relationships with the PCP after completing treatment. This was partly attributed to 
patients rarely seeing the PCP during their cancer care. Throughout the cancer process, 
patients forged strong relationships with oncology team members and preferred to continue 
their care with them. However, oncologists felt that the transition back to the PCP needed 
to happen and the Journey Forward Survivorship Care Plan could help facilitate these 
discussions with the patient. This was critical because oncologists reported that they 
continued to treat survivors for non-cancer related health conditions. 
And then we try to get people back to primary care and I don't know how 
well, that's difficult too, because people have a weak relationship with their 
primary care doc. Once they start coming here, usually with the intense 
treatment time, we manage almost everything. Cause we mess everything 
up with the chemotherapy and so, we take care of it. But once we are done 
we really don't want to deal with the diabetes, or the hypertension, and 
everything. We really don't want to deal with that stuff. And we much 
rather they go back to primary care. 
Oncologist viewed the SCP as an opportunity to reaffirm to survivors that the primary care 
setting is still their medical home and that the PCP continues to play an important role in 
their health care. Of course, PCPs and oncologists reported that there were significant 
barriers to establishing a good relationship with the patient. One of the major barriers was 
that a substantial number of patients at BMC did not have a primary care doctor. Oncology 
health care providers described that patient navigators were instrumental in finding patients 
new PCPs and scheduling appointments, but patients refused to see a new doctor. 
Additional barriers included losing trust m the PCPs and difficulties getting to 
appointments, such as transportation issues. 
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Sometimes we make the appointments with the PCP ... but it's very difficult. 
They don't want to go ... [They say] I don't trust them anymore. Or you 
know, they'll say they had a doctor for a year or 2 and now they left and 
they have another doctor. It's the sort of things you might expect. 
Both PCPs and oncology health care providers indicated that PCPs needed to be better 
integrated in the patient's cancer treatment plan in order to strengthen relationships and 
improve communication. They felt the SPC could help facilitate this. One suggestion was 
for the oncologist to recommend to the cancer patient to visit their PCP at least one time 
during their cancer treatment. 
Oncologists also felt the adapted Journey Forward Survivorship Care Plan could 
help standardize survivorship care at BMC. Generally, post-treatment information at BMC 
is provided to cancer patients verbally. The information given to patients also varies by 
physician and department. Oncologists reported that an SCP could help standardize the 
information given to colorectal cancer patients when they complete treatment. It could also 
help standardize how clinical information is transferred to the PCP and help determine at 
what point patients are transitioned completely to the primary care setting. Additionally, 
oncologists reported that it could standardize how follow-up care is delivered for each 
cancer type. For example, what is the length of follow-up and who is responsible for 
providing follow-up. It could also help ensure that evidence-based or consensus based 
follow-up guidelines are followed for each cancer type. Some providers reported that 
recommendations for follow-up testing varied by oncologists and that they may not always 
be evidence-based. Once PCP said, "They also do a lot of what's not evidence based. I 
mean I've seen that. I think that if you can standardize that here, that would be huge." 
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Theme 5: Important for Information Sharing 
Survivors 
Survivors appreciated that the SCP was portable and that it could be taken home 
and shared with family members. They reported that family members often had questions 
related to their cancer treatment and they couldn't provide a response because they didn't 
know or didn't remember the information. The Journey Forward Survivorship Care Plan 
would allow family members to have access to this information and become better 
informed about the cancer. Survivors also thought the SCP was important for sharing 
cancer information with new PCPs or other specialty doctors. Survivors also wanted 
wanting to be kept abreast of what information was communicated to their PCPs, as they 
felt their PCPs were not well informed of their cancer care. 
Primary Care Physicians 
PCPs reported that the SCP could help improve communication and information 
sharing between the oncology specialists and PCPs. Both oncologists and PCPs reported 
that communication about the patients care did not always occur and if it did, it was through 
occasional notes on the EMR system or via letters. However, these methods were not seen 
as effective. Some PCPs did not have access to the EMR system. Others said the notes 
were "not provider friendly" while others felt they did not get the information they needed 
from oncology notes. In addition, the notes were almost exclusively on the patient's 
treatment and not follow-up care. 
There's not a lot of good communication between specialty providers and 
primary care. When you are at the same institution it's different because 
you have access to ... those records .. . But you know, reviewing records, an 
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oncology record that's not geared towards primary care providers, to guide 
primary care providers, I might not get the information I need anyways from 
reviewing the record. So, you know, I would assume that, a care plan that's 
targeting primary care providers is going to give different information. 
PCPs also reported that information was not sent to them routinely. One PCP said, "Rarely, 
they will contact a provider electronically through the electronic medical record, through 
flagging, like email. And very rarely, there would be sort of a page. But I can count on 
one hand how many times, in my 15 years of practice, that's actually happened." PCPs 
often had to rely on the patient's recollection of what occurred during their treatment. As 
a result, PCPs reported feeling unprepared to answer patient questions about their cancer 
care once they were transitioned back to the primary care setting. 
What happens is that, my patients either disappear for the length of time that 
they are getting treatment or they disappear but come back for like an acute 
visit, like knee pain ... And they'll say, oh by the way, and they'll tell me their 
version of what's happening, which I often can't figure out if they are doing 
well or not ... and I don't as a routine matter, get the notes sent to me in 
Logician .... It would be easier if it [the notes] were just sent to me routinely 
and they [the patient] were scheduled to come see me. Cause it would get 
everything gearing up for the survivorship stuff easier, if they weren't 
coming back after 9 months and you were like, what the hell happened. Are 
they cured? Are they in remission? Are they doing poorly? I don't know. 
Communication in regards to a patient's care usually occurred if there was a crisis or 
emergency or if the PCP made an effort to contact the oncologist directly. 
Oncologists 
Similar to PCPs, oncologist reported the value ofSCPs in communicating and sharing 
information; especially as it relates to what the oncologist will do and follow-up with and 
what they expect the PCP to do and follow-up on. They also expressed the importance of 
sharing the SCP with survivor' s family members. They suggested that survivors come to 
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the last treatment visit accompanied by a family member or someone who could serve as a 
source of support and help reinforce the follow-up instructions in the SCP. This was 
strongly recommended for survivors whose primary language was not English and who 
may face language barriers to understanding the SCP. It was also deemed important to 
revisit the SCP with some patients during their follow-up appointments in order emphasize 
the importance of follow-up care. 
Theme 6: Format and Layout Needs Improvement 
Survivors 
Overall, survivors felt the length of the Journey Forward Survivorship Care Plan 
was appropriate and that the sections were well organized. Survivors did want to take more 
an active approach to their care and recommended that a calendar be included in the 
Summary Page. This would allow them to manually input future appointment dates. They 
also reported that certain sections of the SCP, like the table with the follow-up schedule, 
should be labeled and clearly indicate that it contained their follow-up schedule for the next 
five years. One last recommendation was to move the "symptoms to watch out for" section 
to the beginning of the SCP. 
130 
Primary Care Physicians 
How the information was presented in the Journey Forward Survivorship Care Plan 
did not always make sense to providers. A few providers were not pleased with the format, 
layout, and presentation of the clinical information, especially the Treatment Summary 
section. 
It's not clear that the treatment plan & summary is titled quite clear. It 
doesn't look like a summary. It doesn't look like a plan. I'm not sure what it 
looks like actually. So, I don't know that that is the title of the section. 
Both PCPs and oncology providers expressed that the Journey Forward 
Survivorship needed to be better organized in order to improve readability for the patient 
and providers. The PCPs recommended that cancer type and date of diagnosis be listed 
first in the treatment summary section. One PCP said, "I guess the one thing that I feel like 
I would want to see right here is the date of their diagnosis. Cause right away you wonder 
how far out they are." 
Some also indicated that headings in the SCP needed to be clearer. For example, 
the Background Section was renamed "Cancer Background Section." All tables, grids, 
and sections should also be appropriately labeled. Other PCPs felt that certain components 
of the SCP, like staging of the disease, should be in separate subsections and that dates for 
treatments and procedures should always be listed first. 
Oncologists 
Oncology providers reported that the Treatment Summary section should be 
separated by major treatment type and each section should be clearly labeled surgery, 
chemotherapy, and radiation. This was in response to providers feeling that the treatment 
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information in the Journey Forward Survivorship Care Plan was "lumped" into one section 
without clearly distinguishing between the different treatments. Oncologists also reported 
wanting the dates for each treatment listed first in each section to ensure consistency 
throughout the document. Both oncologists and PCPs also preferred a shorter SCP; 
consisting of no more than two pages. Reasons for a shorter SCP included time constraints 
for reviewing the information as well as the burden of creating them. Oncologists and PCPs 
also expressed that the Treatment Summary should be the shortest section of the Journey 
Forward Survivorship Care Plan while the Follow-Up Care section should be the longest. 
Results of Knowledge Based Questionnaire 
After the interview, survivors were asked to complete a brief questionnaire. The 
questionnaire was designed to assess a survivor's perceived knowledge of cancer treatment 
and follow-up care. For example, one of the questions was, "After seeing the survivorship 
care plan, I would know exactly the stage of my cancer." The results of the survey showed 
that 100% of survivors agreed or strongly agreed that after seeing the adapted Journey 
Forward Survivorship Care Plan (Summary Page and Journey Forward) they would know 
the stage of their disease, symptoms to report to their doctor, how to manage their health 
risks, how often to schedule follow-up visits with the cancer doctor, and how to contact 
their cancer doctors. Only 75% of survivors reported that they knew how to make an 
appointment with a social worker or patient navigator and knew the health risks they faced 
due to their cancer treatment. These results suggest the adapted Journey Forward 
Survivorship Plan may need to include a section to inform survivors that they can self-refer 
to a social worker or patient navigator or they can ask their cancer doctor for a referral. 
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Additionally, the section on late and long-term effects may need to be more patient friendly 
in order to increase survivor awareness of their health risks post-treatment. Of course, the 
findings of this questionnaire should be interpreted with caution. First, this Ql project had 
a very small number of participants and thus conclusions about the data cannot be made. 
Secondly, the SCP was not tailored for each individual survivor. The SCP was based on a 
fictitious colorectal cancer survivor. As a result, the questionnaire does not assess true 
knowledge of cancer treatment and follow-up care. Lastly, the interviewer was present at 
the time the questionnaire was being completed. This could have influenced the responses 
given by the participants. 
4. Summary 
Primary care physicians and colorectal cancer survivors at Boston Medical Center 
were enthusiastic about the Journey Forward Survivorship Care Plan and Summary Page. 
Oncology health care providers were also supportive of the concept of an SCP. All three 
participating groups expressed that the adapted Journey Forward Survivorship Care Plan 
could be helpful in a number of areas. This included increasing patient knowledge of their 
cancer and post-treatment care; increasing communication among PCPs and oncology 
providers; better integration ofPCPs in the patient's cancer care; standardizing follow-up 
care practices at the BMC cancer center; and serving as an instructional guide for PCPs on 
follow-up care. Although all groups thought the Journey Forward Survivorship Care Plan 
had the potential to be a valuable tool, they expressed that the care plan could be improved. 
The suggested revisions to the Journey Forward Survivorship are summarized in Table 8. 
It was suggested that the Journey Forward Survivorship Care Plan be simpler, reduce the 
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amount of clinical information in the Background and Treatment summary section, include 
more patient friendly medical terms, and focus more on late and long-term effects of 
treatment. 
Table 8: Suggested Revisions to the Journey Forward Survivorship Care Plan Template 
for Colon Cancer 
SCP Template Suggested Changes and Revisions 
Section 
Recommended 
by:* 
General 
Information 
(e.g .. , patient 
name, phone 
number) 
Provide heading for first section that describes P 
patient's contact information. Possible heading 
is "Patient Information." 
The domain "support contact" is confusing. S, P 
Rename "alternate contact." 
Add healthcare proxy to contact information 
Care Team Add patient navigator, gastroenterologist, and 
s,o 
S,P,O 
(e.g., name and pharmacist as part of care team. 
phone number of 
oncologist) 
Background 
Information 
(e.g., stage, site 
in colon, genetic 
testing) 
List patient's primary medical/health provider at P 
the cancer center first and label "primary 
contact." 
Include location of each care team provider 
The section name "Background Information" is 
too general. Rename section to "Cancer 
Background Information" 
Add cancer type and date of diagnosis. 
0 
P,O 
P,O 
Create staging section and included staging group P,O 
and TNM staging system. 
Unclear what information the domain "cancer 
detection" is requesting. Change wording to 
"how cancer was detected" 
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0 
Revisions 
made 
(Yes/No) 
Yes 
Yes 
Yes 
Yes, accept 
pharmacist 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Add domain for "results of genetic testing." P,O 
Add up to date problem list, medication list, and S,P 
allergy list 
Include narrative box where oncology providers S,P 
can write 2 to 3 sentences on patient's story 
Unclear if the field "CEA" is requesting pre and 0 
post results. Rename "Pre and Post CEA" 
Add domain with ostomy nurse/clinic contact 0 
information 
The following domains were recommended for P,O 
removal from SCP: Site in colon, predisposing 
conditions, genetic testing pre-op colonoscopy to 
cecum, and other lesions. 
Treatment Plan Created subsections sections for surgery, P,O 
& Summary chemotherapy, and radiation. 
(e.g., 
chemotherapy List treatment dates first in each subsection P,O 
treatment dates, 
side effects) 
Add dates of when pre-treatment and post- 0 
treatment information was collected. 
Change wording of "other health concerns" in P,O 
order to capture only key health issues. Rename 
to "Other Major Health Concerns" 
Expand the domain on central venous catheter. 0 
Include comment box for oncologist to write 
instructions on maintenance. 
Adjust chemotherapy section to allow reporting 0 
of multiple rounds of chemotherapy. 
The following fields were recommended for P,O 
removal from SCP: Patient's height, weight, 
BSA, BMI, ECOG Performance Status, 
Nutritional Status, Treatment on Clinical Trials, 
lymph nodes, Hospitalizations for toxicities, 
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No; section 
removed 
No; outside 
scope of 
SCP 
Yes 
No; section 
removed 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes; except 
for clinical 
trials 
treatment tolerance, side effects during treatment, 
Hypersensitivity, and Growth factor given. 
Include patient friendly definitions for key S,P,O Yes 
medical terms. 
Follow-up care Indicate what happens after 5 years and which p Yes 
(e.g., patient provider is responsible for long term follow-up. 
concerns, post-
treatment 
follow-up 
schedule) 
Add narrative box where doctors can write 2-3 p No; may 
sentences on the patient' s risk of recurrence or mcrease 
risk for secondary cancer. patient fear 
Indicate frequency of screening for other cancer p y 
types 
Include complete list of cancer medications s No 
Expand information on diet and nutrition S,P Yes 
Expand information on mental health and S,P Yes 
facilitate referral to mental health provider 
Rename field "needs/concerns" to be more S,P,O Yes 
specific. 
Indicate who is responsible for speaking to the p No; should 
patient about their needs/concerns and be both P 
implementing suggested interventions. andO 
Provide name/label for the table containing the S,P,O Yes 
follow-up testing schedule. Name table 
"Recommended Follow-Up Tests for Your 
Cancer" 
Insert introductory statement for follow-up tests s Yes 
and general cancer screening subsections. 
Insert support resources available for patients. s Yes; 
inserted in 
summary 
page 
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Possible Side 
Effects of 
Treatment 
Symptoms to 
Watch For 
It is unclear if section refers to side effects 
experienced during the cancer treatment or are 
these are late and long term effects. Remove 
section and incorporated into "Late and Long 
Term Effects of Treatment" 
p 
Survivors recommended this section be placed in S 
the front page of the SCP. 
Yes 
Yes 
*S indicates survivor. P indicates primary care physician. 0 indicates oncology providers. 
When making changes to the SCP, the following factors were considered: 1) 
Priority was given to issues/concerns raised by survivors, 2) Changes were made depending 
on number of participants who brought the issue up, and 3) Changes had to meet and align 
with CoC accreditation standards and 10M recommendations. 
Several revisions were also suggested for the Summary Page. These are outlined 
in Table 9. The major changes were to include a definition of cancer, simplify the 
language, and include examples of survivor resources available at the BMC Cancer Center. 
Table 9: Revisions to the Survivorship Care Plan Summary Page 
SCP Template Suggested Changes and Revisions 
Section 
Summary of 
Cancer 
Treatment 
Include definition/description of the stage 
Include definition of cancer 
Increase font size for "Congratulations!" 
Add more space for oncologists to decide if 
they want to include treatment dates for 
surgery, chemotherapy, and radiation. 
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Recommended 
by: 
s 
s 
0 
0 
Revisions Made 
to Final 
Summary Page 
(Yes/No) 
Yes 
Yes; included as 
supplementary 
material 
Yes 
Yes 
Include space for oncologist to insert 0 Yes 
hormone therapy given and date. 
See my Doctor Include the following beginning statement: p Yes 
for Follow-Up "At this time in your care, it is 
Visits recommended that you follow these steps." 
Yes 
Reword section to "See my cancer doctor S,P 
for follow-up visits and tests 
Get Incorporate section into "See my doctor for P,O Yes 
Recommended Follow-up Visits." 
Scans 
General Cancer The following fields were recommended P,O Yes 
Screenings for removal from the Summary Page: 
general cancer screenings and maintaining 
good healthy habits. Include a general 
statement such as "Make sure to talk to 
your primary care doctor about getting 
regular cancer screenings and maintaining 
good healthy habits." 
Watch out for Include the following statement, "if you 0 Yes 
New Symptoms experience any of these symptoms and are 
bothered by them contact your primary care 
doctor or oncologist" 
Maintain Good Include visit your primary care and take P,O No; section 
Healthy Habits care of your skin removed 
Insert general statement for physical 0 
activity such as, "talk to your primary care 
doctor if exercise is right for you" 
Knowhow to Clarify what is meant by "everyday health s Yes 
call for Care concerns" 
Yes 
Include name and contact information for S,P 
primary care provider 
Resources Provide examples of hospital resources for S,P,O Yes 
Available cancer survivors 
*S indicates survivor. P indicates primary care physician. 0 indicates oncology providers. 
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In summary, the final adapted version of the Journey Forward Survivorship Care 
Plan for colorectal cancer takes into account the needs and preferences of low-income 
survivors, PCPs, and oncology health care providers at BMC. This QI study showed that 
survivors and PCPs at Boston Medical Center want to receive a survivorship care plan but 
it needs to be more focused on follow-up care and should be written in a language that is 
acceptable to both PCPs and patients. Lastly, an implementation plan at BMC will need to 
be solidified and the adapted Journey Forward Survivorship Care Plan will need to be 
evaluated in future QI projects. In Chapter 4, a plan for implementation at Boston Medical 
Center is proposed. 
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CHAPTER4: 
IMPLEMENTING THE SURVIVORSHIP CARE PLAN AT BOSTON MEDICAL 
CENTER 
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Introduction 
A survivorship care plan is a written document that provides a summary of a cancer 
patient's treatment history and a plan for ongoing follow-up care.22•23 In 2006, the Institute 
of Medicine (I OM) recommended that every cancer patient receive a survivorship care plan 
after completing cancer treatment. 5 In 2012, the Commission on Cancer (CoC) joined this 
effort by issuing new mandates that require CoC accredited cancer programs to provide 
cancer patients with a survivorship care plan. 26 The survivorship care plan has been 
recommended in response to cancer survivors feeling that they are lost in transition after 
completing cancer treatment. 5 After treatment, survivors have been shown to experience 
a multitude of complications including an increased risk of secondary cancers, depression, 
family issues, and financial difficulties. 5,6 Survivors have also expressed confusion about 
what to expect after cancer treatment and who to contact for their follow-up care. 5 A 
survivorship care plan can help cancer survivors navigate their life after cancer treatment. 
In order to provide the best care for cancer survivors and meet the new mandates 
from the Commission on Cancer (CoC), the Journey Forward Survivorship Care Plan was 
adapted for low-income colorectal cancer survivors at Boston Medical Center. Over 70% 
of cancer patients at Boston Medical Center are underserved and a survivorship care plan 
that meets their unique needs is imperative. This chapter presents the final adapted Journey 
Forward Survivorship Care Plan and a toolkit to assist Boston Medical Center in preparing 
and delivering the survivorship care plan to colorectal cancer survivors. 
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OVERVIEW OF THE TOOLKIT 
Purpose of the Toolkit 
The purpose of this toolkit is to assist oncology health care providers at Boston 
Medical Center in preparing a survivorship care plan for low-income colorectal cancer 
survivors. A survivorship care plan is a document that provides a summary of a cancer 
patient's treatment history and a plan for ongoing follow-up care. The survivorship care 
plan is intended to facilitate communication between the patient, primary care provider, 
and oncology care team about the patient's post-treatment care needs.22,23 
Who is the toolkit designed for? 
The toolkit is designed for anyone in cancer care who will be responsible for 
creating and discussing the survivorship care plan with patients and their families. For the 
purposes of this toolkit, the individual(s) designated to create and discuss the survivorship 
care plan will be called a survivorship professional. The survivorship professional could 
be any member of the oncology team such as a patient navigator, social worker, nurse, 
nurse practitioner, oncologist, radiation oncologist, and surgeon. While any of these team 
members can fill the role of the survivorship professional it is important to identify early 
on who will be responsible for creating and providing the survivorship care plans. 
Content of the Toolkit 
The toolkit introduces oncology health care providers to survivorship care plans. 
The content of the toolkit is divided into three sections: 1) Staff training on survivorship 
care planning, 2) Special considerations for delivering the survivorship care plan to low-
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income colorectal cancer surviVors, and 3) Resources and materials needed for 
implementation. Examples of materials included in the toolkit are a survivorship care plan 
template, cover letter to send to primary care providers with the survivorship care plan, and 
a flowchart outlining the process for implementation. The toolkit also considers barriers 
unique to minority populations including languages barriers, health literacy, and 
communication challenges with primary care physicians and oncology providers. 
144 
TOOLKIT SECTION 1: 
Training oncology health care providers on survivorship care plans 
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Training Curriculum Overview 
The training curriculum, agenda, and PowerPoint presentation in this toolkit can be used 
as a guide to train survivorship professionals at Boston Medical Center on survivorship 
care plans. The three goals of the training are: 
1. Provide survivorship professionals with a basic understanding of survivorship care 
plans and how they can contribute to a cancer patient's long-term health. 
2. Describe how Boston Medical Center can meet the Commission on Cancer 
accreditation standards for survivorship care plans by the year 2015. 
3. Provide survivorship professionals with the support and tools they need to prepare 
a survivorship care plan for each cancer patient after they complete active cancer 
treatment. 
The training curriculum is divided into 4 modules: 
1. Challenges Facing the Cancer Survivor Population 
2. Overview of Survivorship Care Plans 
3. Boston Medical Center Survivorship Care Plan Template 
4. Preparing and Delivering the Survivorship Care Plan 
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8:30A.M. 
8:50A.M. 
9:20A.M. 
9:50A.M. 
10:20 A.M. 
10:30 A.M. 
11:00 A.M. 
12:00 P.M. 
. 12:30 P.M. 
1:00 P.M. 
1:30 P.M. 
Suggested Agenda 
Survivorship Care Plan Training Program 
(Insert Date) I (Insert Time) 
Welcome and Introductions 
Overview of Training Goals and Objectives 
Module 1: Challenges facing the cancer survivor population 
Module 2: Overview of survivorship care plans 
Module 3: Introduction to the Boston Medical Center (BMC) 
Survivorship Care Plan Template 
Break 
Module 4: Preparing and delivering the Boston Medical Center 
(BMC) Survivorship Care Plan to patients and primary care 
providers 
Epic Survivorship Care Plan Demonstration 
Lunch 
Special considerations for delivering the survivorship care plan to 
low-income colorectal cancer survivors 
Review resources and materials for implementation 
Questions and Answers 
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MODULE 1: 
Challenges Facing the Cancer Survivor Population 
Introduction 
This module provides brief statistics on cancer survivorship and examples of some of the 
late and long-term effects oftreatment. 
Definition of a Cancer Survivor 
A cancer survivor can be any person who172: 
• Has had a cancer diagnosis 
• Has finished cancer treatment and has no evidence of the disease 
• Has lived cancer free for five years or longer 
Key Statistics on Cancer Survivors 
• There are an estimated 13.7 million cancer survivors in the U.S.47 
• Among male survivors, the most common cancers are prostate (43%), colorectal 
(9%), and melanoma (7%).47 
• Among female survivors, the most common cancers are breast ( 41% ), uterine 
corpus (8%), colorectal (8%).47 
• Approximately, 64% of cancer survivors were diagnosed five or more years agoY 
• The majority of cancer survivors are age 70 or older (45%).47 
• African Americans and ethnic minorities represent 12% of the cancer survivor 
population.155 
• There are an estimated 344,000 cancer survivors in MA.47 
• The majority of cancer survivors in MA have been diagnosed with breast, prostate 
or colorectal cancer.48 
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Consequences of Treatment on Cancer Survivors 
After cancer treatment, survivors may experience a number of late and long-term effects. 
Long-term effects of cancer begin during treatment and continue after treatment ends while 
late effects develop years later. 51 The extent to which these late and long-term effects occur 
in cancer survivors depends on a number of factors including cancer type, stage of the 
disease, treatment received, genetic predisposition, comorbidities, lifestyle behaviors, age, 
gender, and race/ethnicity.5 Examples of these late and long-term effects are listed below5: 
• Physical 
Chronic Pain 
Fatigue 
Infertility 
Heart disease 
Kidney problems 
Liver problems 
Osteoporosis 
Secondary cancers 
Impaired kidney function 
Scar tissue 
• Psychological 
Depression 
Anxiety 
• Social 
Fear of Recurrence 
Isolation 
Family distress 
Changes in interposal relationships 
Concerns with finances and work 
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MODULE2: 
Overview of Survivorship Care Plans (SCP) 
Introduction 
This module provides an introduction to survivorship care plans, the essential 
components of a care plan, and the potential benefits to survivors. 
What is a survivorship care plan (SCP)? 
• An SCP is a hard copy or electronic document that contains important information 
about a cancer patient's treatment.22,23 It consists of two major components: 
o A summary of a cancer patient's treatment history 
Example: Type of cancer, stage of the cancer, treatment received 
o Plan for ongoing follow-up care 
Example: Schedule of recommended tests (e.g., colonoscopy) for the 
next five years 
• SCPs were first recommended by the Institute of Medicine (IOM) and Presidents 
Cancer Panel in response to cancer survivors feeling that they were "lost in transition" 
after completing cancer treatment. 5 
• SCP is created for the patient by the oncology care team. 5 
• SCP should be personalized for each patient. 5 
• Both the patient and their primary care physicians should receive a copy of the SCP 
after treatment is complete.5 
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What information should be included in the survivorship care plan? 
Table 10 outlines the key elements that are recommended for inclusion by the Institute of 
Medicine. 5 It is important to note that these are recommendations and not all survivorship 
care plan templates that are currently available include all of these components. However, 
a good plan will include most of these elements. 5 
Table 10: Elements of a Survivorship Care Plan Recommended by the Institute of 
Medicine 
Treatment Summary should include ... Follow-Up Care plan should include ... 
• Diagnostic tests performed and results • Recommended screening and 
surveillance schedule 
• Tumor characteristics including cancer • Need for ongoing adjuvant therapy 
site and stage 
• Treatment(s) administered including 
regimen and dose 
• Clinical trial information 
• Services provided to patient during 
treatment such as counseling 
• Contact information for key medical 
providers 
• Key point of contact for continuing 
care 
• Information on late and long term 
effects of treatment 
• Information on signs of recurrence or 
secondary cancers 
• Information on consequences of 
cancer treatment such as financial 
concerns and sexual intimacy 
• Recommendations for health living 
such as exercise and tobacco cessation 
• List of survivor resources 
Source: Institute of Medicine. Cancer Survivorship Care Planning Fact Sheet. November 2005 . 
Available at: www.iom.edu/ 
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Why the push by national experts to provide survivorship care plans? 
• Survivors are "lost in transition" 
Confused about what to expect after cancer treatment5 
Unsure who is responsible for their follow-up care (primary care provider or 
oncologist)5 
Feel abandoned by their cancer care team 5 
Experience a multitude of complications including an increased risk of secondary 
cancers, depression, family issues, and fmancial difficulties. 5,6 
• Survivors do not always get the care they need 
Example: Survivors report that their mental health needs are not being addressed. 
Referrals to psychosocial support services, like a therapist or support group, do not 
always occur.68 
Example: Sexuality counseling is rarely available to cancer survivors. 5 
• Poor communication between patient, primary care physicians (PCPs), and oncology 
care providers 
Cancer patients rarely see the primary care physician during treatment. By 
the time treatment ends, PCPs have not seen their patients for months and 
may not be familiar with the details of their treatment and what their role is 
in caring for survivors. 5,24 
PCPs not always familiar with survivorship care guidelines and how to care 
for survivors.22 . 
Medical providers do not receive formal training and education on how to 
care for cancer survivors. 5 
What are the potential benefits of survivorship care plans? 
A survivorship care plan may help: 
152 
• Increase a survivor' s knowledge of their cancer and follow-up needs (e.g., future 
tests) so they can be better informed and empowered to take a greater role in their 
care.24,89 
• Educate survivors on possible symptoms related to their treatment and late and long 
term effects to watch out for. If survivors are aware ofthese symptoms and effects, 
they can report it to their providers in a timely manner, potentially leading to better 
management and earlier detection. 5 
• Reduce a cancer survivor's perceived sense of abandonment from their cancer care 
team.5 
• May be a prime opportunity to promote positive behavioral and lifestyle changes 
(e.g., maintain a healthy weight) that can reduce a survivors risk of recurrence and 
secondary cancers.66 
• Promote adherence to follow-up test and routine surveillance by improving a 
patient' s understanding of required tests, their purpose, and which provider is 
responsible for administering the tests.24 
• Promote continuity of care and communication with the PCP by clearly outlining 
what needs to be done (e.g., surveillance, psychosocial assessment) and who is 
responsible for that aspect of care.5•13 
153 
Commission on Cancer Accreditation Standards at Boston Medical Center 
• What is the Commission on Cancer? 
"The Commission on Cancer (CoC) is a consortium of professional organizations 
dedicated to improving survival and quality of life for cancer patients through 
standard-setting, prevention, research, education, and the monitoring of 
comprehensive quality care.'m 
• What does the Commission on Cancer say about survivorship Care Plans? 
CoC Standard 3.3 states, "The cancer committee [should] develop and implement 
a process to disseminate a comprehensive care summary and follow-up plan to 
patients with cancer who are completing cancer treatment. The process [should be] 
monitored, evaluated, and presented at least annually to the cancer committee and 
documented in minutes."26 
The SCP should be prepared by the principal provider (e.g., medical oncologist) 
who coordinated the treatment. 26 
The SCP should be given to the patient upon completion of treatment. 26 
The SCP template should include the minimum elements set forth by the Institute 
of Medicine (Table 9).26 
• When does Boston Medical Center need to begin providing patients with a survivorship 
care plan? 
The Boston Medical Center Cancer Care Center is one of 1 ,500 Commission on 
Cancer accredited programs. 
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By the end of2014/early 2015, Boston Medical Center should have a plan in place 
and begin to provide cancer patients with a survivorship care plan upon completion 
of treatment. 26 
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MODULE3: 
Introduction to the Boston Medical Center (BMC) Survivorship Care Plan Template 
Introduction 
This module provides an overview of the Boston Medical Center Survivorship Care Plan. 
Boston Medical Center will provide cancer patients who finish cancer treatment with a 
Summary Page and an adapted Journey Forward Survivorship Care Plan. Together these 
documents comprise the BMC survivorship care plan. The two documents are described 
below. The templates are available for review in Section 3 of this toolkit. 
Summary Page 
The summary page is a simplified version of the Journey Forward Survivorship Care Plan 
written at a fifth grade reading level for patients and their families. The summary page is 
one page in length (front and back) and is available in Spanish. The goal of the summary 
page is to provide colorectal cancer survivors with a brief snapshot oftheir cancer treatment 
and provide important steps for follow-up care. The summary page takes into account 
health literacy levels, the importance of including culturally appropriate survivorship 
resources, and the follow-up preferences and needs identified by colorectal cancer patients 
at BMC through a Quality Improvement project. For example, colorectal cancer survivors 
indicated that they wanted a calendar included in the summary page to input future follow-
up appointment dates. As a result, a calendar was included in the summary page. Table 
11 provides additional information on the seven components included in the summary 
page. 
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Table 11: Survivorship Care Plan Summary Page for Colorectal Cancer 
Care Plan Element 
Summary ofYour Cancer 
Treatment 
What out for new 
symptoms or other health 
issues 
See your cancer doctor for 
follow-up visits and tests 
Talk to your Primary Care 
Doctor about getting 
regular cancer screenings 
Talk to your Primary Care 
Doctor about maintaining 
healthy habits 
Know who to call for your 
care 
Resources for staying 
healthy 
Descri tion 
Provides brief snapshot of the treatment delivered to the patient. 
Includes 5 main areas: 
Date of diagnosis 
Type of cancer 
Stage of the cancer and what the stage means 
Major cancer treatment received (e.g. , radiation) 
Cancer treatment dates 
Provides a list of symptoms colorectal cancer survivors should be 
aware of and report to their doctors. 
Symptom list is from the American Society of Clinical Oncology 
Survivorship Care Plan Surveillance Guidelines 
A calendar lays out how often the survivor should see their cancer 
doctors and what tests will be performed. 
The calendar allows the survivor to write down the dates of future 
appointments for the ftrst year after treatment. 
Serves as a prompt for survivors to speak to the primary care 
doctor about other cancer screenings 
Serves as a prompt for survivors to speak to the primary care 
doctor about healthy habits like exercise and eating healthy 
Lists the name and phone number of their primary care doctor and 
primary cancer care provider 
Lists several BMC resources for survivors and the phone number 
for cancer support services 
Adapted Journey Forward Survivorship Care Plan 
The Journey Forward Survivorship Care Plan is one of four existing survivorship care plans 
available to cancer centers for use with patients completing active cancer treatment. 
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Journey Forward was developed by the UCLA Comprehensive Cancer Center, the National 
Coalition for Cancer Survivorship, WellPoint, and Genentech.9 It is a free downloadable 
software program that is installed on computers and can be used to personalize the care 
plan for each patient. 
Journey Forward is modeled after the American Society of Clinical Oncology survivorship 
care plan templates and are available for each major cancer site including colorectal, breast, 
prostate and lung.9 In research studies, the Journey Forward Survivorship Care Plan has 
preferred by both patients and primary care providers due its simplicity, format, and 
content.25 
At Boston Medical Center, the Journey Forward Survivorship Care Plan was adapted for 
low-income colorectal cancer survivors. Feedback on the care plan was obtained from 
eight colorectal cancer survivors, five primary care physicians, and 13 oncology health 
providers. Table 12 provides a brief overview of each of the sections included in the 
adapted Journey Forward Survivorship Care Plan. 173 
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Table 12: Adapted Journey Forward Survivorship Care Plan for Colorectal Cancer 
Care Plan Element 
Patient Information 
Medical Care Team 
Cancer Background 
Information 
Surgery 
Chemotherapy 
Radiation 
Patient Needs/Concerns 
Descri tion 
Includes the name and contact information of the survivor 
Provides the names and contact information of all the members of 
the survivor' s cancer care team 
Provides background information on the cancer such as date of 
diagnosis and stage of the disease 
Describes the treatment received with start and stop dates 
Describes the treatment received with start and stop dates 
Describes the treatment received with start and stop dates 
Provides information on the needs and concerns of the patient. 
Also includes suggested interventions. 
This section is intended to be completed while discussing the SCP 
with the patient. 
Recommended Follow-Up Lays out a follow-up plan for the next 5 years. 
Tests for Your Cancer 
Recommended General 
Cancer Screenings 
Late effects of treatment 
Symptoms to watch for 
Clearly states how often the survivor should see their cancer 
doctors and what tests will be performed. 
Provides information on what other cancer screening tests are 
needed and who is responsible for this aspect of care. 
Lists possible short and long-term effects of treatment 
Provides a list of symptoms colorectal cancer survivors should be 
aware of and report to their doctors. 
Symptom list is from the American Society of Clinical Oncology 
Survivorship Care Plan Surveillance Guidelines 
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MODULE4: 
Preparing and Delivering the Survivorship Care Plan 
Introduction 
This module provides suggestions and recommendations on implementing the survivorship 
care plan at Boston Medical Center. This includes: 
1. Who should prepare the care plan for each colorectal cancer patient? For example, 
who will collect and input patient data in the care plan? 
2. Who should review and discuss the care plan with the patient? 
3. When is the best time to review the BMC Survivorship Care Plan with the patient 
Who will receive a survivorship care plan? 
The goal at Boston Medical Center is to provide all cancer survivors and their primary care 
doctors with a survivorship care plan upon completion of treatment. Boston Medical 
Center will begin by preparing care plans for colorectal cancer survivors who have finished 
primary cancer treatment such as chemotherapy, radiation, and surgery. The survivorship 
care plan will be given to both the survivor and their primary care provider. Care plans for 
other cancer types will be phased in at the cancer center in order to address survivor needs 
and meet CoC accreditation standards. 
Who will prepare the survivorship care plan? 
There is a great deal of variation in regards to who should prepare survivorship care plans. 
Some cancer centers rely on nurses and medical providers (e.g., oncologist) while other 
use a combination of nurses and patient navigators. 24 At BMC, a survivorship professional 
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will be designated to create the care plan. A survivorship professional may be an 
oncologist, radiation oncologist, surgeon, nurse, social worker, or patient navigator. The 
survivorship professional should have expertise in cancer care and/or have been trained to 
use and deliver the survivorship care plan to patients. A job description for the survivorship 
professional is available in Section 3. 
How will the BMC Survivorship Care Plan be created? 
The BMC Survivorship Care Plan templates will be available through EPIC (BMC's 
electronic medical record system) for oncology providers to prepare and deliver to their 
patients and primary care physicians. Some of the patient data in the SCP will 
automatically populate on the BMC Survivorship Care Plan (e.g., demographics and cancer 
staging) while other sections will need to be manually inputted (e.g., chemotherapy 
regimens). 
Instructions: At this point during the training session, the facilitator/trainer will provide a 
demonstration of EPIC and how to access and complete the survivorship care plan. 
Suggested process for preparing and delivering the BMC survivorship care plan 
1. Survivorship professional inputs the clinical and follow-up information in the 
survivorship care plan. The SCP is available through the EPIC electronic medical 
record system. 
2. Survivorship professional reviews the information in the SCP prior to meeting with the 
patient to ensure accuracy. Changes are made if needed. 
3. The SCP is printed and a packet is created for the patient. 
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The packet could include: Summary Page, SCP, list of defmitions of key 
medical terms, and the BMC survivor newsletter. 
Packets can be pre-made and the SCP inserted once ready. 
A summary page is available for Spanish speakers. 
4. Survivorship professional reviews the information in the SCP with the patient at their 
last treatment visit. In addition to reviewing the information, the patient should be 
linked to any resources (e.g., nutritionist, psychologist). 
Last treatment visit is defmed as the last visit for curative intent (e.g. , 
chemotherapy, radiation, surgery). 
If a patient does not have a medical oncologist, the radiation oncologist or 
surgeon reviews the information in the SCP. 
5. Final changes are made to the SCP based on input from the patient (if needed). 
6. The SCP is attached to the problem list on the EPIC electronic medical system for 
access by the patient's PCP. 
7. If the patient's PCP does not have access to the EPIC EMR system, a cover letter along 
with the SCP will be mailed. 
When is the best time to review the BMC survivorship care plan with the patient? 
Based on survivorship care plan studies, the best time to review the care plan with the 
patient is: 1) At the last treatment visit or 2) At the three month follow-up visit. 
Reviewing the survivorship care plan with the patient should not exceed beyond the six 
month visit.24 
How will the BMC survivorship care plan be sent to the primary care provider? 
The survivorship care plan can be sent to the primary care provider via two different 
methods: 
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1. If the provider has access to EPIC, the SCP will be sent via EPIC. 
2. If the provider does not have access to EPIC, the SCP will be mailed to the 
primary care provider with a cover letter. 
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TOOLKIT SECTION 2: 
Special Considerations for Delivering the Survivorship Care Plan to Low-Income 
Cancer Survivors 
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Introduction 
Cancer health disparities are defined as differences in the prevalence, incidence and burden 
of disease among specific groups. 174 Two groups that suffer disproportionally from cancer 
disparities are low-income and racial/ethnic populations.32,81,155 These groups experience 
disparities along the entire cancer care continuum including prevention, screening, 
treatment, and survival. Contributing to these disparities are fmancial barriers (e.g., lack of 
health insurance), environmental factors (e.g., access to needed specialist), risk promoting 
behaviors (e.g., physical inactivity) cultural factors (e.g., mistrust of the health care 
system), and medical provider biases (e.g., lower likelihood of providing pain 
medication). 155,175 Because of these disparities, it is important to consider a cancer 
survivor's health literacy, language, culture, education, and race/ethnicity when delivering 
a survivorship care plan. 
Key Statistics: Cancer Survivorship Disparities 
Low-Income Survivors 
• Cancer survivors with low SES expenence later stage diagnosis, suboptimal 
treatment, and inadequate follow-up care. 80,89,100 
• After cancer treatment, survivors with low SES are more likely to report symptoms 
such as pain, fatigue, and depression. 153,176 
• Survivors oflow SES need additional assistance with appointments, transportation, 
and medical care costs. 155 
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• Patient and provider communication is not as frequent among survivors of low 
SES. 155 
• Minorities are disproportionately represented among the poor, unemployed, and 
undereducated. 100 In Massachusetts, 30% ofBlacks and 38% ofHispanics are living 
below the federal poverty line. 102 
African American Cancer Survivors 
• African Americans have the highest cancer death rate of all racial and ethnic 
groups. Cancer deaths are 32% higher for Black men and 16% higher for Black 
women.84 
• After completing treatment, African American survivors report lower physical 
functioning and general health and greater role limitations than White survivors.88 
• Because African Americans are often diagnosed at later stages of the disease and 
receive more aggressive treatment, studies report that they may be at any increased 
risk for late and long term effects. 89 
Hispanic Cancer Survivors 
• For most cancers, Hispanics have lower incidence and lower mortality rates than 
non-Hispanic, Whites.92 However, they are more likely to be diagnosed at later 
stages.93 Low screening participation for certain cancers, like colorectal cancer, is 
a contributing factor to advanced disease.94 
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• Hispanic survivors are less likely to receive pain medication for cancer treatment 
and to have lower health related quality of life. 95 
Special Considerations for Delivering the SCP to Low-Income Cancer Survivors 
The recommendations listed below are based on the survivorship literature and fmdings 
from a qualitative study and Quality Improvement project conducted among cancer 
survivors at BMC. 
0 Encourage the survivor to bring a family member to the last treatment visit or three 
month follow-up visit 
Rationale: 
Family support and social support is critical in overcoming barriers to 
survivorship care. 68 
In some cultures, family is instrumental in making health related 
decisions. 115 Family members are often the ones to assist the survivor with 
implementing or supporting health care changes/decisions. 
Having a family member at the last visit could help survivors retain some 
of the medical information and instructions being given by the medical 
provider. 24 
Family support seems to diminish after treatment is complete. An SCP can 
serve as a tool to educate family members and caregivers about the needs 
of survivors post-treatment and what they can do to assist them during this 
transition process.24 
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D Encourage survivor to make an appointment with PCP immediately following 
treatment. If possible, the social worker, patient navigator, or administrative staff 
should assist the survivor in scheduling the appointment. 
Rationale: 
Survivors have reported poor communication and poor relationships with 
their PCP after treatment. 5,153 
After cancer, patients are expected to transition back to their PCP for their 
everyday health needs. Unfortunately, many survivors do not visit their 
PCPs and continue to visit their oncologist for all their health needs. 111 
D If patient does not speak English, ensure interpreter is available in person to review 
the SCP. If the interpreter is only available over the phone, ensure that the 
interpreters have been trained to provide information in the SCP. 
Rationale: 
Survivors m the Quality Improvement project at BMC preferred if 
interpreters were available in person to discuss the survivorship care plan. 
Survivors reported that information and communication often got lost with 
over the phone interpreters. 
D Assess and address psychosocial/mental health needs: Ask questions like, how are 
you feeling emotionally? Do you feel like you need to speak with someone? (If so, 
encourage support group meetings). 
Rationale: 
Psychological issues are common among cancer survivors (e.g., distress, 
anxiety, and depression).68 
Survivors have reported that their psychosocial/mental health needs are not 
being addressed after cancer treatment. 68 
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Survivors want information and resources related to their mental health 
concerns. 
Providing appropriate psychological support is critically important for 
survivors as individuals with depression and mental health problems have 
been shown to be less likely to engage in positive health behaviors and 
cancer screenings. 155 
0 Provide information and referrals to a social worker or patient navigator 
Rationale: 
Survivors who participated in the Quality Improvement project at BMC 
reported needing assistance with transportation, food, and housing. A few 
survivors noted they did not have a patient navigator or social worker to 
assist them with these challenges. They thought the SCP could serve as a 
resource for referral to a navigator or social worker. 
D Ensure that the patient understands the information. 
Rationale: 
The oncology team can use probes or questions to ensure that the survivor 
understands the information in the survivorship care plan. For example, the 
provider can ask questions such as "Can you explain this to me in your own 
words?" and "Can you summarize the information we just went over?'' 
D Encourage patient to ask questions or voice their concerns. 
Rationale: 
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Culturally, African Americans and Hispanics may not feel comfortable 
asking their physicians questions. 177 Often times, patients may feel 
embarrassed, feel rushed during the medical visit, or may view asking 
questions as a sign of disrespect. 
The oncology team can encourage the survivors to ask questions while 
reviewing the survivorship care plan. 
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TOOLKIT SECTION 3: 
Resources and Materials for Implementation 
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Flowchart: 
Delivering the Survivorship Care Plan to Colorectal Cancer Patients at BMC 
r 
""' 
r 
"" 
r 
"""' Survivorship 
SCPpacket Professional* Survivorship 
completes Professional printed for the 
Summary Page reviews SCP for patient prior to 
and SCP for CRC accuracy visit 
\.. 
patient on EPIC 
~ \.. \.. ~ ! 
I 
r 
""' Survivorship 
r 
"" 
r 
""" Professional Final changes SCP shared with 
reviews SCP with the ........... madetoSCP PCP via electronic 
patient during last based on input medical record 
treatment visit or 3 from patient (if system, email, or 
month follow-up visit needed) mailing 
\.. ~ \... ...i 
"' 
..) 
*Survivorship professionals may include oncologists, radiation oncologists, surgeons, 
nurses, nurse practitioners, social workers, and patient navigators. These are individuals 
who have expertise in cancer care and/or have been trained to use and deliver the 
Survivorship Care Plan to patients. 
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Date: 
Name 
Address 
City, State 
Zip Code 
Dear Dr. 
Letter to Primary Care Provider 
------------------
Boston Medical Center is currently providing Survivorship Care Plans to patients that have 
completed their cancer treatment. 
As (patient name) is a patient of yours, I am sending a copy of the 
survivorship care plan for your records. The survivorship care plan has important details 
about the cancer treatment delivered to your patient and provides guidelines for monitoring 
and maintaining their health post-treatment. 
If you have any questions about your patient's cancer care, please contact 
------------(cancer center provider name) at (phone number). 
Thank you, 
(Insert name) 
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Title: 
Specific Duties 
Skills: 
Job Description Survivorship Professional 
Survivorship Professional 
• Input patient clinical information in the BMC survivorship 
care plan, such as chemotherapy drug name and number of 
cycles 
• Check patient surveillance schedule to ensure it meets the 
American Society of Clinical Oncology (ASCO) 
recommended guidelines 
• Update clinical and follow-up information in the survivorship 
care plan as needed 
• Assure survivorship care plan is sent to the patient's primary 
care physician 
• Assure patient receives a copy of the survivorship care plan 
• Work collaboratively with members of the oncology team to 
ensure timely scheduling of follow-up care appointments 
• Provide patient education on symptoms to watch out for, 
managing late and long-term effects, other recommended 
cancer screenings, and healthy behaviors. 
• Facilitate referrals to support services such as a counselor, 
social worker, support group, and nutritionist. 
• Assess language needs and coordinate interpreter services in 
advance in needed. 
• Be the main point of contact for the patient should they have 
any questions regarding their survivorship care plan 
• Background in oncology or oncology care coordination 
• Experience with the EPIC electronic medical system 
• Excellent communication skills, both written and oral 
• Ability to work with diverse populations 
• Spanish speaker preferred 
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BOSTON MEDICAL CENTER 
Summary of Your Cancer Treatment and Follow-Up Care 
CONGRATULATIONS! You have completed this stage of your cancer treatment for colon cancer. This 
document will help you understand what to expect during your follow-up visits. 
Summary of Your Cancer Treatment 
Patient Name: 
Date Diagnosed with Cancer: 
Type of Cancer: 
Stage of Cancer: 
Cancer Treatment You Received: 0 Chemotherapy 
0 Radiation 
0 Surgery 
OOther __ _ 
Start Date: ___ _ 
Start Date: ___ _ 
Start Date: ___ _ 
Start Date: ___ _ 
Important Steps for Follow-Up in Your Cancer Treatment 
1. Watch out for new symptoms or other health issues 
End date: ___ _ 
End date: ___ _ 
End date: ___ _ 
End date: ___ _ 
If you experience any of these symptoms and are worried by them contact your primary care doctor or 
cancer doctor: 
• Blood in the stool 
• Abdominal pain 
• Change in bowel habits 
• Cough that doesn' t go away 
• Bone pain 
• New lumps 
• Nausea 
• Vomiting 
• Loss of appetite 
• Weight Loss 
• Fatigue or feeling really tired 
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2. See your cancer doctor for follow-up visits and tests 
It is important that you keep all your appointments with your cancer doctors after treatment ends. During your appointments, your cancer doctor will 
check to see that you are healthy and that your cancer has not come back. Typically, follow-up for your cancer care will continue for 5 years after 
treatment ends. This calendar will help you plan your follow-up care visits for the first year. 
Important Follow-Up Appointments for Your First Year After Treatment 
Follow-up Test Recommendation Appointment Appointment Appointment Appointment Location 
I 2 3 4 
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--
MediClll 
history/physical exam Time: 
--
Time: 
- -
Time: 
--
Time: 
--
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--
CEA Test 
Time: Time: Time: Time: 
-- -- -- --
Once in year Date: 
--
None None None 
Cf SClln (chest & 
abdomen) Time: 
--
Once in year Date: 
--
None None None 
Colonoscopy 
Time: 
--
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--Counseling visits 
Time: Time: Time: Time: 
-- -- -- --
3. Talk To Your Primary Care Doctor About Getting Regular Cancer Screenings 
4. Talk To Your Primary Care Doctor About Maintaining Healthy Habits 
5. Know Who To Call For Your Care 
Your primary contacts for your cancer care are: 
Primary Care Provider: ____ (name) _____ (phone number) 
Cancer Center Provider: ____ (name) (phone number) 
6. Resources For Staying Healthy 
Boston Medical Center has free programs to support you and your family after cancer treatment like: 
• Support Groups (English, Spanish, and Haitian Creole) 
• Spirituality Group 
• Zumba 
To fmd out about these and other programs call or email Cancer Support Services at 617-638-7 540 I cancersupport@bmc.org 
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IT Dictionary for 
Summary of Your Cancer Treatment and Follow-Up Care Page 
Overview 
The IT dictionary contains the fields/answers for each of the sections of the Summary Page. 
This dictionary will be used to build the survivorship care plan on the EPIC electronic 
medical record system. 
Survivorship Care Plan Field Answers 
Patient N arne Manually inputted or automatically 
populated from patient medical record 
Date diagnosed with cancer Manually inputted or automatically 
populated from patient medical record 
Type • Colon 
• Rectal 
Stage of cancer • 0: This is often a pre-cancerous 
condition and means your cancer is 
within the lining of the colon or 
rectum. 178 
• 1 : The cancer has spread through the 
innermost lining of the colon to the 
second and third layers of the colon 
wall. It has not spread outside the 
colon. 178 
• 2: The cancer has spread outside the 
colon to nearby tissues. 178 
• 3: Cancer has spread to nearby lymph 
nodes, but not to other parts of the 
body. 178 
• 4: Cancer has spread to other parts of 
the body. 178 
Cancer treatment you received • Chemotherapy 
• Radiation 
• Surgery 
• Other 
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BOSTON MEDICAL CENTER 
Survivorship Care Plan for Colorectal Cancer 
*Adapted from the Journey Forward Survivorship Care Plan 
This Survivorship Care Plan was created especially for you. It has important information about your 
cancer treatment, follow-up care visits, and steps you can take to live a healthy life after cancer. 
IMPORTANT CONTACT INFORMATION 
Personal Information 
Patient Name 
Phone (home) 
Phone (cell) 
Date of Birth 
Age at diagnosis 
Alternate Contact Name: Phone: 
Healthcare Proxy Name: Phone: 
Your Medical Care Team Address Phone Number 
Your Primary Contact 
at the Cancer Center: 
Hematologist/Oncologist: 
Radiation Oncologist: 
Gastroenterologist: 
Primary Care Physician: 
Nurse/Nurse Practitioner: 
Social Worker: 
Patient Navigator: 
Other: 
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BACKROUND INFORMATION ABOUT YOUR CANCER 
Cancer Dia2nosis 
Type of Cancer 
Date you were diagnosed with 
cancer 
How was your cancer detected? 
First time diagnosed DYes 
with cancer? D No (cancer type) (year of diagnosis) 
Stage of Your Cancer Stage: 
T Stage 
--
N Stage 
--
M Stage 
--
Family History? DYes Ifyes, describe: 
D No 
Notable Pathologic Findings 
Has Ostomy? DYes If yes, instructions/Comments: 
D No 
Other major health concerns 
Additional comments 
SUMMARY OF YOUR CANCER TREATMENT 
Date of your surgery 
Type of surgery 
Ongoing side effects 
Additional comments 
Chemotherapy 
Dates of chemotherapy Date Started: Date Completed: 
treatment 
Central Venous Catheter DYes DNo 
Needed 
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Chemotherapy Drug Name: # of cycles administered: % dose reduction: 
Name 1: 
Name 2: 
Reason for stopping 
chemotherapy 
Disease status at the end of 
treatment 
Ongoing side effects 
Additional comments 
Radiation 
Dates of radiation treatment Date Started: I Date Completed: 
Area of body treated 
Radiation dose 
Ongoing side effects 
Additional comments 
Clinical Trial Information 
Patient on a clinical trial? DYes DNo 
Dates of clinical trial Date Started: I Date Completed: 
Name of clinical trial 
Name of clinical trial contact Name: I Phone Number: 
person 
YOUR FOLLOW-UP CARE 
This section has information about the care you will need after your finish your cancer treatment. It 
also has information to help you live a healthy life after cancer. 
After talkin2 to my cancer doctor, I am worried about ... 
My Concerns: Recommendations from my cancer doctor: 
My cancer coming back • I need to know that these feelings are normal, and they won't cause 
the cancer to come back. 
• Referral for cognitive behavioral therapy or counseling 
• Referral to support group 
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Fatigue • Regular physical activity (e.g. walking 20 minutes daily) I 
Evaluation for hypothyroidism, anemia, depression I • 
Diet • Referral to a nutritionist 
Financial Concerns: • Referral to a social worker 
Other: 
Recommended Follow-Up Tests 
What tests will I need? Year 1 Year2 Year3 Year 4 & 5 Coordinating 
Provider 
Medical history/physical Every 3 Every 3 Every 3 Every 6 
months months months months 
exam 
CEA Test Every 3 Every 3 Every 3 
months months months 
CT Scan (Chest & Abdomen) Once in year Once in year Once in year Every year 
Colonoscopy Once in year 
Counseling Visits Every 3 Every 3 Every 3 Every 3 J months months months months 
***After 5 years, your cancer doctor and primary care doctor will talk with you and your family about 
next steps in your follow-up care. * * * 
Recommended General Cancer Screenin s 
Don't forget to get screened for other cancer types. People who have been successfully treated for 
cancer may have a greater chance of having other cancers. Speak with your primary care doctor about 
how often you should get screened for other cancers. 
D Based on your cancer, routine cancer screening is appropriate. 
D Other comments 
--------------------------------
I Late Effects of Your Cancer Treatment 
What are late effects? Late effects are those side effects that you might experience after your 
treatment has stopped. They may happen months or years after you finish treatment. Your doctors will 
work with you to monitor these side effects . Based on the treatment you received, you may be at risk 
for these possible late effects: 
• Surgery 
o Bowel problems, such as diarrhea, fecal leakage/incontinence, constipation, 
bowel obstruction, hernia, pain, colostomy, sexual dysfunction, psychological 
distress 
• Chemo/biotherapy 
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o Fatigue, peripheral neuropathy 
• Radiation 
o Fatigue, scarring, bowel obstruction, rectal or bladder irritation. 
• Other 
o Cancer recurrence or second primary cancers 
I Symptoms to Watch Out For 
You should report these signs and symptoms to your primary care doctor or cancer doctor if persistent: 
• Blood in stool 
• Abdominal pain 
• Change in bowel habits 
• Cough that doesn't go away 
• Bone pain 
• New lumps 
• Nausea 
• Vomiting 
• Loss of appetite 
• Weight loss 
• Fatigue 
Survivorship Care Plan Prepared by: Date: 
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IT Dictionary 
for 
Survivorship Care Plan for Colorectal Cancer 
*Adapted from the Journey Forward Survivorship Care Plan 
Overview 
The IT dictionary contains the fields/answers for each of the sections of the adapted 
Journey Forward Survivorship Care Plan. This dictionary will be used to build the 
survivorship care plan on the EPIC electronic medical record system. 
Survivorship Care Plan Field Answers 
Patient Name Manually inputted or automatically 
Phone (home) populated from patient medical record 
Phone (cell) 
Date of birth 
Age at diagnosis 
Alternate Contact Name 
Alternate Contact Phone 
Health Care Proxy Name 
Health Care Proxy Phone 
Your primary contact at the cancer center Manually inputted 
Hematologist/oncologist Manually inputted or automatically 
Radiation oncologist populated from patient medical record 
Gastroenterologist 
Primary care physician 
Nurse/nurse practitioner 
Social worker 
Patient navigator 
Other 
Type of cancer • Colon 
• Rectal 
Date of diagnosis Manually input or automatically populated 
from patient medical record 
How was your cancer detected? • Colorectal cancer screening 
• Presented with symptoms 
0 Pain in the belly 
0 Blood in the stool 
0 Diarrhea 
0 Constipation 
0 Fatigue 
0 Unexplained weight loss 
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• Other (manually input) 
First time diagnosed with cancer? • Yes 
• No (manually input cancer type) 
Stage of your cancer • 0 
• 1 
• 2 
• 3 
• 4 
T Stage • Tl 
• T2 
• T3 
• T4a 
• T4b 
N Stage • Nx 
• NO 
• Nl 
• Nla 
• Nlb 
• Nlc 
• N2 
M Stage • MO 
• Mla 
• Mlb 
Family History • Yes 
• No 
If yes, describe Manually input description regarding 
family history 
Notable pathologic fmdings Manually input 
Has ostomy? • Yes-Temporary 
• Yes-Permanent 
• No 
Instructions/ comments: Manually input instructions/comments 
Other major health concerns • Anemia 
• Asthma 
• Congestive heart failure 
• Chronic Obstructive Pulmonary 
Disease 
• Depression 
• Diabetes 
• Eating disorder 
• Gynecologic problems 
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• Heart attack 
• High blood pressure 
• Liver disease 
• Migraine headaches 
• Osteoporosis 
• Osteoarthritis 
• Renal disease 
• Rheumatoid Arthritis 
• Other (manually input) 
Additional comments Manually input additional comments 
Date of surgery Manually inputted or automatically 
populated from patient medical record 
Type of surgery • Right hemicolectomy 
• Tranverse colectomy 
• Left hemicolectomy 
• Temporary colectomy 
Ongoing side effects • Pain 
• Diarrhea 
• F ecalleakage 
• Constipation 
• Colostomy 
• Sexual dysfunction 
• Other 
Additional comments Manually input additional comments 
Dates of chemotherapy treatment 
Date Started • Manually input start date or 
automatically populated from patient 
medical record 
Date Completed • Manually input end date or 
automatically populated from patient 
medical record 
Central venous catheter needed • Yes 
• No 
Chemotherapy drug name • 5-FU +LV (Mayo clinic regimen) 
• 5-FU +LV (Roswell park 
regimen) 
• Capecitabine 
• FLOX 
• FOLFOX4 
• FOLFOX6 
• Modified FOLFOX6 
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• Uracil-Tegafur + Leucovorin 
• XELOX 
• Other 
# of cycles administered Manual input 
% dose reduction Manual input 
Reason for stopping chemotherapy • Completed treatment 
• Progression of disease on 
treatment 
• Toxicity of treatment 
• Other health concerns 
Disease status at the end of treatment • No evidence of disease 
• Persistently elevated tumor marker 
• Possible recurrence based on 
1magmg 
• Evidence of persistent/recurrent 
disease 
Ongoing side effects • Hair loss 
• Neuropathy 
• Low blood count 
• Fatigue 
• Diarrhea 
• Dehydration 
• Nausea/vomiting 
• Other 
Additional comments Manually input 
Dates of radiation treatment 
Date Started • Manually input start date or 
automatically populated from patient 
medical record 
Date Completed • Manually input end date or 
automatically populated from patient 
medical record 
Area of body treated Manually inputted or automatically 
populated from patient medical record 
Ongoing side effects • Nausea 
• Vomiting 
• Rectal irritation 
• Bladder irritation 
• Tiredness 
Additional comments Manually input additional comments 
Patient on clinical trial • Yes 
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• No 
Dates of clinical trial 
Date Started • Manually input start date or 
automatically populated from patient 
medical record 
Date Completed • Manually input end date or 
automatically populated from patient 
medical record 
N arne of clinical trial Manually input 
Name of clinical trial contact person Manually input 
My concerns: • Depression 
• Anxiety 
• Screening for other cancers 
• Bone health 
• Fatigue 
• Pain 
• Marital/partner/family relationships 
• Diet 
• Exercise 
• Smoking cessation 
• Weight gain or overweight 
• Cancer coming back 
• Immunizations 
• Insomnia 
• Memory problems or confusion 
• Intimacy and sexuality 
• Employment, insurance, other 
fmancial issues 
• Legal issues 
• Other 
What tests will I need? • Medical history/physical exam 
• CEA test 
• CT scan (chest & abdomen) 
• Colonoscopy 
• Counseling visits 
Medical History Year 1 • Every 3 months 
• Every 4 months 
• Every 5 months 
• Ev~6months 
Medical History Year 2 • Every 3 months 
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• Every 4 months 
• Every 5 months 
• Every 6 months 
Medical History Year 3 • Every 3 months 
• Every 4 months 
• Every 5 months 
• Every 6 months 
Medical History Year 4 & 5 • Every 3 months 
• Every 6 months 
• Every 9 months 
• Every year 
CEA Test Year 1 • Every month 
• Every 2 months 
• Every 3 months 
• Every 4 months 
• Every 5 months 
• Every 6 months 
• Once in year 
CEA Test Year 2 • Every month 
• Every 2 months 
• Every 3 months 
• Every 4 months 
• Every 5 months 
• Every 6 months 
• Once in year 
CEA Test Year 3 • Every month 
• Every 2 months 
• Every 3 months 
• Every 4 months 
• Every 5 months 
• Every 6 months 
• Once in year 
CEA Test Year 4 & 5 • Every 3 months 
• Every 4 months 
• Every 5 months 
• Every 6 months 
CT scan Year 1 • Every 6 months 
• Once in year 
CT scan Year 2 • Every 6 months 
• Once in year 
CT scan Year 3 • Every 6 months 
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• Once in year 
CT scan Year 4 & 5 • Every 6 months 
• Once in year 
• Once in 2 years 
Colonoscopy Year 1 • Not needed 
• Once in year 
Colonoscopy Year 2 • Not needed 
• Once in year 
Colonoscopy Year 3 • Not needed 
• Once in year 
Colonoscopy Year 4 & 5 • Not needed 
• Once in year 
Counseling visits Year 1 • Every 3 months 
Counseling visits Year 2 • Every 6 months 
Counseling visits Year 3 • Once in year 
Counseling visits Year 4 & 5 • Not needed 
Coordinating Provider Manually inputted or automatically 
populated from patient medical record 
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Cancer 
Cancer stage 
Carcinoembryonic 
antigen (CEA) test 
Central Venous Catheter 
Chemotherapy 
Clinical trial 
Colonoscopy 
Computerized tomography 
(CT) scan 
Metastasis 
Ostomy 
Radiation 
Side Effects 
Cancer Dictionary 
Cancer is a group of diseases that have to do with cells. 
Cells are small units that make up all living things. 
Cancer happens when the cells inside your body do not 
grow normally. 179 
Cancer stage is extent of a cancer in your body. Doctors 
determine the stage by: 180 
• the size of the tumor (T) 
• Whether the lymph nodes have cancer (N), 
• If the cancer has spread to other parts of the 
body (M) 
The CEA test is a blood test. High levels of CEA 
may mean that the cancer has retumed. 173 
A long, thin flexible tube put into your arm or chest. It is 
used to take blood samples and to give medicines like 
chemotherapy.180 
Chemotherapy is a drug therapy that kills cancer cells or 
stops them from multiplying. It can also harm healthy 
cells, which causes side effects. 181 
Clinical trials are research studies that help doctors fmd 
out how well new treatments work in people. 181 
This is test that uses a tub with a light bulb and camera 
and lets your doctor look for polyps or second cancers in 
the rectum and colon. 173 
A CT scan is a picture of the inside if your body 
created by a computer linked to an x-ray machine. 180 
The spread of cancer from one part of the body to 
another. 181 
An ostomy is an opening created in abdomen to help you 
get rid of body waste like feces. 180 
Radiation is the use of high-energy X- rays used to kill 
cancer cells. 181 
Problems that happen because of the cancer treatment. 
For example, vomiting and hair loss. 180 
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CHAPTERS: 
DISCUSSION & CONCLUSION 
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1. Introduction to the Chapter 
This dissertation is one of the few studies that explores the expenences and 
perceptions of low-income Black and Hispanic cancer survivors as they move from 
treatment to survivorship. This is an important first step in understanding how diverse 
cancer survivors perceive life after treatment. The results from the qualitative investigation 
in Chapter 2 help inform future survivorship interventions and the design of survivorship 
care plans (SCP) that are relevant, culturally appropriate, useful, and tailored to the needs 
of low-income minority survivors. 
A second and third aim of this dissertation was to adapt and test the usability of an 
already existing survivorship care plan, called Journey Forward, for low-income colorectal 
cancer survivors at Boston Medical Center. This work builds upon the previous literature 
on SCPs and the use of Quality Improvement (QI) methods to improve products and health 
system processes. By engaging in QI, the SCP was adapted to meet the cultural beliefs, 
information needs, and preferences identified by low-income colorectal cancer survivors. 
The remainder of this chapter presents the major findings of the dissertation. The 
findings are organized by: 1) Study 1: Qualitative study on the transition experiences of 
low-income Black and Hispanic cancer survivors and 2) Study 2: Quality Improvement 
project on the adaptation and usability of the Journey Forward Survivorship Care Plan. 
Future research and practical implications are also presented. 
192 
2. Study 1: Qualitative study on the transition experiences of low-income Black and 
Hispanic Cancer Survivors 
The findings in Study 1 suggest that for low-income Black and Hispanic cancer 
survivors the transition to survivorship is a long-term process that is complicated by factors 
such as poor mental health, no family support, poverty, and lack of understanding of the 
importance of follow-up visits and tests. These factors prevent survivors from moving 
beyond their cancer diagnosis and shifting their focus to post-treatment care and health. 
One major finding was the importance of mental health after treatment. Low-
income Black and Hispanic cancer survivors viewed mental health just as important as 
their physical health. Almost all survivors reported experiencing feelings of depression 
and loneliness. In fact, depression was cited as the most the common challenge. For many, 
depression was not just the result of a cancer diagnosis, but was also exacerbated by life's 
circumstances such as inadequate housing, language issues, immigration status, and 
problems within the family such as drug use and violence. Among Spanish speaking 
survivors, the limited availability of Spanish speaking mental health programs and 
providers, was also cited as a challenge. Behavioral interventions that are culturally 
appropriate, led by racially and ethnically diverse staff who speak the patient's language, 
and that extend beyond nonprofessional support (e.g., support groups) may be important in 
addressing the mental health needs of Black and Hispanic cancer survivors. 
Competing priorities, both health and non-health related, also deterred survivors 
from adhering to follow-up visits and initiating positive behavioral changes. Survivors 
consistently reported comorbid conditions (e.g., diabetes) and access to healthy foods as 
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challenges and stressors that hindered their full recovery post-treatment. For example, 
survivors were well aware that eating healthier foods and exercising were important for 
their health. However, they could not afford to purchase fruits, vegetables, meats, and 
healthier products. They also did not have access to exercise facilities in their 
communities. The cost of bus and train fare as well irregular bus service schedules also 
discouraged survivors from attending survivorship programs at the cancer center. Cancer 
centers will need to employ techniques to help overcome some of these challenges. For 
example, offering free bus or train fare for survivors who attend survivorship programs. 
Another finding is that survivors did not know or understand the purpose of follow-
up visits and why the visits were scheduled so regularly. Survivors consistently reported 
confusion as to why they had to see their medical oncologists every three months if they 
no longer had cancer. This illustrates the need for oncology to provide the survivor with 
structured education and information on follow-up care visits, including why they are 
necessary, what the tests would tell them about the cancer, and the importance of not 
missing appointments. 
Spirituality was also significant to low-income Black and Hispanic survivors and 
may be important for addressing issues related to fear of recurrence. Survivors who 
reported doing well post-treatment and coping with negative thoughts related to their 
cancer returning were those who engaged in spiritual activities, such as prayer. Linking 
survivors to spiritual resources at the cancer center and in the community may assist them 
in finding meaning in their cancer and coping with post-treatment doubts and fears. 
Family dynamics is also crucial to the health of low-income Black and Hispanic 
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survivors. Survivors who reported difficulties adjusting to life after cancer treatment were 
those who did not have the support of their families; those who did not share their cancer 
diagnosis because it was considered a cultural taboo; survivors who expressed problems 
within the family (e.g., husbands leaving their wives after a cancer diagnosis); and 
immigrants who did not have any family members living in the U.S. For these survivors, 
possible interventions may include family counseling, inviting family members to support 
groups, and providing the survivor with strategies and information they can use to speak 
with their family members about the cancer and post-treatment needs. 
The last major finding was that Black and Hispanic survivors did not view their 
PCPs as having a central role in their cancer care, during or after treatment. A few 
survivors had been with their PCPs for years while other survivors had new PCPs after 
completing treatment. Those with newer PCPs reported poorer communication and poorer 
relationships, which contributed to the absence of conversations regarding their cancer 
history. The SCP, adapted in Study 2, may reduce this communication gap with the patient. 
Additionally, with the growth of Patient Centered Medical Homes, the hope is that care 
will be better coordinated and patients will forge stronger relationships with their PCPs. 
Of course, it may also be important to provide trainings to PCPs on survivorship issues 
unique to Black and Hispanic survivors and the best methods for communicating with them 
about post-treatment care. Retention of PCPs at community health centers is also another 
issue that needs addressing. Many survivors reported that new PCPs were assigned to them 
almost every year because their previous provider was no longer at the community health 
center. Having a consistent medical provider may be important in increasing trust, 
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communication, and involvement in cancer care. 
Consistency with the Literature 
Many of the findings in this dissertation are consistent with the literature on 
survivorship. Typically, survivors go through a period of acceptance and adjustment after 
completing treatment. 5 This period of adjustment is an ongoing process that can lasts for 
months and sometimes years. It is a period that is often replete with psychological 
challenges, such as depression, distress, and anxiety.68 These problems are compounded 
by social and financial factors such as low SES, lack of social support, and the health care 
system itself (e.g., poor communication between the patient and physicians). 68 
Additionally, it is not surprising that most survivors interviewed in this study reported 
being depressed. Studies have found that survivors of low SES have higher levels of 
psychological distress than other survivors. 153 This is partly due to the physical, social, 
cultural, and health care system challenges they experience throughout their lives. 
Unfortunately, Black and Hispanic survivors also reported that their mental health 
issues were not being addressed effectively by their care team. Specifically, they reported 
worrying about the cancer on a daily basis, crying, fearing that the cancer would return, 
and feeling anxious when going in for surveillance testing. These are problems that are 
commonly reported among many cancer survivors. Research has documented consistently 
that survivors have unmet psychosocial needs and that these needs are not often assessed 
by their physicians. 68 In a survey conducted by the American Society of Clinical 
Oncologist, over one third of oncologists reported that they do not routinely screen patients 
for distress. 154 Routine screening does not always occur because of time constraints, lack 
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of education and training, lack of reimbursement, and unavailability of support services. 154 
Providing appropriate psychological support is critically important for survivors as 
individuals with depression and mental health problems have been shown to be less likely 
to engage in positive health behaviors and cancer screenings. 155 They also have worse 
health outcomes. Given that Black and Hispanic cancer survivors in this qualitative study 
reported skipping cancer treatments, surveillance tests, and follow-appointments, greater 
attention will need to be paid to addressing their mental health concerns through effective 
interventions, education, and survivorship care planning. 
Unique to Black and Hispanic survivors in this study was the burden of follow-up 
appointments. In other published studies, survivors have viewed their follow-up 
appointments as a safety net and a way to ensure that their cancer is being monitored. 5 
Black and Hispanic survivors, however, often questioned why they needed to see their 
oncologists so frequently if there cancer was gone. They preferred not to come in as often 
to see their oncologist. This is a concern as some research exists indicating that African 
American and low SES survivors are less likely to adhere to follow-up visits, which are 
critical for the management of treatment related symptoms and surveillance for 
recurrence. 155 This emphasizes the need to educate patients on the purpose of follow-up 
visits as well as symptoms to watch out for, how to reduce risk of recurrence, and late and 
long-term effects. 
Summary of key findings from Study I: 
• Mental health and psychological well-being are the largest concerns among low-
income Black and Hispanic cancer survivors. 
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• Low-income Black and Hispanic cancer survivors understand that healthy eating 
and physical activity are important to maintaining a healthy life after cancer. 
However, access and affordability ofhealthy of foods and exercise facilities prevent 
them from initiating these positive health behaviors. 
• Cost of bus and train fare as well as the distance to the cancer center prevent 
survivors from participating in survivorship programs, such as the support groups. 
• Low-income Black and Hispanic cancer survivors are not aware of why they need 
follow-up visits and tests. 
• Spirituality and God are important for coping with fear of recurrence. 
• There is an urgent need for primary care providers to become better integrated in a 
survivor' s treatment and post-treatment care. 
• Family dynamics are important in maintaining good mental health and 
understanding post-treatment information. 
3. Specific Aim 2 and 3: Adapting and testing the usability of an already existing 
survivorship care plan for low-income colorectal cancer survivors 
During the adaptation of the Journey Forward Survivorship Care Plan, there were 
several cultural and socioeconomic related modifications recommended by low-income 
CRC survivors. First, is the importance of family and the role that family plays in making 
and reinforcing health behaviors, like keeping medical appointments. Specifically, 
survivors wanted family members to be present when the oncologist reviewed the 
information in the SCP, as it would increase the families understanding and support of their 
care after treatment. This was especially important for Spanish speaking survivors, who 
indicated that having family members present could assist them in overcoming language 
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barriers; especially as it relates to fully understanding the content ofthe SCP. In addition 
to this, survivors thought the SCP was imperative for sharing information with extended 
family members or family in their home countries. Survivors placed a high value on being 
be able share clinical information with the family. 
A second modification was that Spanish speaking cancer survivors wanted to be 
assured that the information in the SCP would be appropriately translated and interpreted 
in Spanish. They expressed that interpreters often left out critical medical information 
during medical visits with oncologists. Because of this, they were also concerned that an 
oral translation of the SCP would not meet their needs. A potential solution to this may be 
giving interpreters at the cancer center a formal training on SCPs and how to effectively 
translate and communicate the survivorship information to the patient. 
A third modification was for the SCP to help facilitate referrals to patient navigators 
or social workers. Survivors reported that they needed assistance with obtaining mental 
health services, food, and housing. They were not aware that they could self-refer to a 
patient navigator or social worker who could link them to appropriate resources. A fourth 
recommendation was adding definitions and explanations for some of the medical 
vocabulary used in the SCP. Survivors felt some of the language in the SCP was complex 
but they found comfort in having possession of that clinical information. They proposed 
including a glossary at the end of the SCP. The final major recommendation was including 
culturally appropriate hospital and community based survivorship programs, such as 
Spanish-speaking support groups. Overall, however, survivors were excited about the 
adapted version of Journey Forward Survivorship Care Plan and expressed a desire to 
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receive a personalized copy. They found the length of the SCP to be just right. The sections 
also included information that was important for survivors such as the stage of the cancer 
and the provider's contact information. 
Primary care providers and oncologists also expressed that an SCP was necessary 
and should be part of routine oncology care. However, to be of value and useful for low-
income survivors they recommended reducing the amount of clinical information in the 
Journey Forward Survivorship Care Plan as well as shortening the length. 
Summary ofkeyjindingsfrom Study 2: 
• Family members are important to the survivorship care planning process. 
• A lack of well-trained interpreters can be a challenge to orally translating the SCP 
to Spanish speakers. 
• Low-income colorectal cancer survivors want SCPs to serve as a referral 
mechanism to patient navigators and social workers for help with basic needs, like 
housing. 
• Understanding of the SCP can be improved by adding definitions of key medical 
terms. 
• Culturally appropriate survivorship programs are important to include in the SCP. 
4. Public Health and Practice Implications 
The findings from this dissertation have practical implications for cancer centers 
treating diverse populations. The findings from the qualitative study provide cancer centers 
with knowledge and information on the unique post-treatment needs and issues 
experienced by low-income Black and Hispanic survivors. This knowledge can help 
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inform the development of future survivorship interventions and resources that are 
linguistically and culturally appropriate. They can also assist in enhancing and improving 
already existing survivorship programs at the cancer center. For example, incorporating 
topics related to cancer survivorship at support group meetings. The findings suggest that 
there are areas that need improvement, mainly, assessment of mental health and referrals 
to mental health services as well as assistance with basic living needs such as housing, 
access to food, and transportation. Identification of these challenges can assist cancer 
centers in finding and linking survivors to appropriate sources of support. 
The fmal version of the adapted Journey Forward Survivorship Care Plan template 
at Boston Medical Center also has the potential to improve care, standardize survivorship 
practices, and ensure consistency in the post-treatment information being communicated 
to the patient and primary care provider. The goal at BMC is to build the final version of 
the adapted SCP into the EPIC electronic medical record (EMR) system. The EMR would 
directly populate fields in the treatment summary and follow-up sections of the SCP. This 
would minimize the amount of time and work needed by oncology staff to complete the 
SCP for the patient. Additionally, the SCP could allow for more extensive PCP 
involvement in the patient's cancer care. Once the SCP is built in the EMR system, 
oncology can begin creating the SCP as early as the cancer diagnosis and route the 
information to the PCPs; allowing for greater communication and transfer of information. 
With more community health centers becoming Patient Centered Medical Homes 
the SCP could also serve as a model for other specialists referring patients back to the care 
of PCPs for follow-up. Patients with multiple comorbid conditions (e.g., diabetes, heart 
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disease) often see a number of specialists and receive care in different settings. A follow-
up care plan that contains clear instructions for PCPs and patients may prove to be 
beneficial for communicating and improving care for other disease types. 
Findings from the qualitative study and Quality Improvement project can also be 
used to model other disease specific survivorship care plans at BMC, such as an SCP for 
breast and prostate cancer. The participants in the qualitative study represented various 
cancer groups and their experiences and suggestions can help improve the design of other 
SCPs. Lastly, the QI project identified factors unique to low-income survivors in 
survivorship care planning. This information was used to create an implementation toolkit 
for BMC that centered on issues raised by the survivors. 
5. Recommendations for Future Research 
There are several recommendations for future research that emerged from this 
study. First, it may be useful to investigate the transition experiences of minority cancer 
survivors by specific cancer site. Each cancer site has features that are unique to that 
specific cancer and may yield different survivorship experiences. Additionally, it may 
important to explore the unique needs of immigrant population groups. Immigrants in this 
study reported poorer health, less support from family, and more challenges to accessing 
survivorship services and care. An exploratory study can provide valuable knowledge and 
help address some of the challenges experienced by this population. Most importantly, 
future research is needed to evaluate and assess the impact of survivorship care plans on 
minority populations, including those with limited English proficiency. Various research 
designs can be used to evaluate the effects of the survivorship care plan, including a 
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randomized controlled trial or Quality Improvement methods. Possible evaluation 
measures may include: 1) increased survivor knowledge of cancer treatment and follow-
up care, 2) survivor adherence to recommended screening and surveillance tests, 3) 
improved patient and provider communication, 4) improved quality of life, and 5) 
reduction in duplication or gaps in services. This data can provide support and guidance 
on using SCPs effectively to increase surveillance, improve physical and mental health, 
and improve the quality of life of survivors. 
Conclusion 
This dissertation makes important contributions to survivorship research and public 
health practice. Findings illustrate that low-income Black and Hispanic cancer survivors 
have various unmet needs, that range from psychological to social, and could prevent them 
from successfully transitioning to survivorship and adhering to follow-up appointments 
and recommendations from oncologists and PCPs. The fmal version of the adapted 
Journey Forward Survivorship Care Plan for low-income colorectal cancer survivors 
represents an important first towards creating a culturally appropriate SCP that can help 
successfully transition survivors to follow-up care. 
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Appendix A 
Existi.K Strvivormip CarePiu Templates 
Teaplate Wllllite TeaplateAn .. le Leqth Pros Caas 
l .... lljorCIIJICfl' {P~p~) 
Sits 
Amrri:m Society of nw .ciiJICfl' JJrlisar • Bl'fliSt l • T eaplate mDa'ble for • Microsohord template; 
CliaiW OncoloiY 'fivorsldp • Colon lllllldple cucer sits iufOIDIIdon needs to lie m1111111ly 
Surrlvonbip Care I Lq (e.g~ breast, colon) illputtnl by prorider 
Plan • Lymphoma • Only l paps lone I Conllills sq~mte dOCUIIImts for 
• Grnml t1111plate trstmmt SIIJIIJIW'Y md folhnr-up 
for an cmcen plan 
lolii'Dey F ornnl http:/~oan.eyfonr • Bnut 4 I Teq~late mDable for I Software needs m be ilubllnl 
Surrlvonbip Care anl.Of11 • Co loa lllllltiple cucer sits • Time co11111111iag to iaput patimt 
Plan • Lq • Prtferrnllly patimts information 
• Lymphoma IIIII pmillen 
• Prostate • Conllills patient IIIII 
I Geaml tmtlate pmiller toolkits 
for an cmcen • Easiest for padenls to 
rail IIIII IJilllerstuul 
LivestrODg nw .livestrODgcare • Bnut 14 I T emplateavaila'ble for • Surrlvon del'eilp care plan ODiille 
Surrlvonbip Care plm.orcf • Colon multiple cmcer sits bythemsflves 
Plan I Lq • Available ill Spuish • Puts OlliS on patimt to complete 
• Prostate care plan IIIII miew with 
I T emplats for 34 hslthcare 1e1m 
adler CIDCfJ'S I Surrlvon nems to have lmowled1e 
of daei' cecer to complete plan 
( e.1~ medications nctivnl) 
• SCP is 14 PillS lone 
Prscription for Nunillgcmter .com • One template ilr l • Oaly l pa1es Ioiii • Oaly one gmeric cmcer template 
LiviDg ancecen avdable 
• Microsoft word tEmplate; 
information needs to be mmually 
illputtnl by provider 
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Appendix B: Study Recruitment Flyer (English) 
Have you ever been diagnosed with cancer? 
If the answer is yes, we want to hear about your 
experiences! 
JOIN US: 
The Prevention Research Center at Boston University 
is doing a research study to learn more about your 
experiences as a cancer survivor. We are inviting 
cancer survivors who have completed cancer 
treatment to participate in a one-time, 1 hour 
interview. 
WHY?: 
The information you provide us with will help us 
create better programs for cancer survivors after they 
fmish their cancer treatment. 
You may be eligible to participate if: 
• You are Black or Hispanic 
• Completed cancer treatment 
• Were diagnosed with cancer less than 5 years ago 
• Are 18 years of age or older 
• Are low-income 
Each participant will receive a $25 gift card for their 
participation. 
If you are interested in being interviewed, please contact: 
_________ M ________ __ 
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Appendix C: Study Recruitment Flyer (Spanish) 
;,Algona vez ha sido usted diagnosticado con 
cancer? 
i Si la respuesta es si, nosotros queremos escuchar de sus 
experiencias! 
ACOMPANENOS: 
El Prevention Research Center en Boston University 
esta hacienda un estudio de investigaci6n para aprender 
mas acerca de sus experiencias como sobreviviente de 
cancer. Estamos invitando a sobrevivientes de cancer 
que han completado el tratamiento del cancer a participar 
en una entrevista individual de una hora. 
;,PORQUE? 
La informacion que usted nos proporcione nos ayudara a 
crear mejores programas para sobrevivientes de cancer 
despues que terminen su tratamiento de cancer. 
Usted podria ser elegible para participar si: 
• Usted es Negro o Hispano 
• Ha completado su tratamiento del cancer 
• Fue diagnosticado con cancer menos de 5 afios atras 
• Tiene 18 afios de edad o mas 
• Es de bajo ingreso 
Cada participante recibira una tai:jeta de 
regalo de $25 por su participacion. 
Si usted esta interesado en ser entrevistado, llame a: 
__________ & __________ _ 
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Appendix D: Screening Eligibility Form 
Telephone Interview Script 
Instructions: Telephone call to set up interview. 
Good morning/afternoon. May I please speak with _______ ? 
My name is and I am calling from the Prevention Research Center at 
Boston University. How are you doing today? I am calling because at an earlier time you 
indicated (through phone message or email) that you are a cancer survivor and would like 
to participate in a research study that involves an interview 
As you may already, we are conducting interviews to learn more about the experiences of 
cancer survivors during the first few years after they complete cancer treatment. All 
interviews are voluntary and confidential and you will receive $25 for your participation. 
Before we proceed, would it be okay if I ask you a few questions to see if you are eligible 
to be interviewed? I will not write down your answers. 
If yes ----> proceed with the following screening questions: 
1) How old are you? 
2) What is your race/ethnicity? 
3) What type of cancer were you diagnosed with? 
4) What year were you diagnosed with cancer? 
5) Have you completed your cancer treatment? 
If no----> Okay. Thank you for your time. 
If eligible ---> Based on your answers to these questions, you are eligible to be 
interviewed. 
Would you be available for an interview on ____ (date) at 
__ (time) at (location)? 
If no ----> Is there a date and time that would work better for you? 
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Thank you very much for your willingness to be interviewed on . I look 
forward to meeting you. If you have any questions in the meantime feel free to call 
me at and again my name is ____ _ 
If not eligible ----> Based on your answers to these questions, you are not eligible to 
participate because (provide one or more of the reasons below). We appreciate 
your interest in being interviewed and once again, thank you for your time. 
[Participants are not eligible to participate if they are 1) not Black or Hispanic, 2) 
have never been diagnosed with cancer, 3) are 17 years of age or younger, or 3) 
were diagnosed with cancer more than 5 years ago] 
Telephone Script: Leaving a Message 
Instructions: Telephone call to set up interview. 
Good morning/afternoon. This message is for----------'-
My name is and I am calling from the Prevention Research Center at 
Boston University. I am calling because at an earlier time you indicated (through phone 
message or email) that you would like to participate in an interview. 
Please feel free to give me a call at _____ so I can share additional information 
with you and set up an interview. 
I look forward to hearing from you. 
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Appendix E: Demographic Form (English) 
Cancer Survivorship Demographic Questionnaire 
1. What is your race/ethnicity? 
D Black, but not Hispanic/Latino 
D Hispanic/Latina 
D MixedRace 
2. What is your gender? 
D Male D Female 
3. What is your age? 
4. How many years of schooling or education did you complete? 
D Less than a high school diploma 
D High School Diploma 
D 1 to 4 years at a university 
D Bachelor's degree 
D Master' s degree 
D Doctorate 
D Other 
5. Do you work: 
D Full Time D Part Time D Do not work 
6. What is your marital status? 
0 Single, never married 
D Married 
D Widowed 
D Divorced 
7. How many times have you been diagnosed with cancer? _____ _ 
210 
8. [The first time you were diagnosed with cancer], what type of cancer were you 
diagnosed with? ------
9. What stage was your cancer? ______ _ 
10. What year were you diagnosed with [insert cancer type) cancer? 
11. What kind(s) of cancer treatment did you receive for [insert cancer type]? 
0 Chemotherapy 
0 Radiation 
0 Surgery 
0 Other: 
0 I don't know 
12. What year did you complete cancer treatment for [insert cancer type]? ____ _ 
Directions: If the interviewee has been diagnosed with cancer more than once, obtain 
the information below for each cancer diagnosis. 
13. The second time you were diagnosed with cancer, what type of cancer were you 
diagnosed with? ------
14. What year were you diagnosed with [insert cancer type] cancer? 
15. What kind(s) of cancer treatment did you receive for [insert cancer type)? 
0 Chemotherapy 
0 Radiation 
0 Surgery 
0 Other: 
0 I don't know 
16. What year did you complete cancer treatment for [insert cancer type]? ____ _ 
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Appendix F: Demographic Form (Spanish) 
Supervivencia de Cancer: Cuestionario Demognifico 
1. ;,Coal es su raza/etnicidad? 
D Negro, pero no Hispano/Latino 
D Hispano/Latino 
D RazaMixta 
2. ;,Cmil es su sexo/genero? 
D Masculino D Femenino 
3. ;,Que edad tiene usted? 
4. ;,Cuantos aiios de educacion o escuela ha completado usted? 
D Menos de cuarto aiio 
D Diploma de cuarto aiio 
D 1 a 4 aiios de la Universidad 
D Bachillerato 
D Maestria 
D Doctorado 
D Otro 
5. Trabaja Usted: 
D Tiempo Repleto D Media Tiempo 
6. ;, Coal es su estado civil? 
D Soltera/o, nunca casado/a 
D Casado/a 
D Viudo/a 
D Divorciado/a 
D No Trabaja 
7. ;,Cmintas veces has sido diagnosticado con cancer? 
------
8. ;,[La primera vez que fue diagnosticado/a con cancer], con que tipo de cancer fue 
diagnosticado usted? _____ _ 
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9. ;, Cual era Ia etapa de su cancer? _____ _ 
10. ;,Que aiio fue diagnosticado con [inserte tipo de cancer] cancer? 
11. ;,Que tipo(s) de tratamiento recibi6 usted para [inserte tipo de cancer]? 
D Quimioterapia 
D Radiaci6n 
D Cirugia 
D Otro: 
---------
0 Nose 
12. ;,En que aiio termino su tratamiento para [inserte tipo de cancer]? _____ _ 
Direcciones: Si el entrevistado ha sido diagnosticado con cancer mas de una vez, obtenga la 
siguiente informacion para cada diagn6stico de cancer. 
13. ;,La segunda vez que fue diagnosticado/a con cancer, con que tipo de cancer fue 
diagnosticado usted? _____ _ 
14. ;,Que aiio fue diagnosticado con [inserte tipo de cancer] cancer? _____ _ 
15. ;,Que tipo(s) de tratamiento recibi6 usted para [inserte tipo de cancer]? 
D Quimioterapia 
D Radiaci6n 
D Cirugia 
D Otro: 
D Nose 
16. ;,En que aiio termino su tratamiento para [inserte tipo de cancer]? 
------
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Appendix G: Interview Guide (English) 
Cancer Survivorship among Low-Income Black and Latino Survivors 
Interview Guide 
Welcome interviewee as he/she arrives. Provide the participant with a consent form to 
review and sign. 
Introductory Script 
Hello Mr. /Mrs. . Thank you for taking the time to meet with me today. 
My name is and I am with the Prevention Research Center at the Boston 
University School of Public Health. 
I have invited you here today because I am interested in learning more about your 
experiences as a cancer survivor. Specifically, I am interested in your experiences during 
the first few years after you completed cancer treatment. The information you provide us 
with will help us create better programs for cancer survivors after they finish their cancer 
treatment. 
During the interview, I will be asking you a series of questions. It is important for you to 
know that there are no right or wrong answers to the questions I am asking. Therefore, I 
want to encourage you to speak openly about your thoughts and experiences. 
The interview should take less than one hour. I will be tape recording this interview because 
I want to make sure I capture your experiences accurately. 
All of your responses will be kept confidential. This means that everything you say will 
only be shared with the research staff and we will ensure that any information we include 
in our report does not identify you. 
Before we begin, I need to go over the consent form with you. It gives you more 
information about the study and a telephone number you can call if you have questions 
later. I will also give you a copy to keep. 
Are there any questions about what I just explained? 
Okay. Let us begin. 
Questions 
Introductory Question (Question pertains to the overall experience of cancers survivors 
after they complete treatment) 
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1. Tell me what it was like for you to hear your doctor say you were all done with your 
cancer treatment and could return to your everyday life? 
Probes: How did you feel? 
Can you describe a good experience? A bad experience? 
How has life changed for you? 
Concept A: Economic Deprivation (Questions pertain to how economic deprivation such 
as poverty, unemployment, and lack/limited health insurance plays a role in the transition 
from active treatment to post-treatment care.) 
2. When you think back to when you fmished cancer treatment, what can you tell me 
about the things that were most difficult for you? 
Probe: Can you describe any worries or concerns you had after you 
completed treatment? 
3. We know that a cancer diagnosis can cause financial problems for individuals and 
their families. After you completed treatment, what fmancial difficulties did you have 
that affected your life after cancer? 
Probes: What experiences did you have at work? 
What experiences did you have paying for follow-up care (e.g., 
additional screenings)? 
Transportation? 
What experiences did you have with your health insurance? Co-
pays or deductibles? 
Concept B: Social Deprivation (Questions pertain to how social deprivation or 
interactions between the individual and society play a role in the transition from active 
treatment to post treatment care) 
4. How did your family, friends, and others in your life react when you completed 
cancer treatment? 
5. Tell me a story of how it was like for you when you returned home after completing 
all your cancer treatment? 
6. What can you tell me about returning to work after you completed treatment? 
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7. When you completed treatment, did you tum to anyone for help or support in getting 
back to your everyday life? If yes, tell me about it. If not, why not? 
Concept C: Toxic substance and hazardous conditions (Questions pertain to how 
neighborhoods and where you live play a role in the transition from active treatment to 
post treatment care) 
8. Describe how you think living in this neighborhood has affected your life after cancer? 
Probes: What are some barriers you have encountered? 
What have been some positive experiences? 
Concept D: Socially Inflicted Trauma (Questions pertain to how interpersonal and 
institutional racial discrimination may play a role in the transition from active treatment 
to post treatment care. 
9. Can you describe any instances where you did not feel comfortable at the place 
where you received your cancer treatment? 
10. During your cancer, describe the relationship you had with your cancer doctors. 
11. Since you moved from cancer treatment to completing treatment, how has your 
relationship changed with your cancer doctors/oncology specialists? 
Probes: Tell me about any instance (s) where you felt they were 
particularly helpful at addressing your needs as a cancer patient 
(physical, emotional, social)? 
Now can you tell me about any instance (s) where you felt he or she 
was not addressing all of your needs as a cancer patient? 
12. Are you seeing a primary care doctor now for your everyday health concerns? 
If no, who do you see for your everyday health concerns? And why this provider? 
If yes, tell me about your relationship with your primary care doctor. 
Probes: Tell me about any instance (s) where you felt they were 
particularly helpful at addressing your needs as a cancer survivor 
(physical, emotional, social)? 
Now can you tell me about any instance (s) where you felt he or 
she was not addressing all of your needs as a cancer survivor? 
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Concept E: Targeted Marketing of Commodities (Questions pertain to what programs 
and services are available in the community for cancer survivors) 
13. Describe the types of services that are available in your neighborhood to help you live 
a healthy life after cancer? 
Probes: Are there hospitals and clinics? 
Are there grocery stores? 
14. What types of places are available for exercise? How much to you like them? How 
much do you use them? 
If don't use them, why? What might improve the use of these facilities/areas? 
15. If you could choose to participate in any physical exercise or activity, what would 
you choose? Where would you most want to do this activity? Would you prefer 
group activities or individual activities? 
16. Can you tell me about any programs and services in your community for people 
who have completed cancer treatment? 
17. What might you describe as challenges or things that might keep from living a 
healthy life after cancer? 
Concept F: Inadequate Health Care (Questions pertain to availability and dissemination 
of survivorship information and programs to Black and Hispanic populations in health 
care settings) 
18. Describe your last visit with your cancer doctor. 
19. Can you tell me about any information or programs you received that talked about 
what to expect after your treatment was over? 
Probes: Who provided the information? 
What did they provide? 
What the information useful? 
20. Are there things you didn't get that would have been helpful in getting you back to 
your everyday life? 
21. What do you need from the clinic/hospital now that you are done with cancer 
treatment? 
217 
Concept G: Resistance to Racial Oppression (Questions pertain to individual and 
community resources available to counter racism) 
22. [For Spanish speakers] Can you tell me about any cancer survivorship programs 
that available in Spanish? 
23. Can you tell me about any cancer survivorship programs that are specifically for 
African American or Hispanic cancer survivors? 
24. Did your doctor talk to you about any unique issues that Hispanic or Black cancer 
survivors need to be aware of? If so, what? 
Concept H: Physical Activity 
25. What motivates you to participate in physical activity? 
26. Since cancer, how important is physical activity for your health? 
27. How do you think that physical activity effects cancer for cancer survivors? 
Concluding Questions 
28. If you were to create a program for people who have finished cancer treatment, 
what would it look like? 
Probes: What do you think about nutrition information? 
What do you think about information about the side effects of 
treatment after cancer? 
What do you think about follow-up care? 
What do you think about information to better communicate with 
you doctor? 
29. Is there anything else you think I should know to better understand more about your 
experience after completing cancer treatment? 
Wrap-Up 
Thank you for all the information and thoughts you've shared. Your advice will be very 
valuable in helping us to develop future programs and resources for cancer survivors. 
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Appendix H: Interview Guide (Spanish) 
Supervivencia del Cancer entre Sobrevivientes Negros y Latinos de Bajos Ingresos 
Guia de Entrevista 
Dade la bienvenido al entrevistado cuando el I ella llega. Dade al participante un 
formulario de consentimiento para que el/ella lo revise y lo firme. 
Guion de lntroduccion 
Hola Sr. /Sra. . Gracias por tomar de su tiempo para reunirse conmigo hoy. 
Mi nombre es y estoy con el Prevention Research Center de Boston 
University School ofPublic Health. 
Le he invitado hoy aqui, porque estoy interesada en aprender mas acerca de sus 
experiencias como sobreviviente de cancer. En concreto, me interesa saber de sus 
experiencias durante los primeros aiios despues que usted termino su tratamiento de cancer. 
La informacion que usted nos proporcione nos ayudara a crear mejores programas para 
sobrevivientes de cancer despues que terminen su tratamiento de cancer. 
Durante la entrevista, le hare una serie de preguntas. Es importante que usted sepa que no 
hay respuestas correctas o incorrectas. Por lo tanto, quiero que usted hable abiertamente 
acerca de sus pensamientos y experiencias. 
La entrevista debe de to mar menos de una hora. Yo estara grabando esta entrevista porque 
quiero capturar sus experiencias con precision. 
Todas sus respuestas seran confidenciales. Esto significa que todo lo que usted diga solo 
sera compartida con el personal de investigacion y nos aseguraremos de que no sea 
identificado en cualquier informacion que se incluya en el informe. 
Antes de empezar, tengo que repasar el formulario de consentimiento con usted. Le da 
mas informacion sobre el estudio y un nfunero de telefono que puede Hamar si tiene alguna 
pregunta. Tambien le dare una copia para guardar. 
i,Hay alguna pregunta acerca de lo que acabo de explicar? 
Bueno. Comencemos. 
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Preguntas 
Pregunta Introductora (Pregunta se refiere a la experiencia general de sobrevivientes 
despues de completar el tratamiento de cancer) 
1. z,Dime como fue para usted escuchar a su medico decir que usted habia terminado con 
su tratamiento de cancer y que podia volver a su vida cotidiana? 
Sondos: z,C6mo te sentiste? 
z,Me puedes describir una buena experiencia? Una mala 
experiencia? z,C6mo ha cambiado la vida para usted? 
Concepto A: La Privacion Economica (Las preguntas se refieren a como la privaci6n 
econ6mica, como la pobreza, el desempleo, y la falta de seguro medico, juegan un papel 
en la transici6n del tratamiento activo al cuidado post-tratamiento) 
2. Cuando usted piensa atras a cuando termino su tratamiento de cancer, z,Que puede 
decirme acerca de las cosa que fueron mas dificiles para usted? 
Sanda: z,Puede usted describir algunas preocupaciones e inquietudes que 
tuvo despues de completar el tratamiento? 
3. Sabemos que un diagn6stico de cancer puede causar problemas fmancieros para 
individuos y sus familias. Despues de completar el tratamiento, z,cuales fueron las 
dificultades financieras que usted tuvo que afect6 a su vida despues del cancer? 
Sondas: z,Que experiencias has tenido en el trabajo? 
z, Que experiencias has tenido pagando por el cui dado de 
seguimiento (por ejemplo, examenes adicionales )? 
l, Transportaci6n? 
z,Que experiencias has tenido con su seguro medico? z,Los co-
pages o deducibles? 
Concepto B: Privacion Social (Las preguntas se refieren a como las carencias sociales o 
las interacciones entre el individuo y Ia sociedad juegan un papel en Ia transici6n del 
tratamiento activo al cuidado post-tratamiento) 
4. z,C6mo reacciono su familia, amigos, y otras personas en su vida cuando termino su 
tratamiento de cancer? 
5. z,Digame una historia de como fue para usted cuando termino su tratamiento de 
cancer y regreso a su casa? 
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6. (,Que me puede decir usted de como fue su experiencia cuando regreso al trabajo 
despues que completo su tratamiento? 
7. Cuando termino su tratarniento, (,te acercaste a alguna persona para ayuda o apoyo a 
regresar a su vida cotidiana? Si es asi, cuentame. Sino, (,por que no? 
Concepto C: Condiciones de sustancias toxicas y peligrosas (Las preguntas se refieren 
a Ia como viviendo en viviendas publicas juegan un papel en Ia transici6n del tratamiento 
activo a/ cuidado post-tratamiento) 
8. (,Describe como cree que viviendo en este barrio, es decir Ia zona afuera de Ia vivienda 
publica, ha afectado a su vida despues del cancer? 
Sondas: (,Cuales son algunas de las barreras/obstaculos que ha encontrado? 
(, Cmiles han sido algunas experiencias positivas? 
Concepto D: El Trauma Infligido Socialmente (Las preguntas se refieren a como Ia 
discriminacion racial que es interpersonal o institucional pueden jugar un papel en Ia 
transici6n del tratamiento activo a/ cuidado post-tratamiento) 
9. (,Puede describir alglin instante cuando no se sintio comodo en ellugar donde recibio 
su tratamiento para el cancer? 
10. Durante su cancer, describe Ia relacion que tenia con su oncologo/medico especialista 
de cancer. 
11. Desde que termino su tratamiento de cancer y ahora que ha completado su tratarniento, 
(,como ha cambiado su relacion con su oncologo/medico especialista de cancer? 
Sondas: Digame de un instante cuando sintio que ellos fueron 
particularmente util en ayudarles con sus necesidad como paciente de 
cancer (fisico, emocional, social) 
Ahora digame de un instante cuando usted sintio que el o ella no fue util en 
ayudarles con sus necesidades como paciente de cancer. 
12. (,Estas viendo a un medico de cabecera para sus necesidades de salud diarias? 
Si no, (,a quien ve para sus problemas de salud? (, Y porque este proveedor? 
Si es asi, dime acerca de su relacion con su medico de cabecera. 
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Sondas: Digame de un instante cuando sintio que ellos fueron 
particularmente util en ayudarles con su necesidad como sobreviviente de 
cancer (fisico, emocional, social). 
Ahora me puede decir de un instante cuando usted sintio que el o ella no 
fueron util en ayudarles con sus necesidades como sobreviviente de cancer. 
Concepto E: Marketing de productos basicos (Las preguntas se refieren a programas y 
servicios que est an disponibles en !a comunidad para sobrevivientes de cancer) 
13. z,Describe los tipos de servicios que estan disponibles en su vecindario que le ayudan 
a vivir una vida saludable despues del cancer? 
Sondas: z,Hay hospitales y centres de salud? z,Hay supermercados? 
14. z,Que tipos de lugares estan disponibles para hacer ejercicios? z,Cuanto te gustan? 
z,Cuanto lo usas? 
Sino lo usan, z,por que? z,Que podria mejorar el uso de estos lugareshireas? 
15. z,Si usted pudiera elegir participar en cualquier ejercicio o actividad fisica, que 
escogerias? Donde quisiera hacer esta actividad? z,Preferiria actividades de grupo o 
actividades individuales? 
16. z,Me puede decir sobre programas y servicios en su comunidad para las personas que 
han completado el tratamiento de cancer? 
17. z,Cuales son algunos de los obstaculos/desafios o cosas que pueden impedir que 
viva una vida saludable despues del cancer? 
Concepto F: Atencion de Salud Inadecuada (Las preguntas se refieren a la 
disponibilidad y difusi6n de informacion y programas de sobrevivientes para la 
poblaci6n de negros y Iatinos in centros de salud) 
18. (_Describe su Ultima visita con su medico especialista en cancer (onc6logo)? 
19. z,Me puede decir acerca de cualquier informacion o programas que recibio que hablaba 
acerca de que esperar despues que su tratamiento habia terminado? 
Sondas: z,Quien le dio la informacion? 
z,Que fue lo que te dieron? 
z,Fue utilla informacion? 
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20. (,Hay cosas que hubieran sido util en ayudarle a volver a su vida cotidiana [vida despues 
del cancer]? 
21. (,Que necesita del hospital [lugar donde recibio tratamiento para el cancer] ahora que 
ha terminado con el tratamiento del cancer? 
Concepto G: Resistencia a Ia Opresion Racial (Las preguntas se refieren a recursos 
individua/es y comunitarios disponibles para luchar contra e/ racismo) 
22. [Para personas que hablan espaiiol] (,Me puedes decir acerca de algunos programas 
de supervivencia de cancer que estan disponibles en espafi.ol? 
23. (,Me puedes decir acerca de algunos programas de supervivencia de cancer que son 
especificamente para sobrevivientes negro o hispanos? 
24. (,Le ha hablado su medica acerca de problemas Unicos que los sobrevivientes 
hispanos o negros deben de tener un cuenta? Si es asi, que? 
Concepto H: Actividad Fisica 
25. (,Que te motiva participar en la actividad fisica? 
26. Desde el cancer, (,cmil importante es la actividad fisica para su salud? 
27. (,Como cree que la actividad fisica afecta el cancer para los sobrevivientes de 
cancer? 
Preguntas Finales 
28. Su usted fuera a crear una programa para personas que han terminado el tratamiento 
de cancer, (,que le gustaria? 
Sondas: (,Que piensa acerca de la informacion nutricional? 
L,Que piensa acerca de la informacion sobre los efectos al largo 
plazo? 
(,Que piensa sobre el cuidado de seguimiento? 
L,Que piensa acerca de informacion para comunicarse mejor con 
su medico? 
29. (,Hay algo mas que usted crea que yo debo de saber para entender mejor sus 
experiencia despues de completar el tratamiento de cancer? 
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Conclusion 
Gracias por toda la informacion y todo lo que ha compartido. Su consejo sera muy valioso 
para ayudarnos a desarrollar futures programas y recursos para sobrevivientes de cancer. 
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Appendix 1: Consent Form (English) 
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TilE BOST01\ ' MEDICAL C£,VTER N!E1)1D \ L 
RESEARCH CONSENT FORM 
The Transition from Active Treatment to Post Treatment Care: Experiences of Low-
Income Black and Hispanic Cancer Survivors 
Title of Project: The Transition from Active Treatment to Post Treatment Care: 
Experiences of Low-Income Black and Hispanic Cancer Survivors 
Principal Investigator: Shioban Torres 
Backgroynd 
After completing cancer treatment, many cancer survivors have a hard time returning to life after 
cancer. Some survivors have major physical problems, such as pain and being tired, while 
others have a hard time getting follow-up care from their healthcare team . 
We are asking you to take part in this research study so we can learn more about the thoughts 
and feelings of cancer survivors as they move from active cancer treatment to post-treatment 
care. Specifically, we want to learn about what happens to Black and Hispanic cancer survivors 
as they complete cancer treatment and return to their everyday life . 
We hope that this study will help us create better programs to support Black and Hispanic 
cancer survivors make the transition from active treatment to post-treatment care. Participants 
for this study will be Black and Hispanic cancer survivors and participation will take 
approximately 60 minutes. This study is sponsored by the Prevention Research Center. 
pyrpose 
The purpose of this research study is to better understand the experiences of Black and 
Hispanic cancer survivors as they move from active cancer treatment to life after treatment. 
What Happens In Thjs Research Stydv 
You will be one of approximately 40 subjects to be asked to participate in this study. 
All or part of the research in this study will take place at the following location(s): Boston 
University Medical Center. 
If you choose to be in this study, you will be asked to participate in a one-time interview, which 
will take approximately 60 minutes. Prior to beginning the interview, you will be asked to read 
and sign a consent form . Then you will be given a short demographic survey to fill out. The 
demographic survey will include questions on age, gender, education level, and cancer 
diagnosis . 
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BOST0,\ 1 U:V!Vf~RS/1T SU/00/.S Of' :\IF.I>ICINE. 
PUBLIC 1/E.·II-Tl/. DENTAl. MEDICINE AVD BOSTC.:)N '·. 
Til£ BOSTON MEDICAL CESTER MEDlD \L 
RESEARCH CONSENT FORM 
The Transition from Active Treatment to Post Treatment Care: Experiences of Low-
Income Black and Hispanic Cancer Survivors 
Title of Project: The Transition from Active Treatment to Post Treatment Care: 
Experiences of Low-Income Black and Hispanic Cancer Survivors 
Principal Investigator: Shioban Torres 
After completing the consent form and short demographic survey, the interview will begin. The 
questions during the interview will ask you how you felt after you completed cancer treatment. 
The interviewer will also ask about your relationship with your doctors, experiences with 
returning to work, and types of programs in your community for cancer survivors. If you do not 
feel comfortable answering any of the questions during the interview, you may say so and the 
interviewer will move on to the next question. The interview will be tape-recorded, but no-one 
will be identified by name on the tape. 
Rjsks and Discomforts 
There are no major risks associated with this study. There is, however, the potential risk of loss 
of confidentiality. Every effort will be made to keep your information confidential; however, this 
cannot be guaranteed. Some people may feel uncomfortable talking about some of the topics in 
the interview. You do not need to answer any question if you do not wish to do so. You do not 
have to give a reason for not responding to the question. 
There may be unknown risks/discomforts involved. Study staff will update you in a timely way 
on any new information that may affect your health, welfare, or decision to stay in this study. 
potentjal Benefits 
You will receive no direct benefit from your participation in this study. However, your 
participation may help the investigators better understand how to create programs to support 
Black and Hispanic cancer survivors make the transition from active treatment to post-treatment 
care. 
A!ternatjyes 
Your alternative is to not participate in the study. 
• 
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THE BOSTON MEDICA L CE.\'TER N!l.:."')1CAL 
RESE.6RCH CONSENT FORM 
The Transition from Active Treatment to Post Treatment Care: Experiences of Low-
Income Black and Hispanic Cancer Survivors 
Title of Project: The Transition from Active Treatment to Post Treatment Care: 
Experiences of Low-Income Black and Hispanic Cancer Survivors 
Principal Investigator: Shioban Torres 
Sybject Costs and payments 
There are no costs to you for participating in this research study. 
You will receive a $25 gift card for participating in the interview. 
Confjdentjalitv 
All information that you provide will be kept confidential. All data will be maintained in a secure 
building and in a locked file cabinet. Only study personnel will have access to this information. 
Information from this study may be reviewed and photocopied by state and federal regulatory 
agencies such as the Office of Human Research Protection as applicable, and the Institutional 
Review Board of Boston University rvledical Center. Information from this study may be used for 
research purposes and may be published, however, your name will not be used in any 
publications . 
Sybjecfs Rjghts 
By consenting to participate in this study you do not waive any of your legal rights . Giving 
consent means that you have heard or read the information about this study and that you 
agree to participate. You will be given a copy of this form to keep. 
If at any time you withdraw from this study you will not suffer any penalty or lose any benefits 
to which you are entitled. 
You may obtain further information about your rights as a research subject by calling the 
Office of the Institutional Review Board of Boston University rvledical Center at 617-638-
7207. If this study is being done outside the United States, you can ask the investigator for 
contact information for the local Ethics Board. 
The investigator or a member of the research team will try to answer all of your questions . If you 
have questions or concerns at any time, or if you need to report an injury while participating in 
this research, contact Shioban Torres at 508-858-8216 during the day and after hours . 
• 
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TilE BOSTON MEDICAL C£,\'TEH 
RESEARCH CONSENT FORM 
The Transition from Active Treatment to Post Treatment Care: Experiences of Low-
Income Black and Hispanic Cancer Survivors 
Title of Project: The Transition from Active Treatment to Post Treatment Care: 
Experiences of Low-Income Black and Hispanic Cancer Survivors 
Principal Investigator: Shioban Torres 
Rjght to Refuse or Withdraw 
Taking part in this study is voluntary. You have the right to refuse to take part in this study. If 
you decide to be in the study and then change your mind, you can withdraw from the research. 
Your participation is completely up to you. Your decision will not affect your being able to get 
health care at this institution or payment for your health care. It will not affect your enrollment in 
any health plan or benefits you can get. 
If you choose to take part, you have the right to stop at any time. If there are any new findings 
during the study that may affect whether you want to continue to take part, you will be told about 
them as soon as possible. 
The investigator may decide to discontinue your participation without your permission 
because he/she may decide that staying in the study will be bad for you, or the sponsor may 
stop the study. 
Signing this consent form indicates that you have read this consent form (or have 
had it read to you), that your questions have been answered to your satisfaction, 
and that you voluntarily agree to participate in this research study. You will 
receive a copy of this signed consent form. 
Subject (Signature and Printed Name) 
Person Obtaining Consent (Signature and Printed Name) 
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Appendix J: Consent Form (Spanish) 
FORMULARIO DE CONSENTMIENTO PARAPARTICIPAR EN INVESTIGACION 
La Transici6n de Tratamiento Activo al Cuidado Post-Tratamiento: Experiencias de Negros e hispanos de Baja 
lngreso 
H-31254- La Transici6n de Tratamiento Activo at Cuidado Post-Tratamiento: Experiencias de Negros e 
hispanos de Bajo lngreso 
lnvestigador Principal: Shioban Torres 
Antecedentes 
Despues de ccmpletar el tratamiento de cancer, muchos sobrevivientes de cancer tienen dificultades 
regresando a su vida despues del cancer. Algunos sobrevivientes tienen problemas ffsicos, como dolor y 
cansancio, mientras que otros tienen dificultades obteniendo cuidado de seguimiento de su equipo de 
atenci6n medica. 
Les estamos pidiendo que participe en este estudio de investigaci6n para que podamos aprender mas acerca 
de los pensamientos y sentimientos de los sobrevivientes de cancer mientras pasan de Ia etapa de 
tratamiento activo al cuidado post-tratamiento. En concreto, queremos conocer lo que sucede con los 
sobrevivientes de cancer hispanos y Negro, cuando completan el tratamiento del cancer y vuelven a su vida 
cotidiana. 
Esperamos que este estudio nos ayude a crear mejores program as para apoyar a los sobrevivientes de 
cancer hispanos y Negro en su transici6n de tratamiento activo ha cuidado post-tratamiento. Los participantes 
de este estudio seran sobrevivientes de cancer hispanos y Negro y participaci6n tamara aproximadamente 60 
minutes. Este estudio esta patrocinado por el Prevention Research Center. 
prop6sjto 
El prop6sito de este estudio de investigaci6n es comprender mejor las experiencias de los sobrevivientes de 
cancer hispanos y Negro mientras pasan de Ia etapa de tratamiento activo a Ia vida despues del tratamiento. 
Qyt sucede en este esJydjo de jnyestjgacj6n 
Usted sera uno de aproximadamente 40 sujetos a los que se le pedira participar en este estudio. 
Todo o parte de Ia investigaci6n que se realice en este estudio tendra Iugar en el(los) siguiente(s) lugar(es): 
Boston University Medical Center. 
Si usted accede a participar en este estudio, se le pedira participar en una sola entrevista, que durara 
aproximadamente 60 minutes. Antes de comenzar Ia entrevista, se le pedira que lea y firme un formulario de 
consentimiento. Luego se le dara una breve encuesta demografica para llenar. La encuesta demografica 
incluye preguntas sabre su edad, sexo, nivel educative, y el diagn6stico de cancer. 
Despues de ccmpletar el formulario de consentimiento y Ia encuesta demografica, Ia entrevista comenzara. 
Las preguntas durante Ia entrevista seran acerca de como se sentia despues de terminar el tratamiento del 
cancer. El entrevistador tambien le preguntara acerca de su relaci6n con sus medicos , las experiencias con el 
regreso al trabajo, y los tipos de programas en su comunidad para sobrevivientes de cancer. Si usted nose 
siente c6modo respondiendo a alguna de las preguntas durante Ia entrevista, simplemente dejenos saber, y el 
~ ' ~ IRB NUMBER : H-31254 
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entrevistador seguira a Ia siguiente pregunta. La entrevista sera grabada, pero nadie sera identifico por su 
nombre. 
Rjesgos e lncomodjdad 
No hay mayores riesgos asociados con este estudio. No obstante, existe el riesgo potencial de perdida de Ia 
confidencialidad. Se realizarfm todos los esfuerzos para conservar su informaci6n en forma confidencial; sin 
embargo, noes posible garantizar esto. Algunas personas podrfan sentirse incomodas al hablar sobre algunos 
de los temas en Ia entrevista. Usted no tiene que contestar cualquier pregunta con Ia que nose sienta 
c6modo. Usted no tiene que dar una raz6n porno responder a Ia pregunta. 
Debido a que Ia encuesta y entrevista es an6nima, el riesgo de que su identidad se conozca es muy pequeria. 
Pueden existir riesgos/incomodidades desconocidas involucradas en esta encuesta. El personal del estudio lo 
mantendra al tanto acerca de cualquier nueva informaci6n que pueda afectar su salud, bienestar, o decisi6n 
para continuar con el estudio . 
Posjbles beneficjos 
Usted no recibira ningun beneficio directo por participar en este estudio. Sin embargo, su participacion puede 
ayudar a que los investigadores entiendan mejor c(mo crear programas de apoyo para sobrevivientes de 
cancer hispanos y Negro mientras pasan de Ia etapa de tratamiento activo a Ia vida despues del tratamiento. 
AJternativas 
Usted tiene Ia a~ernativa de no participar en el estudio. 
Costos y pagos del syjeto 
No existe costo alguno por su participaci6n en este estudio de investigaci6n. 
Usted recibira $25 por participar en Ia entrevista. 
Confidencjalidad 
Cualquier informacion que usted nos proporcione se mantendra confidencial. Todos los datos se mantendran 
en un edificio seguro y en un archivero cerrado bajo llave. Solo el personal del estudio tendra acceso a esta 
informaci6n. 
La informacion correspondiente a este estudio puede ser revisada y fotocopiada por Ia las agencias federales 
y estatales de regulaci6n tales como Ia Oficina para Ia Protecci6n de Ia lnvestigaci6n Humana segun sea 
necesario, y Ia Junta de Revision lnstitucional del Boston University Medical Center. La informacion de este 
estudio puede ser utilizada para prop6sitos de investigaci6n y puede ser publicada. Sin embargo, su nombre 
no sera divulgado en ninguna de dichas publicaciones. 
perechos del Syjeto 
AI consentir su participaci6n en este estudio, usted no renuncia a ninguno de sus derechos legales. Dar su 
consentimiento significa que usted ha escuchado y leido Ia informaci6n perteneciente a este estudio y que 
esta de acuerdo en participar. Se le entregara una copia de este formulario para su archive. 
Si en cualquier memento, usted se retira del estudio, no sufrira ninguna sanci6n ni perdera ningun beneficio al 
que tenga derecho. 
'" 1 ~ IRB NUMBER : B-31254 
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entrevistador seguira a Ia siguiente pregunta. La entrevista sera grabada, pero nadie sera identifiCo par su 
nombre. 
RjesgQS e lncoDl9djdad 
No hay mayores riesgos asociadas con este estudio. No obstante, existe el riesgo potencial de perdida de Ia 
confidencialidad. Se realizaran todos los esfuerzos para conservar su informacion en forma confldencial; sin 
embargo, noes posible garantizar esto. Algunas personas podrian sentirse incomodas al hablar sabre algunos 
de los temas en Ia entrevista. Usted no tiene que contestar cualquier pregunta con Ia que nose sienta 
c6modo. Usted no tiene que dar una raz6n par no responder a Ia pregunta. 
Debido a que Ia encuesta y entrevista es anonima, el riesgo de que su identidad se conozca es muy pequefia. 
Pueden existir riesgos/incomodidades desconocidas involucradas en esta encuesta. El personal del estudio lo 
mantendra al tanto acerca de cualquier nueva informacion que pueda afectar su salud, bienestar, o decision 
para continuar con el estudio. 
Posibles bereficios 
Usted no recibira ningun beneficia directo par participar en este estudio. Sin embargo, su participacion puede 
ayudar a que los investigadores entiendan mejor cemo crear programas de apoyo para sobrevivientes de 
cancer hispanos y Negro mientras pasan de Ia etapa de tratamiento activo a Ia vida despues del tratamiento. 
A!ternatjyas 
Usted tiene Ia atternativa de no participar en el estudio. 
Costas y pagos del syjeto 
No existe costa alguno par su participacion en este estudio de investigaci6n. 
Us ted recibira $25 par participar en Ia entre vista. 
Confidencjalidad 
Cualquier informacion que usted nos proporcione se mantendra confidencial. Todos los datos se mantendran 
en un edificio seguro yen un archivero cerrado bajo llave. Solo el personal del estudio tendra acceso a esta 
informacion. 
La informaci6n correspondiente a este estudio puede ser revisada y fotocopiada par Ia las agencias federales 
y estatales de regulaci6n tales como Ia Oficina para Ia Protecci6n de Ia lnvestigacion Humana segun sea 
necesario, y Ia Junta de Revision lnstttucional del Boston Universtty 1\A:ldical Center. La informacion de este 
estudio puede ser utilizada para propositos de investigaci6n y puede ser publicada. Sin embargo, su nombre 
no sera divulgado en ninguna de dichas publicaciones. 
perechos del Syjeto 
AI consentir su participacion en este estudio, usted no renuncia a ninguno de sus derechos legales. Dar su 
consentimiento significa que usted ha escuchado y leido Ia informacion perteneciente a este estudio y que 
esta de acuerdo en participar. Se le entregara una copia de este formulario para su archive. 
Si en cualquier momenta, usted se retira del estudio, no sufrira ninguna sancion ni perdera ningun beneficia al 
que tenga derecho. 
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Appendix K: Survivorship Care Plan Summary Page (English) 
~erCare 
'--Center 
BOSTON MEDICAL CENTER 
Summary of Your Cancer Treatment and Follow-Up Care 
CONGRATULATIONS! You have completed this stage of your cancer treatment for colon cancer. This 
document will help you understand what to expect during your follow-up visits. 
Summary of Your Cancer Treatment 
Patient Name: 
Date Diagnosed with Cancer: 
Type of Cancer: 
Stage of Cancer: 
Cancer Treatment You Received: D Chemotherapy 
D Radiation 
D Surgery 
DOther __ _ 
Start Date: ___ _ 
Start Date: __ _ 
Start Date: ___ _ 
Start Date: ___ _ 
Important Steps for Follow-Up in Your Cancer Treatment 
1. Watch out for new symptoms or other health issues 
End date: ___ _ 
End date: ___ _ 
End date: ___ _ 
End date: ___ _ 
If you experience any of these symptoms and are worried by them contact your primary care doctor or 
cancer doctor: 
• Blood in the stool 
• Abdominal pain 
• Change in bowel habits 
• Cough that doesn't go away 
• Bone pain 
• New lumps 
• Nausea 
• Vomiting 
• Loss of appetite 
• Weight Loss 
• Fatigue or feeling really tired 
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2. See your cancer doctor for follow-up visits and tests 
It is important that you keep all your appointments with your cancer doctors after treatment ends. During your appointments, your cancer doctor will 
check to see that you are healthy and that your cancer has not come back. Typically, follow-up for your cancer care will continue for 5 years after 
treatment ends. This calendar will help you plan your follow-up care visits for the first year. 
Important Follow-Up Appointments for Your First Year After Treatment 
Follow-up Test Recommendation Appointment Appointment Appointment Appointment Location 
l 2 3 4 
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--
Medical 
history/physical exam Time: 
--
Time: 
--
Time: 
--
Time: 
--
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--
CEA Test 
Time: Time: Time: Time: 
-- -- -- --
Once in year Date: 
--
None None None 
CT scan (chest & 
abdomen) Time: 
--
Once in year Date: 
--
None None None 
Colonoscopy 
Time: 
--
Every 3 months Date: 
--
Date: 
--
Date: 
--
Date: 
--
Counseling visits 
Time: Time: Time: Time: 
-- -- -- --
3. Talk To Your Primary Care Doctor About Getting Regular Cancer Screenings 
4. Talk To Your Primary Care Doctor About Maintaining Healthy Habits 
5. Know Who To Call For Your Care 
Your primary contacts for your cancer care are: 
Primary Care Provider: ____ (name) _____ (phone number) 
Cancer Center Provider: ____ (name) (phone number) 
6. Resources For Staying Healthy 
Boston Medical Center has free programs to support you and your family after cancer treatment like: 
• Support Groups (English, Spanish, and Haitian Creole) 
• Spirituality Group 
• Zumba 
To find out about these and other programs call or email Cancer Support Services at 617-638-7540 I cancersupport@bmc.org 
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Appendix L: Survivorship Care Plan Summary Page (Spanish) 
~erCare 
'-Center 
BOSTON MEDICAL CENTER 
Resumen de Su Tratamiento del Cancer y Su Seguimiento 
jFELICIDADES! Usted ha completado esta etapa de su tratamiento del cancer de colon. Este documento le 
ayudara a entender que se espera de usted durante sus visitas de seguimiento. 
Resumen de su tratamiento de su cancer 
Nombre del paciente: 
Fecha diagnosticado/a con cancer: 
Tipo de Cancer: 
Etapa de Cancer: 
Tratamiento ya recibido: D Quimioterapia 
D Radiaci6n 
D Cirugia 
DOtro 
Fecha de inicio: 
Fecha de inicio: 
Fecha de inicio: 
Fecha de inicio: 
Fecha de fmalizaci6n: 
Fecha de fmalizaci6n: 
Fecha de fmalizaci6n: 
Fecha de fmalizaci6n: 
Pasos lmportantes a Seguir para su Tratamiento de Cancer 
1. Este atento a nuevos sintomas o otros problemas de salud. 
Si usted tiene algunos de estos sintomas y esta preocupado, llame a su doctor de cabecera o a su doctor asignado 
a! cuidado de su salud: 
• Sangre en las heces 
• Dolor abdominal 
• Cambia de los habitos intestinales 
• Tos que no cesa 
• Dolor en los huesos 
• Nuevo n6dulos 
• Nauseas 
• V6mitos 
• Perdida de apetito 
• Perdida de peso 
• Fatiga o sensaci6n de cansancio 
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2. Vea a su doctor del cancer para sus citas de seguimiento y pruebas. 
Es importante que mantenga sus citas con los medicos encargados de su cancer despues de que su tratamiento finalice. Durante 
sus citas, su medico del cancer se encargara de que usted se mantenga sano y que su cancer no haya regresado. Haga un 
seguimiento para el cuidado de su cancer por los proximos 5 aiios despues de finalizar su tratamiento. Este calendario le 
ayudara a planear sus citas de seguimiento por el primer afio. 
Citas de seguimiento importantes para su primer aiio 
Citas de seguimiento Recomendaciones Cita Cita Cita Cita Ubicaci6n 
1 2 3 4 
Cada 3 meses Fecha: Fecha: Fecha: Fecha: 
-- -- -- --
Historial 
medico/exameo fisico Hora: Hora: Hora: Hora: 
- - -- -- --
Cada 3 meses Fecha: Fecha: Fecha: Fecha: 
-- - - -- --
ExameoCEA 
Hora: Hora: Hora: Hora: 
-- -- --
--
Una vez al ai!o Fecha: 
--
Ninguna Ninguna Ninguna 
Tomografia 
Computada (CT scan) Hora: 
--(de abdomen y pecho) 
Una vez al ai!o Fecha: 
--
Ninguna Ninguoa Ninguna 
Coloooscopia 
Hora: 
--
Cada 3 meses Fecba: Fecha: Fecha: Fecha: 
-- -- -- --
Visitas de coosejeria 
Hora: Hora: Hora: Hora: 
- -
-- -- --
3. Hable con su doctor de cabecera para hacerse pruebas para detectar el cancer. 
4. Hable con su doctor de cabecera para mantener h:ibitos saludables. 
5. Saber a quien Hamar para su cuidado. 
Contactos para su cuidado del cancer: 
Doctor de cabecera: _____ (nombre) ______ (numero de telefono) 
Doctor del cancer: _____ (nombre) (numero de telefono) 
6. Recursos para mantenerse saludable. 
Boston Medical Center tiene programas gratuitos de apoyo para usted y su familia despues del tratamiento de cancer como: 
• Grupos de apoyo en Espafiol 
• Grupos espirituales 
• Zumba 
Para aprender mas sobre estos programas llamenos o mandenos un correo electr6nico al Centro de Apoyo del Cancer a1617-638-
7540 I cancersupport@bmc.org 
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Appendix M: Final Adapted Version of Journey Forward Survivorship Care Plan 
~erCare 
'--Center 
BOSTON MEDICAL CENTER 
Survivorship Care Plan for Colorectal Cancer 
*Adapted from the Journey Forward Survivorship Care Plan 
This Survivorship Care Plan was created especially for you. It has important information about your 
cancer treatment, follow-up care visits, and steps you can take to live a healthy life after cancer. 
IMPORT ANT CONTACT INFORMATION 
Personal Information 
Patient Name 
Phone (home) 
Phone (cell) 
Date of Birth 
Age at diagnosis 
Alternate Contact Name: Phone: 
Healthcare Proxy Name: Phone: 
Your Medical Care Team Address Phone Number 
Your Primary Contact 
at the Cancer Center: 
Hematologist'Oncologist: 
Radiation Oncologist: 
Gastroenterologist: 
Primary Care Physician: 
Nurse/Nurse Practitioner: 
Social Worker: 
Patient Navigator: 
Other: 
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BACKROUND INFORMATION ABOUT YOUR CANCER 
Cancer Dia2nosis 
Type of Cancer 
Date you were diagnosed with 
cancer 
How was your cancer detected? 
First time diagnosed DYes 
with cancer? D No (cancer type) (year of diagnosis) 
Stage of Your Cancer Stage: 
T Stage 
--
N Stage 
--
M Stage 
--
Family History? DYes If yes, describe: 
D No 
Notable Pathologic Findings 
Has Ostomy? DYes If yes, instructions/Comments: 
D No 
Other major health concerns 
Additional comments 
SUMMARY OF YOUR CANCER TREATMENT 
Surgery 
Date of your surgery 
Type of surgery 
Ongoing side effects 
Additional comments 
Chemotherapy 
Dates of chemotherapy Date Started: Date Completed: 
treatment 
Central Venous Catheter D Yes D No 
Needed 
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Chemotherapy Drug Name: # of cycles administered: % dose reduction: 
Name 1: 
Name2: 
Reason for stopping 
chemotherapy 
Disease status at the end of 
treatment 
Ongoing side effects 
Additional comments 
Radiation 
Dates of radiation treatment Date Started: I Date Completed: 
Area of body treated 
Radiation dose 
Ongoing side effects 
Additional comments 
Clinical Trial Information 
Patient on a clinical trial? DYes DNo 
Dates of clinical trial Date Started: I Date Completed: 
Name of clinical trial 
Name of clinical trial contact Name: I Phone Number: 
person 
YOUR FOLLOW-UP CARE 
This section has information about the care you will need after your finish your cancer treatment. It 
also has information to help you live a healthy life after cancer. 
After talkin2 to my cancer doctor, I am worried about ... 
My Concerns: Recommendations from my cancer doctor: 
My cancer coming back • I need to know that these feelings are normal, and they won't cause 
the cancer to come back. 
• Referral for cognitive behavioral therapy or counseling 
• Referral to support group 
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Fatigue • Regular physical activity (e.g. walking 20 minutes daily) 
• Evaluation for hypothyroidism, anemia, depression 
Diet • Referral to a nutritionist 
Financial Concerns: • Referral to a social worker 
Other: 
Recommended Follow-Up Tests 
What tests will I need? Year 1 Year2 Year3 Year4& 5 Coordinating 
Provider 
Medical history/physical Every 3 Every 3 Every 3 Every 6 
exam 
months months months months 
CEA Test Every 3 Every 3 Every 3 
months months months 
CT Scan (Chest & Abdomen) Once in year Once in year Once in year Every year 
Colonoscopy Once in year 
Counseling Visits Every 3 Every 3 Every 3 Every 3 
months months months months 
***After 5 years, your cancer doctor and primary care doctor will talk with you and your family about 
next steps in your follow-up care.*** 
I Recommended General Cancer Screenings 
Don't forget to get screened for other cancer types. People who have been successfully treated for 
cancer may have a greater chance of having other cancers. Speak with your primary care doctor about 
how often you should get screened for other cancers. 
D Based on your cancer, routine cancer screening is appropriate. 
D Other comments 
----------------------------------
I Late Effects of Your Cancer Treatment 
What are late effects? Late effects are those side effects that you might experience after your 
treatment has stopped. They may happen months or years after you finish treatment. Your doctors will 
work with you to monitor these side effects. Based on the treatment you received, you may be at risk 
for these possible late effects: 
• Surgery 
o Bowel problems, such as diarrhea, fecal leakage/incontinence, constipation, 
bowel obstruction, hernia, pain, colostomy, sexual dysfunction, psychological 
distress 
• Chemo/biotherapy 
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o Fatigue, peripheral neuropathy 
• Radiation 
o Fatigue, scarring, bowel obstruction, rectal or bladder irritation. 
• Other 
o Cancer recurrence or second primary cancers 
lliJilptoms to Watch Out For 
You should report these signs and symptoms to your primary care doctor or cancer doctor if persistent: 
• Blood in stool 
• Abdominal pain 
• Change in bowel habits 
• Cough that doesn' t go away 
• Bone pain 
• New lumps 
• Nausea 
• Vomiting 
• Loss of appetite 
• Weight loss 
• Fatigue 
Survivorship Care Plan Prepared by: Date: 
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Appendix N: Survivor Survey (English) 
Survey for Colorectal Cancer Survivors 
Instructions: Please rate the following questions as best you can. Please do not provide 
your name. The purpose of the survey is to help us better understand the survivorship care 
plan. There are no right or wrong answers. Your responses to this survey are confidential. 
Strongly Disagree Neither Agree Strongly 
Disagree Agree nor Agree 
Disagree 
After seeing the survivorship 
care plan, I would know exactly 
the stage of my cancer. 
After seeing the survivorship 
care plan, I would know what 
symptoms to report to my 
providers. 
After seeing the survivorship 
care plan, I would know the 
health risks that I face due to the 
cancer treatments. 
After seeing the survivorship 
care plan, I would know what to 
do to manage my health risks. 
After seeing the survivorship 
care plan, I would know when 
and how often to schedule 
follow up visits with my cancer 
doctor. 
After seeing the survivorship 
care plan, I would know my 
cancer doctors ' contact 
information. 
After seeing the survivorship 
care plan, I would know to make 
an appointment with a social 
worker or patient navigator. 
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Appendix 0: Survivor Survey (Spanish) 
Encuesta Para Sobrevivientes de Cancer Colorectal 
Instrucciones: Conteste las siguientes preguntas lo mejor que pueda. Por favor, no de su 
nombre. El prop6sito de la encuesta es ayudarnos a entender mejor el plan de cuidado 
para sobrevivientes. No hay respuestas correctas o incorrectas. Sus respuestas a esta 
encuesta son confidenciales. 
Moyen En Nide De Muyde 
desacuerdo desacuerdo acuerdo, ni acuerdo acuerdo 
en 
desacuerdo 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se 
exactamente la etapa de 
mi cancer. 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se 
cuales son los sintomas 
que debo de inf6rmale a 
mis proveedores de salud. 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se 
cuales son los riesgos de 
salud que enfrento debido 
al cancer. 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se 
c6mo manejar mis 
riesgos de salud. 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se 
cuando y con que 
frecuencia debo de tener 
citas de seguimiento con 
mi medico de cancer. 
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Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se Ia 
informacion de contacto 
de mis medicos del cancer. 
Despues de ver el plan de 
cuidado para 
sobrevivientes, yo se hacer 
una cita con una 
trabajadora social o un 
navegador de pacientes. 
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Appendix P: Quality Improvement Interview Guide-Survivors (English) 
Survivorship Care Plan for Low-Income Colorectal Cancer Survivors 
Interview Guide 
Welcome interviewee as he/she arrives. 
Introductory Script 
Hello my name is (moderator name). I am a member of the study team 
from the Prevention Research Center at the Boston University School of Public Health. 
I wanted to begin by thanking you for being here today. I have invited you here today 
because I am interested in learning about your preferences regarding the content and format 
of a survivorship care plan for colorectal cancer survivors at Boston Medical Center. A 
survivorship care plan is a document that contains a patient's cancer history and 
recommendations for ongoing care after treatment ends. The information you provide us 
with today will help us create a better survivorship care plan for cancer survivors after they 
finish their cancer treatment. 
During the interview, I will be asking you a series of questions. It is important for you to 
know that there are no right or wrong answers to the questions I am asking. Therefore, I 
want to encourage you to speak openly about your thoughts and experiences. 
The interview should take less than an hour. I will be tape recording this interview because 
I want to make sure I capture your experiences accurately. 
All of your responses will be kept confidential. This means that any information we include 
in our report does not identify you. 
After the interview, we will ask you to respond to a brief survey. Filling out the survey 
will not take more than an additional 10 minutes of your time. 
Are there any questions about what I just explained? 
Okay. Let us begin. 
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Questions 
Background Questions 
Objective: To assess participant background knowledge of survivorship care plans. 
A survivorship care plan is a document that contains a patient's cancer history (e.g., your 
cancer type) and recommendations for care after treatment ends (e.g., schedule of tests). 
1. What do you think about Boston Medical Center providing cancer patients with a 
survivorship care plan after they finish treatment? 
2. Have you heard of a survivorship care plan? 
Probe: If yes, what have you heard about them? 
3. Have you ever received one? 
Content and Format of Survivorship Care Plans 
Objective: To assess understandability of the survivorship care plan 
I am going to show you an example of a survivorship care plan called Journey Forward. 
This survivorship care plan is based on a fictitious patient with colorectal cancer. Please 
take a few minutes to read it and review it. (Approximately 10 minutes) 
4. What are your initial thoughts on the Journey Forward Survivorship Care Plan? 
5. Let's go through each section of the Journey Forward Survivorship Care Plan: 
Probes: What does this mean to you? 
Can you explain this section in your own words? 
6. Is it the survivorship care plan easy to understand? 
Probes: What makes it easy to understand? 
What makes it difficult to understand? 
Objective: To assess informativeness of the survivorship care plan 
7. Let's go through each section of the Journey Forward Survivorship Care Plan: 
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Probes: Is this section helpful to you? 
What do you like about it? 
What don't you like about it? 
What do you think about the information (content) included in this 
section? · 
What information do you think is missing from the survivorship care plan? 
What changes would you recommend? 
8. Would you find something like this helpful for yourself? 
Probes: If no, why not? 
If yes, how would this be helpful? 
How would you use the survivorship care plan? 
Objective: To assess readability of the survivorship care plan 
9. Is the information presented in a way (format) that helps you understand it? 
Probes: What do you think about how the survivorship care plan is 
organized? 
Is it easy to read? 
10. What do you think about the format of the survivorship care plan? 
Probes: What recommendations do you have for formatting or organizing 
the survivorship care plan? 
11. What do you think about the words, subheadings, and phrases that were used? 
Probes: Are the headings in each section clear and easy to understand? 
12. What do you think about the length? 
13. Did you think the amount of information was too much, too little? 
Objective: To obtain feedback on the Summary Page of the survivorship care plan 
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We have created another document that would serve as a cover page to the Journey 
Forward Survivorship Care Plan. Please take a few minutes to read it and review it. 
(approximately 5 minutes) 
14. What do you think about including a summary page that contains a checklist of 
the top 5 things that cancer survivors need to do after treatment ends? 
15. What do you think should be included on this summary page? 
Probes: What do you think is missing from the summary page? 
16. What do you think about the format of the summary page? 
17. What do you like about it? 
18. What don't you like about it? 
19. What do you think about the wording? 
20. Would this cover sheet be useful to you? 
Objective: To assess delivery of survivorship care plans 
21. Who would you think should review the information in the survivorship care plan 
with you? 
22. When do you think it would be the best time to receive a survivorship care plan? 
Probes: Before treatment ends? 
After treatment ends? 
Who do you think should get a copy? 
23. What are your thoughts on the survivorship care plan only being available in 
English? 
Concluding Questions 
24. What suggestions do you have to improve the survivorship care plan? 
25. Is there anything else you think I should know to better understand your thoughts 
on this survivorship care plan? 
247 
Wrap-Up 
Thank you for all the information and thoughts you've shared. The information you 
provided will be very valuable in helping us to develop survivorship care plans for cancer 
survivors. Please take a few minutes to complete the survey. 
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Appendix Q: Quality Improvement Interview Guide-Survivors (Spanish) 
Plan de Cuidado Para Sobrevivientes de Cancer Colorectal Con Bajo Ingreso 
Guia de Entrevista 
Darle la bienvenido al entrevistado cuando el I ella llega. 
Guion de Introducci6n 
Hola Sr. /Sra. . Mi nombre es y estoy con el Prevention 
Research Center de Boston University School of Public Health. 
Queria empezar por dandole las gracias por estar aqui hoy. Le he invitado hoy aqui, porque 
estoy interesada en aprender acerca de sus preferencias con respecto al contenido y el 
formato de un plan de cuidado para sobrevivientes de cancer colorectal en Boston Medical 
Center. Un plan de cuidado para sobrevivientes es un documento que contiene el historial 
medico de un paciente de cancer y recomendaciones para el seguimiento de su cuidado 
despues que el tratamiento termine. 
Durante la entrevista, le hare una serie de preguntas. Es importante que usted sepa que no 
hay respuestas correctas o incorrectas. Por lo tanto, quiero que usted hable abiertamente 
acerca de sus pensamientos y experiencias. 
La entrevista debe de to mar menos de una hora. Yo estara grabando esta entrevista porque 
quiero capturar sus experiencias con precision. 
T odas sus respuestas seran confidenciales. Esto significa que nos aseguraremos de que no 
sea identificado en cualquier informacion que se incluya en el informe. 
Despues de la entreviste, le pediremos que responda a un breve cuestionario. El 
cuestionario tomara menos de 10 minutos en contestar. 
L,Hay alguna pregunta acerca de lo que acabo de explicar? 
Bueno. Comencemos. 
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Preguntas 
Preguntas Introductorias 
Objetivo: Evaluar el conocimiento de los participantes acerca del plan de cuidado para 
sobrevivientes. 
Un plan de cuidado para sobrevivientes es un documento que contiene el historial medico 
de un paciente de cancer (ej. tipo de cancer) y recomendaciones para el seguimiento de su 
cui dado despues que el tratamiento termine ( ej. calendario de examenes de seguimiento) 
1. 1.., Que piensa usted acerca de Boston Medical Center dandole a los pacientes de 
cancer un plan de cuidado para sobrevivientes despues de terminar el tratamiento? 
2. 1..,Has oido hablar de un plan de cuidado para sobrevivientes? 
Sondas: Si es asi, 1..,que has escuchado acerca de ellos? 
3. 1..,Alguna vez has recibido uno? 
Contenido y Formato del Plan de Cuidado para Sobrevivientes 
Objetivo: Evaluar Ia comprensibilidad de un plan de cuidado para sobrevivientes 
Te voy a mostrar un ejemplo de un plan de cuidado para sobrevivientes llamado Travesia 
Hacia Delante (Journey Forward). Este plan de cuidado para sobrevivientes esta basado 
en un paciente ficticio que tiene cancer colorectal. Por favor t6mese algunos minutes para 
leerlo y revisarlo. (Aproximadamente 10 minutes) . 
4. 1..,Cuales son sus pensamientos iniciales sobre el plan de cuidado para 
sobrevivientes llamado Travesia Hacia Delante? 
5. Vamos a revisar cada secci6n del plan de cuidado para sobrevivientes: 
Sondas: (,Que signi:fica esto para ti? 
1..,Puedes explicar esta secci6n en sus propias palabras? 
6. 1..,Es facil de entender el plan de cuidado para sobrevivientes? 
Sondas: 1..,Que hace que sea facil de entender? 
1.., Que hace que sea dificil de entender? 
Objetivo: Evaluar !a capacidad informativa del plan de cuidado para sobrevivientes 
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7. Vamos a revisar cada seccion del plan de cuidado para sobrevivientes: 
Sondas: Esta seccion, i_,es de ayuda para usted? 
(,Que te gusta de esta seccion? 
(,Que note gusta de esta seccion? 
(,Que piensa usted acerca de la informacion ( contenido) incluida en 
esta seccion? 
(,Que informacion crees que falta en el plan de cui dado para 
sobrevivientes? 
i., Que cam bios recomendarias? 
8. i_,Encontrarias algo aside ayuda para usted? 
Sondas: Sino, worque no? 
Si es asi, (,como podria ser esto de ayuda para usted? 
(,Como usarias el plan de cui dado para sobrevivientes? 
Objetivo: Evaluar Ia legibilidad del plan de cuidado para sobrevivientes 
9. i_,Esta la informacion presentada en una manera (formate) que le ayuda a 
entenderlo? 
Sondas: (,Que piensa usted acerca de como esta organizado el plan de 
cuidado para sobrevivientes? 
i_,Es facil de leer? 
10. (,Que piensa usted acerca del formate del plan de cuidado para sobrevivientes? 
Sondas: (,Que recomendaciones tiene usted para mejorar el formato o la 
organizacion del plan de cuidado para sobrevivientes? 
11. (,Que piensa usted ace rca de las palabras, subtitulos, y frases que se utilizaron? 
Sondas: Los titulos de cada seccion, i_,son claros y facil de entender? 
12. i.,Piensas que la seccion esta muy larga o muy corta? 
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13. i,Piensa usted que la informacion incluid~ en la seccion es mucha o muy poca? 
Objetivo: Obtener informacion sabre Ia pagina de resumen del plan de cuidado para 
sobrevivientes 
Hemos creado otro documente que servini como una pagina delantera para el plan de 
cuidado para sobrevivientes llamado Travesia Hacia Delante. Por favor tomese algunos 
minutos para leerlo y revisarlo. (Aproximadamente 5 minutos). 
14. l,Que piensa usted acerca de la inclusion de una pagina de resumen que contiene 
una lista de las 5 cosas que sobrevivientes de cancer deben de hacer despues que 
terminan el tratamiento? 
15. l,Que crees que se debe de incluir en esta pagina de resumen? 
Sondas: l,Que crees que hace falta en esta pagina de resumen? 
16. i,Que piensas sobre el formato de la pagina de resumen? 
17. i, Que te gusta? 
18. i, Que no te gusta? 
19. i, Que piensa usted acerca de las palabras y frases? 
20. Esta pagina de resumen, i,le ayudaria? 
Objetivo: Evaluar Ia entrega del plan de cuidado para sobrevivientes 
21. i, Qui en crees que deberia de revisar la informacion del plan cui dado para 
sobrevivientes con usted? 
22. i,Cuando crees que seria el mejor momento para recibir un plan cuidado para 
sobrevivientes? 
Sondas: i,Antes que termine el tratamiento? 
i,Despues que termine el tratamiento? 
l,Quien crees que deberia obtener una copia? 
23. El plan de cui dado para sobrevivientes solo esta disponible en Ingles. i, Cuales son 
sus pensamientos sobre esto? 
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Preguntas Finales 
24. l,Que sugerencias tiene para mejorar el plan de cuidado para sobrevivientes? 
25. i,Hay algo mas que usted cree que debo de saber para entender mejor sus 
pensamientos sobre el plan de cuidado para sobrevivientes? 
Conclusion 
Gracias por toda la informacion y todo lo que ha compartido. La informacion que nos 
proveiste sera muy valiosa para ayudarnos a desarrollar un plan de cuidado para 
sobrevivientes. Por favor tome algunos minutos para completar la encuesta. 
253 
Appendix R: Quality Improvement Interview Guide-Providers 
Primary Care Physician and Oncology Care Team 
Survivorship Care Plan Interview Guide 
Welcome interviewee as he/she arrives. 
Introductory Script 
Hello . Thank you for taking the time to meet with me today. My name is 
_______ and I am with the Prevention Research Center at the Boston University 
School of Public Health. 
I have invited you here today because I am interested in learning about your preferences 
regarding the content and format of a survivorship care plan for colorectal cancer survivors 
at Boston Medical Center. A survivorship care plan is a document that contains a patient' s 
cancer history and recommendations for ongoing care after treatment ends. The 
information you provide us with today will help us create a better survivorship care plan 
for cancer survivors after they finish their cancer treatment. 
During the interview, I will be asking you a series of questions. It is important for you to 
know that there are no right or wrong answers to the questions I am asking. Therefore, I 
want to encourage you to speak openly about your thoughts and experiences. 
The interview should take less than half an hour. I will be tape recording this interview 
because I want to make sure I capture your experiences accurately. 
All of your responses will be kept confidential. This means that any information we include 
in our report does not identify you. 
Are there any questions about what I just explained? 
Okay. Let us begin. 
254 
Background Questions 
Objective: To assess participant background knowledge of survivorship care plans and 
obtain information on the delivery of survivorship information at the cancer center. 
A survivorship care plan is a document that contains a patient's cancer history (e.g. , 
cancer type) and recommendations for care after treatment ends (e.g., surveillance 
schedule). 
1. What do you think about Boston Medical Center providing their patient's with a 
survivorship care plan? 
2. Have you heard of a survivorship care plan? 
Probe: If yes, what have you heard about them? 
3. Have you ever created a survivorship care plan for a patient? 
4. Have you ever received a survivorship care plan for a patient? 
Content and Format of Survivorship Care Plans 
Objective: To assess understandability of the survivorship care plan 
I am going to show you an example of a survivorship care plan called Journey Forward. 
This survivorship care plan is based on a fictitious patient with colorectal cancer. Please 
take a few minutes to read it and review it. (Approximately 10 minutes) 
5. What are your initial thoughts on the Journey Forward Survivorship Care Plan? 
6. Let's go through each section of the Journey Forward Survivorship Care Plan: 
Probes: What does the information mean to you? 
Is the information easy for you to understand? 
7. Would it be easy for your patients to understand? 
Probes: What makes it easy to understand? 
What makes it difficult to understand? 
8. How do you think this survivorship care plan should be structured for: 
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a. Low income cancer survivors? 
b. Racial/ethnic populations? 
c. Patients who speak multiple languages? 
d. Primary care providers? 
Objective: To assess informativeness of the survivorship care plan 
9. Let's go through each section of the Journey Forward Survivorship Care Plan: 
Probes: Would this section be helpful to you? 
Would this section be helpful to your patients? 
What do you like about it? 
What don't you like about it? 
What do you think about the information (content) included in this 
section? 
What information do you think is missing from the survivorship care plan? 
What changes would you recommend? 
10. Would you find something like this helpful for yourself? 
Probes: If no, why not? 
If yes, how would this be helpful? 
How would you use the survivorship care plan? 
Objective: To assess readability of the survivorship care plan 
11. Is the information presented in a way (format) that would help you understand it? 
Probes: What do you think about how the survivorship care plan is 
organized? 
Is it easy to read? 
12. Is the information presented in a way that (format) would help your patients 
understand it? 
13. What do you think about the format of the survivorship care plan? 
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Probes: What recommendations do you have for formatting or organizing 
the survivorship care plan? 
14. What do you think about the words, subheadings, and phrases that were used? 
Probes: Are the headings in each section clear and easy to understand? 
15. What do you think about the length? 
16. Did you think the amount of information was too much, too little? 
Objective: To assess the two page summary sheet for cancer patients 
We have created another document that would serve as a cover page to the Journey 
Forward Survivorship Care Plan. Please take a few minutes to read it and review it. 
(approximately 5 minutes) 
17. What do you think about including a summary page that contains a checklist of 
the top 5 things that cancer survivors need to do after treatment ends? 
18. What do you think should be included on this summary page? 
Probes: What do you think is missing from the summary page? 
19. What do you think about the format of the summary page? 
20. What do you like about it? 
21. What don't you like about it? 
22. What do you think about the wording? 
23. Would this cover sheet be useful for cancer patients? 
Objective: To assess delivery of survivorship care plans 
24. Who do you think should be responsible for creating the survivorship care plan 
for patients? 
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25. How would this plan be created and deliver for patients who do not speak 
English? 
26. How long do you think should be sent creating the survivorship care plan? 
27. Who would you think should review this with your patient? 
28. When do you think it would be best to deliver this plan to the patient? 
Probes: Before treatment ends? 
After treatment ends? 
Who do you think should get a copy? 
What if this were online? 
29. How do you think the survivorship care plan should be delivered to primary care 
physicians? 
30. How do you suggest Boston Medical Center implement the survivorship care 
plan? 
31. What do you foresee as barriers to the implementation of survivorship care plans? 
Concluding Questions 
32. What suggestions do you have to improve the survivorship care plan? 
33. Do you think this survivorship care plan would help meet the needs of cancer 
survivors and primary care physicians at Boston Medical Center? 
34. Is there anything else you think I should know to better understand your thoughts 
on this survivorship care plan? 
Wrap-Up 
Thank you for all the information and thoughts you've shared. Your advice will be very 
valuable in helping us to develop survivorship care plans for cancer survivors. Please take 
a few minutes to complete the survey. 
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Appendix S: Training Slides 
Survivorship Care Plan: 
Plan for Implementation 
Toolkit Training PowerPoint 
Agenda 
-~----------------------· • Overview of Training Objectives 
• Module 1: Challenges facing the cancer survivor population 
• Module 2: Overview of survivorship care plans 
• Module 3: BMC Survivorship Care Plan Template 
• Module 4: Preparing and delivering the survivorship care 
plan 
• EPIC Demonstration 
• Special considerations for delivering the survivorship care 
plan to low-income cancer survivors 
• Questions and Answers 
Training Objectives 
-~----------------------· • Provide you with a basic understanding of survivorship 
and survivorship care plans. 
• Describe how BMC can meet the Commission on 
Cancer accreditations standards. 
• Provide you with the support and tools you need to 
prepare and deliver survivorship care plans to patients 
and primary care providers. 
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Module 1: 
Challenges facing the cancer survivor 
population 
Who is a Cancer Survivor? 
A cancer suNivor can by any person who: 
• Has been diagnosed with cancer 
• Has finished cancer treatment and is considered cancer free 
• Has lived cancer free for 5 years after diagnosis 
Source: Feuerstein, M. Defining cancer survivorship. J. Cancer Surviv. Res. Pract. 1, 5--7 (2007). 
Cancer Survivors: Growing Population 
• 13.7 million cancer survivors in the U.S. 
• 8% African American 
• 4% Ethnic minorities 
• 344,400 survivors in MA 
• Most common cancers in men are prostate, colorectal , and 
melanoma. 
• Most common cancers in women are breast, uterine corpus, 
and colorectal. 
• 64% diagnosed >5 years ago 
American Cancer Society. C.ncet" Fects & F!g.n$ 2012. AltarU, GA: American cancer Society; 2012 
MA BRFSS C. til . Available at: http:J;........w,mau.govtaohhllconaumerlco~ity-haalthlbrflll 
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Cancer Patients at BMC 
• 55.4% of the 2,487 cancer patients are minorities 
- 44.5% Caucasian 
- 40.7% Black 
- 11 .7% Latinos 
• 57.3% of cancer patients are women 
• BMC serves a large immigrant population from 
Africa, the Caribbean, Mexico, and Central and 
South America. 
What is the problem? 
-~------------------------
"Being cancer free is not the same as being free 
of cancer'' 
-Julia Rowland , PhD 
Director, NCI OITice of Cancer Survivorship 
Physical Consequences 
• Chronic Pain 
• Fatigue 
• Sexual dysfunction 
• Infertility 
• Cancer recurrence 
• Second Malignancies 
• Osteoporosis 
• Heart, kidney, and liver problems 
Hewitt. M., Greenfield, S .• StovaU, E. (2006). From C.ncer Patient to Cancer Survivor. l ost in Transition. Wuhington, 
D.C.: 1be Nation~~! Press 
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Psychological Consequences 
-~----------------------· 
• Distress 
• Depression 
• Fear of recurrence 
• Self-esteem/body issues 
• Isolation/loneliness 
• Uncertainty about the future 
Hewitt, M , Greenfield, S., Stovall, E. (2006). From Cancer Patient to Cancer Survivor: Lon in Trarui tion. Wuhington, 
D .C.: The National Press 
Social/Practical Concerns 
-~----------------------· 
• Employment 
• Insurance 
• Financial 
• Information needs 
• Problems with relationships 
Hewitt, M, Greenfield, S., Stovall, E. (2006). From Cancer Patient to Cancer Survh·or: Lost in Transition. Washington, 
D.C. : The Na!ioool Press 
Spiritual Issues 
• Finding new meaning 
• Appreciation of life 
• Sense of purpose 
Howitt, M , G reenfield, S. , Stov&dl , E. (2006). From Cancer Patient to Cancer Survivor: Loll in Transition. Wuhinglon, 
D.C. : ThcNatioi'UI.lPreu 
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Consequences of Cancer Treatment 
Vary by Survivor 
-~----------------------Long term and late effects varv by: 
• Cancer type (e.g., breast, colon) 
• Types of treatment (e.g .. , radiation , chemotherapy) 
• Stage of the disease 
• Age of treatment 
• Genetic vulnerability 
Hewitt, M., Greenfield, S., Stovall , E. (2006). From C1noer Patient to C.rK:er SUrvi\'Or: Lost in Tramitio n. Washington. 
D.C.: The Nat ional Press 
What can we do? 
Use survivorship care plans to improve a cancer 
survivor's care and help avert some of the 
consequences of cancer treatment. 
-~----------------------
Module 2: 
Overview of survivorship care plans 
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What is a Survivorship Care Plan? 
• A patient summary of the treatment received and plan 
for follow-up (e.g., schedule for visits and testing) 
• Communication tool between oncologist, primary care 
provider, and patient 
• Education document for survivors, 
family, and other providers 
, 
• Provided to patients and primary ., 
care providers 
Hewitt , M., Greenfie ld, S., Stovall , E. (2006). From Cancer Patient to Cancer Survivor: 
Lon in Traruition. Washington, D.C.: The Nat i on:~! Press 
.. 
What does a Survivorship Care Plan 
Include? 
• Patient diagnosis, stage, and treatment summary 
• Medical care team contact information 
• Schedule for follow-up tests 
• Information on late and long-term effects 
• List of symptoms to watch out for 
• Recommendations for healthy living 
• List of support resources 
Rational for Survivorship Care Plans 
-~----------------------
• After completing cancer treatment, cancer 
survivors are "lost in transition": 
Lack of awareness of post-treatment needs and health issues 
Unaware of risk of recurrence and secondary cancers 
Unclear of the role of primary care providers and cancer care 
providers 
Feel abandoned by their cancer care team 
Want their PCP to be infonmed of their cancer care 
Hewitt, M., GrC<ln.field, S., Stovall , E. (2006). from Cucer Patient to Cancer Survivor. Lo!l in Transition. Wuhington, 
D .C.: The National Press 
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Survivorship Care is Poorly 
Coordinated 
Poor coordination is a result of: 
• Lack of evidence-based guidelines for follow-up care 
• Poor communication between the primary care provider 
and oncology care team 
• Poor communication between the patient and primary 
care provider 
• No survivorship care training for providers 
• Primary care providers not familiar with how to care for 
cancer survivors 
Hewitt, M., Greenfield, S., Stovall, E. {2006). From Cancer Patient to Cancer Survivo r: Lost in Transition. Washington, 
D.C. : The National Press 
What do we need to do? 
Bridge the Gap: 
Active Treatment ---- Survivorship Care 
Institute of Medicine Recommendations 
-~----------------------
10M and President's Cancer Panel : 
Patients completing primary treatment should be 
provided with a comprehensive care summary and 
follow-up plan that is clearly and effectively explained 
Hewitt , M., Grtx:nfield, S., Stovall, E. (2006). From Canecr Patient to C.ncer Survivor: Lo~t in Transition. Washington, 
D .C .: The Nationa.l Press 
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Commission on Cancer: New Standards 
-~----------------------• By 2015, survivorship care plans must be provided to all cancer patients upon completion of treatment. 
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Potential Benefits of Survivorship Care 
Plans 
............................ 
• Cancer survivors are better informed of the post-treatment care 
• Cancer recurrence and secondary cancers can be caught earlier 
• Late and long-term effects can be prevented and/or managed in a 
timely manner 
• Psychosocial distress can be addressed 
• Can enhance communication between patient and primary care 
provider 
• Can help the primary care provider feel more comfortable in caring 
for the survivor 
Module 3: 
Introduction to the BMC Survivorship Care 
Plan Template 
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Summary Page Overview 
• Serves as a cover page 
• Provides brief snapshot of cancer treatment and steps for 
follow-up care 
• Written at a 5th grade reading level 
• Available in English and Spanish 
• One page in length 
Summary Page Components 
• Summary of your cancer treatment 
Date of diagnosis 
Type of cancer 
Stage of the cancer and what this means 
Major cancer treatment received 
Cancer treatment dates 
What out for new symptoms or other health 
• See your cancer doctor for follow-up visits and tests 
Talk to your primary care doctor about getting regular cancer screenings 
• Talk to your primary care doctor about maintaining healthy habits 
• Know who to call for your care 
Journey Forward Survivorship Care Plan 
-~----------------------· • Based on the American Society of Clinical Oncology follow-up guidelines. 
Templates available for colorectal , \ ==~-=·-: · 
breast, prostate, and lung. ·::::.-=.-::::::-·---
• Preferred by patients and providers 
due to its simplicity, format, and 
content. 
• Available for free, download at 
www.journeyforward.org I 
Journey Forward. Guiding survivors as they move ahead. Available at www.journeyforward.org. 
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-·--·- J 
Adapted Journey SCP 
• Adapted for low-income colorectal cancer 
survivors . 
• Quality Improvement projected conducted with 
8 survivors, 5 primary care providers, and 13 
oncology team members at BMC. 
Elements of Adapted Journey SCP 
.... .................... .. 
• Patient information 
• Medical care team contact information 
• Surgery (details of surgical treatment) 
• Chemotherapy (details of chemotherapy 
treatment) 
• Radiation (details of radiation treatment) 
Elements of Adapted Journey SCP 
.. Cont. ... 
Patient needs/concerns (identified by the patient 
in consultation with the provider) 
• Recommended follow-up tests for your cancer 
• Recommended general cancer screenings 
• Late effects of treatment 
Symptoms to watch for 
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Module 4: 
Preparing and Del ivering the Survivorship Care 
Plan 
Who will prepare the BMC SCP? 
• Trained survivorship professionals will prepare 
the BMC Survivorship Care Plan. This may 
include a combination of: 
Patient navigator 
Social worker 
Nurse 
Nurse practitioner 
Oncologist 
Radiation oncologist 
Surgeon 
How will the BMC SCP be 
• Created? 
BMC SCP template will be available on EPIC 
BMC SCP can be completed on EPIC 
Some of the patient data will automatically populate (e.g., 
patient contact information , medical care team contacts, 
stage of disease, type of cancer). 
Some of the data will need to be manually inputted (type of 
treatment received) 
BMC SCP can be sent to PCP's via EPIC 
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-Process for Preparing & Delivering 
the BMC SCP 
Example 
• Patient navigator gathers and inputs the data in 
the BMC SCP prior to the survivor's last treatment 
visit. 
• Primary oncology provider (e.g. , oncologist, 
radiation oncologist or surgeon) reviews the 
information in the BMC SCP for accuracy . 
• Primary oncology provider reviews the SCP with 
the survivor at the last treatment visit or at the 3 
month follow-up visit. 
Best time to deliver the BMC SCP 
-~----------------------• At the last treatment visit 
• At the 3 month follow-up visit 
• Should not exceed the 6 month follow-up visit 
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Delivering the BMC SCP to 
-
1 
Primarv Care Phvsicians 
• Send to PCP when the patient finishes cancer 
treatment (e.g ., at last treatment visit or 3 
month follow-up visit) 
• Send BMC SCP via: 
- EPIC 
- Mail (if PCP does not have access to EPIC) 
EPIC Demonstration on how to access 
and complete the BMC Survivorship Care 
Plan 
-~----------------------
Special considerations for 
delivering the BMC SCP to 
survivors with low socioeconomic 
status 
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Disparities: Survivorship Care Planning in Low-Income 
Black and Hispanic Cancer Survivors 
-~----------------------• Black and Hispanic cancer survivors bear an unequal 
burden 
Diagnosed at later stages for certain cancers 
Experience differences in treatment 
Report lower quality of life after cancer 
Are more likely to be of lower socioeconomic status 
Blacks have higher cancer mortality rates 
Haynes MA., Smedley 80. ( 1999). Cancer Survivorship· The Unequal Burden of Cancer: An Assessment of NIH 
Research Programs for Ethnic Minorities and the Medically Undcn ervcd. Wuhington. D.C.: The National Prcu 
Checklist for delivering the BMC 
SCP to Survivors with Low SES 
[J Encourage the survivor to bring a family 
member to the last treatment visit or 3 month 
follow-up visit 
[J Encourage survivor to make an appointment 
with the PCP immediately following treatment 
(schedule appointment if possible). 
[J Ensure interpreter is available in person to 
review the BMC SCP. 
Checklist for delivering the BMC 
~~ SCP to Survivors with Low SES 
o Assess and address psychosocial/mental health 
needs. 
o Provide information and referrals to a social worker 
or patient navigator. 
o Ensure the patient understand the information in the 
BMC SCP. 
o Encourage patient to ask questions or voice their 
concerns. 
272 
-~--------------------· 
Questions and Answers 
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